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Abstract 
Bacteriophages have a variety of mechanisms to escape host-encoded restriction and 
modification (R-M) systems. Bacteriophage X has a gene, nil, whose product 
alleviates restriction and enhances modification by a host encoding a type IA R-M 
system. The genes of the type IA R-M systems encode an hetero-oligomeric DNA 
methyltransferase (MTase) that together with an additional subunit forms a DNA 
endonuclease (ENase). Both enzymatic activities share a common subunit for target-
site recognition; unmodified targets are normally a good substrate for the ENase, 
whereas hemimethylated targets, those that are modified on only one strand of the 
duplex, are a good substrate for the MTase. The MTase component of the type-IA R-M 
systems are the only prokaryotic MTases shown to have a strong preference for 
hemimethylated DNA in vivo, and are also the only systems in which restriction is 
alleviated by Ral. This thesis describes an investigation of the mechanism of Ral 
activity, both in vivo and in vitro. 
Unmodified Xrat phages are restricted by bacteria expressing type IA R-M systems, 
presumably restriction occurs before the infecting phage has time to expres's the ral 
gene. In order to examine Ral activity in vivo, the degree of modification of progeny 
phages was measured after a single round of infection on a restriction-proficient strain, 
and the prediction that the progeny of nzr phages are more likely to become modified 
than rat phages was confirmed. This modification would be advantageous to those 
phages that subsequently infect bacteria with an R-M system of the same specificity. 
Interestingly, in some hosts progeny phages were similarly modified irrespective of 
their nil genotype. Some strains of E. coli contain a defective prophage, termed Rac, 
that is known to encode a Ral-like antirestriction function, Lar. The inability to detect 
Ral activity was found to correlate with the presence of the Rac prophage; presumably 
lar is expressed in a sub-population of Rack hosts. The gene encoding lar was isolated 
by cloning DNA fragments from the Rac prophage in a plasmid vector and screening 
for anti-restriction activity. In this way, lar was localised to a 500 bp DNA fragment, 
and was further defined by site-directed mutagenesis in conjunction with an analysis of 
the phenotypes of the mutants, and the polypeptides produced. The predicted amino 
acid sequences of Ral and Lar are remarkably dissimilar, although a number of 
residues do align which may indicate important features for structure and/or function. 
The i-al gene has been overexpressed and its product purified. Methylation assays, 
with purified Ral and the type IA EcoKI MTase failed to show any change in 
methylation activity in the presence of Ral. There are many reasons why no effect of 
Ral was detected, not least that the purification process may disrupt the polypeptides. 
In order to overcome these problems, similar experiments were performed using 
extracts of cells overexpressing ml and the genes encoding the EcoKJ MTase. These 
extracts, like extracts from cells producing only the MTase, methylated synthetic 
hemimethylated substrates efficiently, but only methylated unmodified substrates 
poorly. This is inconsistent with the hypothesis that Ral changes the activity of EcoKI 
from a maintenance MTase to a de novo MTase. An alternative explanation, consistent 
with present results and observations, is that Ral both blocks ENase activity and 
stimulates MTase activity. 
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A 	 adenosine 
aa amino acid 
Ab antibody 
AdoMet S-adenosyl methionine 
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ATP adenosine triphosphate 
bp base pair 
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Bacterial genes are in italics and their products start with a capital letter, e.g. the 
hsdR gene encodes HsdR. Bacteriophage genes occasionally follow different 
conventions, e.g. the ci gene. 
The nomenclature for restriction and modification (R-M) systems is according to 
Smith and Nathans (1973). 
Prophages are indicated in brackets after the host, e.g. BL21(DE3). 
The host on which a bacteriophage was last propagated is indicated after the phage 
symbol, e.g. A,.C600, X.K, and ?.O indicate, respectively, that bacteriophage X 
was grown on C600, on an EcoKJ-modifying strain and on a strain with no R-M 
system. 
Restriction and modification phenotypes are indicated with superscript negative or 
positive symbols, e.g. fin', restriction-deficient modification-proficient strain. 
Subscript letters are used to indicate the R-M system associated with the 
phenotype, e.g. rKmK,  restriction-deficient modification-proficient for EcoKI. 
xi 
Amino acids 
Amino acids Three-letter symbol Symbol 
Alartine Ala A 
Arginine Arg R 
Asparagine Asn N 
Aspartic acid Asp D 
Cysteine Cys C 
Glutamine Gln Q 
Glutamic acid Glu E 
Glycine Gly G 
Histidine His H 
Isoleucine Be I 
Leucine Leu L 
Lysine Lys K 
Methionine Met M 
Phenylalanine Phe F 
Proline Pro P 
Serine Ser S 
Threonine Thr T 
Tryptophan Trp W 
Tyrosine Tyr Y 
Valine Val V 
xii  
The genetic code 
2'" d (across) U C A G 
(down) 3rd (down) 
Phe Ser Tyr Cys U 
U Phe Ser Tyr Cys C 
Leu Ser Ochre Opal A 
Leu Ser Amber Trp G 
Leu Pro His Arg U 
C Leu Pro His Arg C 
Leu Pro Gin Arg A 
Leu Pro Gin Arg G 
Be Thr Asn Ser U 
A lie Thr Asn Ser C 
Be Thr Lys. Arg A 
Met Thr Lys Arg G 
Val Ala Asp Gly U 
G Val Ala Asp Gly C 
Val Ala Glu Gly A 
Val Ala Glu Gly G 
Chapter one: Introduction 
Historical introduction 
Observations consistent with the activity of restriction and modification (R-M) 
systems were made as early as the 1930's (Craigie and Yen, 1938), although an 
explanation based on the non-heritable, host-controlled modification of bacteriophage 
(phage) wasn't offered until the 1950's (Luria and Human, 1952; Bertani and Weigle, 
1953). Bertani and Weigle (1953) noted that phage lambda propagated on E. coli K-
12 grew on the E. coli strains K-12 and C with the same efficiency, however, phage 
propagated on E. coli C grew only poorly on E. coli K-12. Furthermore, only a single 
round of growth on E. coli C was required for the phage to plate with a low efficiency 
on E. coli K-12. 
An idea to account for the restricted growth of unmodified phage was proposed by S. 
Lederberg (1957) who suggested "an agent which .... interferes specifically with 
phage DNA. A possible candidate could be a DNase". Work done by Arber and 
colleagues in the early 1960's, identified the mechanism of host controlled 
modification. The fate of ? grown on E. coli K-12 lysogenic for phage P1 was 
followed in a single round of growth on E. coli K- 12. It was found that about the 
same number of progeny as were used for the infection carried the parental host 
specificity, ?. K (P1), and the rest were protected against restriction by E. coli K-12 
not lysogenic for phage P1. Therefore, the host-specificity of the parent is transferred 
to the progeny, but is not replicated. The link between transferred host specificity and 
parental DNA was demonstrated using deuterium-labelled DNA; labelled phages have a 
higher than normal density. Only DNA containing at least one parental strand retained 
the specificity of the parent, A.K (P 1), and non-deuterated progeny phage conferred 
the host-specificity of the most recent host, X.K. Thus, the host-controlled 
modification is carried on the phage DNA molecule (Arber and Dussoix, 1962) . 32p_ 
labelled DNA and genetic marker rescue experiments with phage X showed that the 
unmodified DNA was digested by the host cell shortly after injection of the DNA 
(Arber and Dussoix, 1962; Dussoix and Arber, 1962). Preliminary work also 
suggested that exchange of bacterial DNA might also be affected by host-specificity 
(Arber and Dussoix, 1962), and was proven using crosses between E. coli K-12 Hfr 
donors and F K-12 (P1) recipients (Arber and Morse, 1965). 
The observation that a methionine auxotroph of E. coli K- 12 starved of methionine is 
unable to confer the host-controlled modification, led Arber (1965a) to suggest that the 
host-specificity was a result of methylation of particular sites on the phage DNA. 
Arber (1965b) also proposed that host-specificity might be determined by a two 
enzyme system; one enzyme a sequence-specific DNA endonuclease (restriction 
endonuclease, ENase), cleaving unmodified DNA, and the other a DNA 
methyltransferase (MTase), altering the DNA so that it was no longer susceptible to 
cleavage. The DNA target site for the ENase and MTase were later shown to be the 
same (Vovis and Zinder, 1975). 
An ENase was identified by Takano and colleagues (1966), using cell-free extracts of 
restrictive bacteria with purified ? DNA as a substrate. They found that unmodified 
DNA was efficiently degraded by the extracts, whereas modified DNA was not. This 
confirmed the idea of 'restriction enzymes'. On this basis, ENases were purified from 
cell extracts of E. coli K-12 and B (EcoKI and EcoBI; Meselson and Yuan, 1968; Linn 
and Arber, 1968; Roulland-Dussoix and Boyer, 1969), and found to have a molecular 
mass of 400 kDa (Meselson et al., 1972). Both enzymes required ATP, S-adenosyl-
L-methionine (AdoMet) and Mg2l  to introduce a number of double stranded scissions 
in either unmodified phage or bacterial DNA. A 'simpler' restriction enzyme, Hindu, 
was purified from Haemophilus influenzae that only required Mg 2 to cleave 
unmodified DNA (Smith and Wilcox, 1970). It became clear there were at least two 
types of R-M enzymes, the simpler type-il (e.g. Hindil) and the more complex type-1 
(e.g. EcoKI and EcoBI; Boyer, 1971). As more R-M enzymes were identified, and 
another group of ATP-dependent endonucleases was found (Kauc and Piekarowitz, 
1978), the host-specificity systems were rearranged into three groups (Yuan, 1981). 
Type I R-M systems 
Genetic determinants 
The observation that bacterial DNA was susceptible to host-controlled restriction and 
modification (Dussoix and Arber, 1962) enabled Boyer (1964) to position the hsd 
locus, for host-specificity of DNA, on the E. coli chromosome by Hfr mapping. He 
found that the restriction and modification genes were linked, and that the hsd loci of 
E. coli K-12 and B were allelic. P1 transduction experiments positioned the hsd loci 
close to serB at 98.5 minutes on the E. coli chromosome (Glover and Colson, 1969). 
The first restriction deficient (r) derivatives of E. coli K-12 and B were isolated by 
Wood (1966). He found that the r mutants were either deficient or proficient in 
modifying ability, rrni7 or rm respectively. He proposed that a common gene product 
was required for both restriction and modification, which was absent in rm strains. 
Complementation studies by Boyer and Roulland-Dussoix (1969), using Hfr, 
identified three genes involved in host-controlled restriction and modification, 
subsequently termed hsdR, M and S. A mutation in hsdR resulted in the loss of 
restriction ability but not modification activity ((m). Mutations in two other genes 
abolished both restriction and modification activity (fm). No mutants were isolated 
that abolished just modification activity (rm) presumably as this would lead to auto-
restriction. The host-specificity genes of E. co/i K- 12 and B were shown to be 
sufficiently related that their gene products could complement each other. This work 
also demonstrated that the hsdS gene product was responsible for the specificity of 
both the restriction and modification activities of the system. Continuing this work 
Glover (1970) proposed that the hsdR, M and S gene products interact to form two 
oligomeric enzymes, HsdM and S forming a strain-specific modification enzyme, and 
HsdR, M and S forming a strain-specific restriction enzyme. This was supported by 
the isolation of a temperature sensitive mutation, Pm, which was mapped to hsdM, 
first by complementation studies (Hubacek and Glover, 1970) then by DNA sequence 
analysis (A. Daniel, unpublished). 
Borck and colleagues (1976) cloned the E. co/i K-12 hsdM and hsdS genes in phage 
X. Clones carrying the genes for K-specific modification were recognised as they 
grew with a high efficiency on E. co/i K-12 after propagation on a non-modifying 
host. One of these phages was then used to recover a clone containing the whole hsd 
region, following integration by homologous recombination and aberrant excision 
resulting in the formation of XhsdRMS (Sain and Murray, 1980). These were 
identified as lysogens of E. co/i C, a strain that does not possess an R-M system 
(Raleigh, 1992), that were phenotypically 	Deletion derivatives of these phages 
and complementation tests showed the gene order to be hsdR, M then S (Sain and 
Murray, 1980). 
At the beginning of the 1980's, five allelic type I R-M systems had been identified, 
EcoKI (from E. co/i K-12), EcoBI (from E. co/i B; Glover and Colson, 1969), EcoAI 
(from E. co/i 157; Arber and Wauters-Willems, 1970), StyLT1II (from S. enterica 
serovar typhimurium LT2; Van Pel and Colson, 1974) and StySPI (from S. enterica 
serovar potsdam; Bullas and Colson, 1975). DNA hybridisation studies and 
immunological methods, using antibodies against EcoKI, indicated sequence similarity 
between EcoKI, EcoBI, StyLTIII and StySPI, but none to EcoAI (Murray et al., 
1982). As more type-I R-M systems were identified (Price et al., 1987a), it became 
clear that they could be further divided on the basis of complementation analysis (Arber 
and Linn, 1969; Glover, 1970; Price et al., 1987a), DNA cross-hybridisation (Sam 
and Murray, 1980; Daniel et al., 1988), and immunological cross reactivity (Murray et 
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al., 1982). EcoKI and relatives constitute the type-IA R-M systems, EcoAI the type-
11B, and EcoR 1241 the type-IC. There is now evidence for a fourth group, type-ID, the 
first representative of which is StySBLI (from S. enterica serovar blegdam; A. 
Titheradge and N. Murray, unpublished; Barcus et al., 1995). The type IA, lB and ID 
hsd genes behave as alleles, and yet some alleles are so dissimilar that their DNA fails 
to cross-hybridise (e.g. EcoKiI and EcoM; Murray etal., 1982). Comparison of the 
nucleotide sequence of the hsd genes, has confirmed this allelic diversity. Some alleles 
of hsdR and hsdM encode polypeptides with very similar amino acid (aa) sequences, 
even when from different species e.g. 94% identity between EcoKI and StyLTffi. 
However, other alleles encode remarkably dissimilar polypeptides, irrespective of the 
host species, and retain little evidence of a common ancestry e.g. 32% identity between 
EcoKI and EcoAI (Sharp et al., 1992; Murray et al., 1993). These genes have been 
termed pseudoalleles (Sharp et al., 1992). This unusual allelic diversity is shared by a 
number of other genes that are concerned with differentiating 'self' from 'non-self, 
for example, the major histocompatibility complex class II locus of mammals and the 
self-incompatibility genes of plants. This allelic diversity indicates a strong selection 
for variation, possibly aided by the lateral transfer of short DNA segments between 
different species (Sharp et al., 1992). 
Sequence comparisons 
Sequence comparisons, between different R-M systems and sequences in the database, 
have been very useful in identifying conserved regions that may serve structural or 
functional roles. A comparison of the predicted aa sequences of the hsdR genes of 
EcoKI, EcoAIIE and EcoR124I has identified seven regions conserved among a family 
of putative helicases, the so-called 'DEAD-box' proteins (Gorbalenya and Koonin, 
1991; Murray et al., 1993). Region I is an abridged version of the 'A' component of 
the NTP-binding motif (Walker etal., 1982), and ATP is known to be both a cofactor 
and substrate in restriction by type I enzymes (Bickle et al., 1978). Region II includes 
the characteristic an sequence DExH, where x is either an A or C. Mutational analysis 
of this region indicates that H is essential for restriction by EcoKI in vivo, as either an 
N or D substitution at this position abolishes activity (G. King, D. Ternent, S. Bolton 
and N. Murray, ms in preparation). It is interesting that substituting D for H blocks 
restriction, as this is a substitution to the super-family consensus, DEAD. Mutational 
analysis of another 'DEAD-box' protein, the translational initiation factor eIF4A, 
demonstrated that activity was abolished if the DEAD motif was changed to DEAH 
(Pause and Sonenberg, 1992). Sequence comparisons, identifying all seven 
conserved motifs, have placed the DExH and DEAD-box proteins in two distinct 
groups, and all of the putative DNA helicases contain the DExH motif (Gorbalenya and 
Koonin, 1991). Two changes have been noted in the original EcoKI sequence (Sam 
and Murray, 1980; Blattner et al., unpublished; GeneBank acc. no. U14003) which 
has meant that region ifi, the SAT motif that was difficult to identify in the original 
alignments (Murray et al., 1993), has been realigned. The presence of these motifs in 
HsdR, and the preliminary analysis of mutants in the DExH motif, would indicate that 
the type I R-M systems may be ATP-dependent DNA helicases. 
A comparison of the predicted aa sequences of a range of methyltransferases has 
identified a number of conserved motifs. The sequence (DIE/S)XFXGXG, termed 
motif I, is found in all MTases that use AdoMet as the methyl donor (Klimisaukas et 
al., 1989; Pósfai et al., 1989). The co-crystal structure of HhaI MTase and AdoMet 
confirmed that these residues interact with AdoMet (Cheng et al., 1993; Klimisaukas et 
al., 1994). A second motif, motif II (NID/S)PP(YIF), is also aligned in MTases that 
methylate the N6 position of adenine, like the MTases of the type-I R-M systems, or 
the N4 position of cytosine (Klimisaukas et al., 1989; Pósfai et al., 1989; Sharp et al. , 
1992). Mutational analysis of these two motifs in EcoKI confirms that motif I is 
required to bind AdoMet. Changes have been made to motif II which don't affect 
AdoMet or DNA binding, and yet abolish enzyme activity. These results imply a role 
for motif II in the catalysis of methyl group transfer (Willcock et al., 1994). The 
sequence of HsdM that includes motif I and motif II has been aligned with the type II 
MTases, and identified a common AdoMet-binding domain (Dryden et al., 1995). The 
crystal structures of a number of type II MTases have been determined (Klimisaukas et 
al., 1994; Labahn et al., 1994) and the tertiary structure of this domain from the type I 
MTase of EcoKT, has been modelled on that of the type II enzyme, HhaI. These 
results suggest a common evolutionary origin for all MTases (Dryden et al., 1995). 
The MTases of the type IA R-M systems are the only prokaryotic MTases shown to 
have a strong preference for hemimethylated DNA in vivo. Mutants of E. co/i K-12 
have been isolated that no longer show this preference for hemimethylated DNA, and 
efficiently methylate unmodified target sites (Kelleher et al., 1991). These mutations 
are loosely clustered in hsdM, and the activity of these mutants indicate de novo 
methylation by EcoKI. 
The three type I R-M systems EcoKI, EcoBI and EcoDI recognise different DNA 
target sequences. When the nucleotide sequence of the hsdS genes from these systems 
was determined, it was apparent that although they share very similar functions, they 
are remarkably dissimilar in primary structure (Gough and Murray, 1983). Gough and 
Murray (1983) identified two highly conserved regions in the nucleotide and predicted 
amino acid sequence, flanked by variable regions that they predicted would encode the 
target recognition domains (TRDs). As the nucleotide sequence of more hsdS genes 
were determined, it became clear that this pattern of variable and conserved regions 
was common to all type I R-M systems that recognised different DNA target sequences 
(figure 1.1; for recent reviews see Bickle, 1993; Barcus and Murray, 1995). Argos 
(1985) identified a short repeat in the predicted aa sequence of EcoKI, EcoBI and 
EcoDI that overlapped the two conserved regions in HsdS. These repeats have since 
been found in all HsdS polypeptides (figure 1.1; Kannan et al., 1989), and residues in 
these regions are now believed to be involved in protein:protein interactions with 
HsdM or R (Cooper and Dryden, 1994; Kneale, 1994). 
The specificities of many of the type-I R-M enzymes have been elucidated (see table 
1.1) by identifying DNA fragments containing targets, either by the 3 H-methyl-
labelling of DNA in vitro (e.g. Nagaraja et al., 1985a) or the restriction of recombinant 
phages (e.g. Gann etal., 1987), and using computers to compare the sequence of the 
mapped fragments. The recognition sequences are asymmetric and bipartite, 
consisting of two short, defined sequence components separated by a non-specific 
spacer of fixed length. Two specific adenine residues within the recognition sequence 
are methylated (Kühnlein and Arber, 1972). The conserved position of these residues 
at 10 or 11 base pairs apart, suggest that the enzyme may bind to the DNA along one 
face of the double helix interacting with the adenine residues in two successive major 
grooves with most of the non-specific spacer sequence in the minor groove (Nagaraja 
et al., 1985b). Methylation interference footprinting, of the EcoKI MTase and DNA, 
confirmed that the base contacts are in the major groove (Powell and Murray, 1995). 
UV crosslinking of an oligonucleotide containing a substitution of thymidine with the 
photoreactive base-analogue bromodeoxyuridine, in the AAC component of the EcoKI 
recognition sequence, also demonstrated a close contact between the recognition 
sequence in the major groove of the DNA and the MTase (Chen etal., 1995). 
Proteolysis of the crosslinked complex and peptide sequencing, identified a tyrosine in 
the amino-variable domain of the HsdS subunit as the site of crosslinking, and this 
residue is conserved among type I systems that have AA in the trinucleotide component 
of their recognition sequence. 
The enzymes 
The restriction enzymes from E. coli K-12 and B (EcoKI and EcoBI) were purified in 
the mid 1960's (Meselson and Yuan, 1968; Linn and Arber, 1968; Roulland-Dussoix 
and Boyer, 1969). Enzymes were also purified from (m and (m strains of E. coli K- 
Eel 
M-1 	 VMM1110 ~ NOMME  $ E/Z - - 
Figure 1.1. Structure of the HsdS subunits. Hatched box, variable regions; open 
box, conserved regions; bars, direct repeats. 
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Type System Specificity Reference 
IA EcoKI AAC (N6 ) GTGC Kan etal., 1979 
EcoBI TGA (N8 ) TGCT Lautenberger etal., 1978 
Ravetch etal., 1978 
EcoDI 'PTA (N7 ) GTCY Nagaraja etal., 1985a 
StySPI AAC (N6 ) GTRC Nagaraja etal., 1985b 
StyLTifi GAG (N6 ) RTAYG Nagaraja etal., 1985b 
EcoR5I new Barcus etal., 1995 
EcoR101 new Barcus etal., 1995 
EcoRl 11 same as EcoBI Barcus etal., 1995 
EcoR12I same as EcoKI Barcus etal., 1995 
EcoR13I new Barcus etal., 1995 
EcoR14I same as EcoBI Barcus etal., 1995 
EcoR23I new Barcus etal., 1995 
EcoR24I same as EcoKI Barcus etal., 1995 
EcoR25I same as EcoRlO Barcus etal., 1995 
EcoR70I same as EcoBI Barcus etal., 1995 
lB EcoAI GAG (N7 ) GTCA Suri etal., 1984b 
EcoEl GAG (N7 ) ATGC Cowan etal., 1989 
StySTI unknown A. Titheradge and N. 
Murray, unpublished 
StySKI unknown D. Ternent, unpublished 
CfrAE GCA (N8 ) GTGG Kannan etal., 1989 
EcoR15I unknown Barcus etal., 1995 
EcoR17I unknown Barcus etal., 1995 
EcoR42I new Barcus etal., 1995 
IC EcoR124I GAA (N6 ) RTCG Price etal., 1987b 
EcoDXXI TCA (N7 ) RTTC Piekarowicz and Goguen, 
1986 
Ecoprrl CCA (N7 ) RTGC Tyndall etal., 1994 
ID StySBLI unknown A. Titheradge, unpublished 
EcoR9I unknown Barcus etal., 1995 
EcoR31I unknown Barcus etal., 1995 
EcoR65I unknown Barcus etal., 1995 
EcoR68I unknown Barcus etal., 1995 
Table 1.1. Type I R-M systems and their recognition sequences. 
12 and B, and found to have the in vitro properties predicted from the phenotypes of 
the strains that they were purified from (Kiihnlein et al., 1969; Hadi and Yuan, 1974). 
Further work estimated the molecular mass of EcoIU to be 400 kDa. When denatured 
the enzyme could be separated into three subunits of estimated molecular mass 135 
kDa (a), 62 kDa (3) and 52 kDa ('y). The molecular ratio was estimated to be 0j3 2y1 
(Meselson et al., 1972). Similar results were found for EcoBI, and inconsistencies 
probably reflect differences in the methods used (Eskin and Linn, 1972a). 
Lautenberger and Linn (1972) purified the MTase from E. co/i B and found it to 
possess the two smaller subunits, 0 and y, demonstrating that the large subunit, 
required for restriction, was dispensable for modification activity. Polypeptide 
analysis of ?thsdRMS, and deletion derivatives of this phage, correlated the 135 kDa 
polypeptide with hsdR, the 62 kDa polypeptide with hsdM, and the 52 kDa 
polypeptide with hsdS (Sain and Murray, 1980). The modification MTase was 
purified from E. co/i K-12 lysogenic for XhsdMS (Suri et al., 1984a) and found to 
have the same properties as the EcoBI MTase purified by Lautenberger and Linn 
(1972). A number of kinetic studies were performed on the methylation properties of 
the restriction enzyme and purified methyltransferase. It was found that the 
methylation of hemimethylated pBR322, obtained by hybridising modified with 
unmodified DNA, was much faster with both enzymes than methylation of unmodified 
DNA. For the restriction enzyme the figure is about 150 times faster, and the MTase 
35 times. 
Large quantities of the EcoKI MTase have been purified (Dryden et al., 1993), and 
used to examine the protein:protein and protein:DNA interactions in more detail. The 
subunit composition of the purified MTase is HsdM2S 1 , and a domain structure of the 
MTase has been derived from limited proteolysis experiments (figure 1.2; Cooper and 
Dryden, 1994). The purified EcoKI MTase has the expected preference for 
hemimethylated DNA substrates (Dryden et al., 1993), but this preference can't be 
explained by differences in the binding affinity of the MTase for unmodified or 
hemimethylated oligonucleotides that contain the EcoKlE target site (Powell et al., 
1993). However, differences are detected by the methylation interference footprinting 
of EcoKJ MTase with DNA of different methylation states (Powell and Murray, 1995). 
In the presence of the cofactor, AdoMet, there is no interference outside of the 
recognition sequence with an unmodified oligonucleotide, but the interference extends 
into the non-specific, spacer-sequence when the target is hemimethylated. Powell and 
Murray (1995) conclude that whether EcoKI restricts or modifies is determined by 
conformational changes in the enzyme, dependent on the methylation state of the DNA 
Figure 1.2. A representation of the domain structure of the EcoKI MTase. Hatched 
circles, variable regions of HsdS; open box, conserved regions of HsdS; Stippled 
objects, HsdM domains; N, amino-terminal domain; C, carboxyl-terminal domain. 
Motif I is in the N-terminal domain of HsdM, and motif II is in a short exposed loop 
between the N and C-terminal domains. The C-terminal domain of HsdM contacts the 
HsdS subunit, and there is a 'tail' that is sensitive to the methylation state of the DNA 
(cooper and Dryden, 1994; Willcock et al., 1994). 
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and the presence of AdoMet. This is detected in changes in the DNA:protein interface 
with the MTase and AdoMet, and supports the hypothesis that the cofactor is used to 
communicate the methylation state of the DNA to the enzyme (Burckhardt et al., 
1981b; Powell and Murray, 1995). 
Reaction mechanism 
Some of the features of the reaction mechanism for EcoKI and EcoBI have been 
elucidated in vitro (Burckhardt et al., 1981 a). 
EcoKI rapidly binds AdoMet. 
EcoKJ-AdoMet undergoes a slow transition to an activated form, EcoKiI*,  which 
continues to have AdoMet bound (Hadi et al., 1975). 
EcoKP forms a non-specific complex with the DNA. 
If the EcoKI recognition site is present on the DNA a more stable complex is 
formed (Yuan et al., 1975). 
Depending on the methylation state of the target sequence, one of several things 
can happen: 
. With a fully methylated site and ATP, the enzyme is released. 
• If the site is hemimethylated, the unmethylated adenine is rapidly methylated. 
This occurs some 150 times faster than the methylation of an unmodified target 
sequence (Suri et al., 1984). ATP and Mg2 stimulate methylation by the 
restriction enzyme (Vovis et al., 1974), however, ATP does not stimulate the 
activity of the EcoKJ methylase (Sun et al., 1984), nor is Mg2 required for 
DNA binding or methylation (Powell et al., 1993; G. King, unpublished). 
• If the target site is unmodified, ATP induces the transition of Ec0KJ*  to 
EcoKr. This form has lost AdoMet and shows a decrease in diameter, 
possibly due to rearrangements in the subunits of the complex (Bickle et al., 
1978; Burckhardt et al., 1981a). The DNA is then translocated past the 
enzyme in an ATP-dependent reaction (Yuan et al., 1980; Rosamond et al., 
1979), followed by the formation of a single-stranded, then double-stranded 
break in the DNA at a non-specific site (Murray et al., 1973a; Meselson and 
Yuan, 1968). The enzyme does not turn over in the cleavage reaction, but it is 
still an active ATPase after DNA cutting is complete (Eskin and Linn, 1972b). 
A model for the cleavage of DNA by EcoKT has been postulated (Burckhardt et al., 
198 lb). The HsdS subunit binds weakly to the recognition sequence, along the minor 
groove. AdoMet binding to HsdM induces a conformational change in the enzyme, 
and the methyl groups of AdoMet would be used to probe the methylation state of the 
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target bases in the major groove. If the DNA was fully modified, the two HsdM 
subunits would not be able to enter the major grooves of the DNA, due to steric 
hindrance from the methylated adenines, and thus remain in an open configuration, 
EcoKIk .  If the DNA was hemimethylated , that is with only one methylated adenine 
residue in the recognition sequence, then one of the HsdM subunits would be able to 
bind to the major grove at the unmodified site. This would result in a partially open 
conformation, EcoK1, and methylation would occur at this site. With unmodified 
DNA, both HsdM subunits would be able to bind to the unmethylated sites and result 
in the formation of a closed conformation, EcoK°, in which the two HsdR subunits 
form a functional restriction complex. In contradiction of this model, the footprinting 
results of Powell and Murray (1995) show that the EcoKI MTase binds to the major 
groove of the DNA. The HsdM subunits could still methylate the adenine in the major 
groove if the base was 'flipped' out of the DNA helix, as has been shown for the type 
II MTase, HhaI (Klimisaukas et al., 1994). In vitro and in vivo results suggest that 
the restriction enzyme bound at the recognition sequence translocates DNA towards 
itself, from both directions, and when two enzymes collide they cut the DNA between 
them (Brammar et al., 1974; Endlich and Linn, 1985; Studier and Bandyopadhyay, 
1988). It has been demonstrated that the EcoKI MTase is able to distinguish the 
methylation state of the target DNA (Sun et al., 1984a; Dryden et al., 1993), thus it 
must be the interaction of the HsdM and S subunits with the DNA target sequence that 
determines the enzymatic action of the complex. 
Evolution of new specificities 
Changes in the specificity of type I R-M systems have been observed in the laboratory, 
both serendipitously, involving homologous recombination, unequal crossing over and 
transposon insertion, or by design using recombinant DNA techniques. The R-M 
system StySQ was the outcome of P1-mediated transduction between two strains with 
different type IA R-M systems (Bullas et al., 1976). StySQ was shown to have arisen 
by homologous recombination between the hsdS central conserved regions of StySPI 
and StyLTIII (figure 1.3a; Fuller-Pace et al., 1984), and the sequence recognised by 
the recombinant system comprised one component of each parental system (Nagaraja et 
al., 1985a; 1985b). An R-M system that recognised the other components of the 
parental systems, StySJ, was similarly isolated after recombination in vivo (Gann et 
at., 1987). These experiments demonstrated that there were two target recognition 
domains, TRDs, one in each half of HsdS, that could be reassorted to generate novel 
DNA specificities. Cowan and colleagues (1989) further defined the target recognition 
domains by using site directed mutagenesis to generate a hybrid system, StySQ*, 
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Figure 1.3. Evolution of new specificities by rearrangements in hsdS. (a) 
Exchange of regions in hsdS identifies two target recognition domains (TRDs) 
corresponding to the two variable regions. (b) Increasing the length of the central 
conserved region, between the TRDs, can also increase the length of the non-specific 
'spacer' sequence in the DNA target. (c) A type I R-M system may be isolated with 
only one kind of TRD. See text for more details. Shading indicates origin of regions 
of HsdS; hatched box, variable region; open box, conserved region; open arrows, 
amino-terminus; filled arrows, repeats; R, purine; Y, pyrimidine; N, any base. 
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(a) 	 HsdS subunit 
	
Enzyme 	Specificity 
GAG (N6) RTAYG 
AAC (N6) GTRC 
AAC (N6) RTAYG 
GAG (N6) GTRC 
AAC (N6) RTAYG 
(b) 
EcaRl24l GAA (N6) RTCG 
EaR124II GAA (N7) RTCG 
EcODXX) 	TCA (N8) AlTO 
EcoDXXsI TCA (N6) TGA 
(c) 
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containing only the HsdS N-terminal variable domain of StySPI and the remaining 
sequence of StyLTIII. StySQ*  recognises the same target sequence as StySQ, 
demonstrating that the N-terminal variable domain is all that is required to specify one 
half-site in the recognition sequence (figure 1.3a). By analogy the C-terminal variable 
domain recognises the other component (Cowan et al., 1989). The same conclusions 
may be drawn from similar experiments that have been performed on the type IC R-M 
systems, EcoR124I and EcoDXXI (Gubler etal.,1992). 
A second R-M system, EcoR 12411, has been isolated that appears to have arisen by 
unequal crossing over between the central conserved regions of two hsdS genes from 
EcoR124I (Price etal., 1989). Recombination lead to an extra 12 bp repeat in the 
hsdS central region of EcoR 12411, compared to EcoR 1241, and the two components of 
the recognition sequence are separated by an extra nucleotide (figure 1.3b). Again, 
similar results have been achieved with EcoDXXI (Gubler and Bickle, 1991). 
Type I R-M systems have been isolated with only one TRD, either as a result of 
transposon insertion (Meister etal., 1993), or mutagenesis (Abadjeva et al., 1993). In 
both cases, the R-M system recognises a symmetrical sequence consisting of two half 
sites, each a single component of the recognition sequence from the parental system 
(figure 1.3c). These recognition sequences are consistent with two truncated HsdS 
subunits being required for DNA recognition, rather than the usual one. 
The repeated sequences in hsdS, the primary structure of it's product, and the isolation 
of a type I R-M system with only one TRD, all indicate that hsdS may have arisen by 
the duplication of a gene encoding only one TRD (Argos, 1985; Kannan etal., 1989). 
This duplication is most apparent in the lB family, in which repeated sequences are 
particularly well conserved (Kannan etal., 1989). 
Type II R-M systems 
The type-11 R-M systems are the simplest of the three classical systems. They have 
been defined as double-stranded endonucleases that recognise specific DNA sequences 
and cleave at a defined point within or close to that sequence (Roberts and Halford, 
1993). The first type II ENase was purified in the late 1960's (Kelly and Smith, 1970; 
Smith and Wilcox, 1970), although it was later shown to be a mixture of two 
enzymes, Hindil and Hindffl (Old etal., 1975). The use of type II ENases in the 
development of recombinant DNA technology meant that by the mid 1970's over 40 
enzymes had been identified (see Roberts, 1976), and there are currently more than 
2400 (Roberts and Macelis, 1993). 
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Most type H R-M systems consist of two separate enzymes with separate activities. 
The res gene encodes a Mg2 -dependent site-specific DNA endonuclease. The mod 
gene encodes a AdoMet-dependent DNA methyltransferase that modifies the same 
sequence, either at the N 4 or N5 position of cytosine, or the N6 position of adenine. As 
expected, the res and mod genes have always been found linked, and efficient cloning 
strategies have been developed that take advantage of this (Lunnen et al., 1988). The 
genes encoding type II R-M systems are found on both bacterial plasmids and 
chromosomes, and the nucleotide sequence for about 60 systems is now known 
(Roberts and Halford, 1993). Interestingly, no aa similarity is seen between the res 
and mod gene products of any cognate systems (Chandrasegaron and Smith, 1988; 
Roberts and Halford, 1993). This lack of similarity may be because the ENase and 
MTase of the systems examined recognise the DNA target in different ways; the ENase 
is normally a dimer and each subunit need only recognise half the recognition 
sequence, whereas the MTase acts as a monomer and must, therefore, recognise the 
complete sequence (Wilson and Murray, 1991). 
The crystal structure of a number of type II ENases and MTases, either free or 
complexed with DNA, are now known. These include EcoRI (complexed with DNA; 
Kim et al., 1990), EcoRV (complexed with DNA; Winkler et al., 1993), BamHI 
(Newman et al., 1994), and Pvull (complexed with DNA; Cheng et al., 1994), and the 
MTases of HhaI (complexed with DNA; Kiirnasaukas et al., 1994) and TaqI (Labahn 
et al., 1994). EcoRI and BamHI have little similarity in primary sequence, but a 
surprising amount of similarity in higher structures (Newman et al., 1994). EcoRV 
shows little structural similarity to either EcoRI or BamHI (Winkler et al., 1993), but 
does to Pvull (Athanasiadis et al., 1994). The structure of EcoRV has been solved in 
three forms, free protein, complexed with non-specific DNA, and complexed with 
DNA containing the EcoRV recognition sequence. Sequence specific contacts, 
between EcoRV and its target, occur between aa in the recognition loop (R-loop) and 
the major grove of DNA. When the DNA target is methylated, and hence not a 
substrate for the ENase, this R-loop is displaced (Winkler et al., 1993). 
The co-crystal structure of the HhaI MTase, trapped in a reaction complex with an 
oligonucleotide containing the HhaI target sequence, shows a novel DNA:protein 
interaction (Kiimisaukas, et al., 1994). The cytosine to be methylated in the DNA 
target sequence is 'flipped out' of the DNA and into the active site of the protein, 
bringing all the components required for methylation together (figure 1.4; Klimisaukas 
et al., 1994). The crystal structure of the TaqI MTase has also been solved, and is 
very similar to HhaI in the region of the active site (Labahn et al., 1994). It seems 
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Figure 1.4. A viev looking do\\ n the DN A axis f We 1/huT Ni tase eovalentiv 
bound to an oligonucleotide containing its recognition sequence. The protein is 
coloured brown, apart for the active-site loop and recognition loops which are white; 
the DNA backbone is magenta; bases are green; S-adenosyl homocysteine is yellow 
(Klimisaukas et al., 1994) 
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likely that this method of accessing nucleotides in a DNA helix will be common to all 
DNA MTases, and maybe other DNA-modifying enzymes (Klimisaukas et al., 1994). 
There are some R-M systems currently classed as type II, which have rather different 
properties. The type-Us are very similar to the type II R-M systems, except that they 
cleave a short distance from their recognition sequence, hence 'Hs' for 'shifted 
cleavage' (Szybalski et al., 1991). Like the type Us systems, Eco571 recognises an 
asymmetric target sequence and cleaves a short distance from this site. This enzyme is 
different, however, in that one subunit is both an ENase and MTase which has an 
absolute requirement for Mg 2 and whose activity is stimulated by AdoMet (Janulaitis 
et al., 1992). Eco571 also has a cognate MTase. The R-M system BcgI cleaves DNA 
bilaterally, either side of its recognition sequence, and consists of two subunits both of 
which are required to form an active ENase and MTase (Kong et al., 1994). These 
unusual enzymes may represent new classes of R-M systems, and Eco571 has been 
tentatively termed a type IV (Janulaitis et al., 1992). 
Type III R-M systems 
The type Ill R-M systems have the smallest number of members, currently only four 
(see Bickle, 1993). The E. coli phage P1 and defective prophage P15, encode very 
similar systems, EcoPI and EcoP 151 respectively (Arber and Dussoix, 1962; Arber 
and.Wauters-Willems, 1970). Haemophilus influenzae strain Rf and many Salmonella 
strains also encode type III systems (Hinfffl and StyLTI respectively; Piekarowicz and 
Kalinowska, 1974; Bullas etal., 1980). There is also some evidence for a system, or 
the remnants of one, in Bacillus cereus (Hegna et al., 1992), and it is probable that 
many other examples of these systems have yet to be identified. 
The type ifi systems are intermediate in complexity, between the type I and type II 
enzymes, and are encoded by two genes, res and mod (lida et al., 1983). MTase 
activity is encoded by the mod gene, which together with the res gene product can 
form an ENase. The DNA is cut 25 or 26 bp downstream from the recognition 
sequence, which are short (5-6 nt), and asymmetric (see Bickle, 1993). Surprisingly, 
only one strand of the DNA is modified, forming N 6 meA. At first, it was difficult to 
see how hosts encoding these systems avoided auto-restriction after replication, until it 
became clear that a single unmodified target is not the substrate for a type ifi ENase 
(Meisel etal., 1992). 
The nature of the target for a type ifi ENase became apparent from an examination of 
the nucleotide sequence of the closely related phages, T3 and T7. Phage T3 is 
restricted by EcoP 151, whereas T7 is not. Phage T7 contains 36 EcoP15I target sites 
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in its genome (Dunn and Studier, 1983), however, they are all in the same orientation 
(Schroeder et al., 1986). Phage T3 contains at least two inverted sites (Kruger et al., 
1990). This strongly suggested that it is the presence of two inversely oriented target 
sequences that elicit DNA cutting. This was further investigated, and shown to hold 
true, for Ml 3 clones containing different numbers and orientations of EcoP 151 sites 
(Meisel et al., 1992). Thus, the EcoP15I recognition target for methylation is 5' 
CAGCAG whereas the target for restriction is two of these, in inverse orientation and 
separated by a variable distance i.e. 5' CAGCAG-N-CTGCTG. A host expressing a 
type ifi R-M system does not cut its own DNA after replication, as there is always one 
methylated site in an inverse-orientated target (figure 1.5; Meisel et al., 1992). 
Sequence comparisons among members of the type ffi R-M systems have revealed 
similar identities to the type I systems. The predicted aa sequence of the mod gene 
product, responsible for DNA sequence specificity and methylation, contains a central 
variable region flanked by two conserved regions. By analogy to the type I systems, 
this variable region probably encodes the DNA target recognition domain (Humbelin et 
at., 1988). Motifs I and II, common to all adenine MTases (Klimisaukas et al., 1989; 
Pósfai et al., 1989), are found in the conserved regions (Dartois et al., 1993). 
Alignment of the res gene products shows little similarity, except in a short central 
region which has near identity and may be involved in subunit interactions (Dartois et 
at., 1993). Like the type I HsdR polypeptide, seven motifs characteristic of 'DEAD-
box' proteins can be found in the predicted aa sequence of type III res gene products, 
indicating that they may both be ATP-dependent DNA helicases (Dartois et al., 1993; 
Murray et al., 1993). This is apparently contradicted by the observation that type Ill 
enzymes can cut DNA without hydrolysing ATP (Yuan et al., 1980). Restriction by 
type III systems require communication between enzymes at two sites (Meisel et al., 
1992), which could be achieved by DNA translocation (Murray et al., 1993). Type I 
R-M systems also translocate DNA before cutting occurs (Yuan et al., 1980; Studier 
and Bandyopadhyay, 1988). DNA translocation by both type I and III systems may 
involve ATP-dependent helicase activity, which is supported by the recent reporting of 
ATP hydrolysis associated with restriction by a type Ill ENases (Saha and Rao, 1995; 
Meisel etal., 1995). 
Modification-dependent systems 
The systems originally described in 1952 by Luria and Human are not classical R-M 
systems, as modified DNA is the target for the ENase and there is no cognate MTase. 
Luria and Human (1952) isolated T-even phages, T*,  that were restricted by E. coli B. 
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Figure 1.5. Targets for restriction and modification by the EcoP 151 R-M system. 
(a) A single DNA target is modified, but two inversely-orientated unmodified sites are 
required for restriction. (b) Protection of host DNA after semi-conservative 
replication. See text for more details. Shaded arrow, EcoP 151 recognition site (5' 
CAGCAG); solid circle, methylated base (Meisel et al., 1992) 
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An understanding of this change in host restriction activity, based on the modification 
of phage DNA, was made in the late 1960's (Revel, 1967; Revel and Luria, 1970). T-
even phages normally contain glucosylated hydroxymethylcytosine (hmC) in place of 
cytosine in their DNA. The 1*  phages do not glucosylate hmC-containing DNA and 
the systems responsible for their restricted growth were termed RglA and Rg1B, for 
restricts glucose-less phages (Revel, 1967; Revel and Luria, 1970). These systems 
may be an evolutionary relic, as the normal glucosylation of phage DNA renders them 
totally resistant to restriction by Rg1A and Rg1B (Revel and Luria, 1970; Bickle and 
KrUger, 1993). However, interest in these systems was stimulated when it became 
apparent that they interfered in the cloning of certain MTases (Blumenthal etal., 1985; 
Noyer-Weidner etal., 1986; Raleigh and Wilson, 1986). Restriction by these systems 
was shown to be both modification-dependent and sequence-specific and they have 
been renamed McrA and McrB, Rg1A and Rg1B respectively, for modified cytosine 
restriction (Raleigh etal., 1989). The region encoding McrB is now known to include 
two genes, mcrB and mcrC (Raleigh, 1992). A third modification-dependent system 
has been identified in E. co!i, termed Mrr, for modified adenine recognition and 
restriction (Heitman and Model, 1987), although phages with cytosine-methylated 
DNA are also restricted (Kelleher and Raleigh, 1991). The hsd, mrr, and mcrBC 
genes are closely linked in both E. co!iK-12 and E. co!i B. This region at 99 minutes 
on the E. co!i chromosome has been termed the immigration control region (Raleigh, 
1992). The mcrA gene is part of e14, a prophage-like element on the E. coli K-12 
chromosome (Hiom and Sedgwick, 1991). 
Distribution of R-M systems 
There is no efficient screen for all types of R-M systems. Methods based on the 
restriction of phages have been generally unsuccessful, because many natural isolates 
of bacteria are resistant to productive phage infection (Bullas etal., 1980; Barcus, 
1993). Other methods rely on similarities with known systems; type II R-M systems 
are detected by their ability to produce discrete DNA fragments, and type I systems 
have been identified using DNA probes derived from the hsd genes (Daniel et al., 
1988). 
Over 2400 type II R-M systems have been identified, mainly due to their importance to 
molecular biologists, and efficient screens that have been developed to identify them 
(Roberts and Macelis, 1993). Sequence-specific DNA endonucleases are identified by 
incubating cell extracts with suitable DNA substrates and looking for discrete 
fragments separated by agarose gel electrophoresis. This activity is normally 
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interpreted as due to the ENase of a type II R-M system. Over 10 000 bacterial strains 
have been examined in this way, and approximately a quarter are thought to encode 
type II R-M systems (Wilson and Murray, 1991; Roberts and Halford, 1993). This 
figure is supported by a systematic screen of the Enterobacteriacea for type II systems, 
which identified sequence-specific endonucleases in 25 % of over 1000 strains tested 
(Janulaitis et al., 1988). 
R-M systems which do not cut DNA at specific points or have other requirements, like 
the type I and type III R-M systems, are not detected in these screens. Only four type 
Ill R-M systems are known, and these were identified by the restriction of phages 
(Bickle, 1993). Type I R-M systems were originally detected by phage restriction, but 
have recently been identified by DNA hybridisation to known hsd genes (Daniel et al., 
1988; Barcus and Murray, 1995; Barcus etal., 1995). A collection representing the 
genotypic diversity of E. coli strains, the ECOR collection (Ochman and Selander, 
1984), has been used to screen for type I R-M systems (Barcus et al., 1995). Probes 
from known hsd genes, of type IA, lB and ID R-M systems, hybridised to the DNA of 
17 strains out of 37 tested in the collection. The distribution of these systems, using a 
dendrogram of the ECOR collection, indicates the horizontal transfer of the hsd genes 
(Barcus et al., 1995). Some of the R-M genes identified in the ECOR collection have 
been cloned, and five new DNA specificities identified (table 1.1; Barcus et al., 1995). 
This brings the total of type I specificities to at least 16. The type Ill systems encode 
four different specificities, and the type II encode over 180 (Roberts and Macelis, 
1993). The selective pressure imposed on a bacterial population for variation in the 
specificity of R-M systems, may be the challenge by phages (Levin, 1986). 
Members of the ECOR collection that did not hybridise to probes of known hsd genes 
may encode other R-M systems, either members of different type I families or other 
types of R-M system, and the screening of strains for type II systems does not identify 
other types of R-M system. It is interesting to note that only one natural isolate, E. coli 
C, has been extensively studied and found not to encode an R-M system (Raleigh, 
1992). However, E. coli C can readily acquire a system by transduction or 
transformation, and it seems likely that the majority of bacteria do possess an R-M 
system. 
Regulation of R-M activity 
It is essential for a bacterium to regulate R-M activity under certain conditions, for 
example when an R-M system is transferred between hosts the DNA of the recipient 
must be modified before an active ENase is produced. Many R-M systems have 
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separate promoters for the genes encoding the MTase and ENase (Wilson and Murray, 
1991), so R-M activity could be modulated by differential gene expression. The 
control of gene expression may involve passive or active mechanisms. The promoter 
for the MTase of PstI overlaps the weaker promoter for the ENase, this would allow 
time for the MTase to accumulate before an active ENase is formed (Walder et at., 
1984). Some of the genes encoding type H systems are transcriptionally regulated by 
repressor-like C proteins of about 100 an with a characteristic helix-turn-helix DNA-
binding motif. The first C gene identified was linked with the genes encoding the 
BamHI R-M system (Nathan and Brooks, 1988), and there is now a small family of 
proteins that regulate the systems of BamHI, PvuII, SmaI, EcoRV, Eco721 and MunI 
(Tao Tao et al., 1991; Siksnys et al., 1994). Little is known about the molecular 
mechanism of C protein activity, although C proteins are probably site-specific DNA-
binding proteins that activate or repress expression of the res and mod genes of the R-
M systems with which they are associated. C proteins are much more similar to each 
other, and to some other gene regulators e.g. A. repressor, than the R-M systems with 
which they are associated, implying that the C genes have been independently recruited 
into different R-M systems (Tao Tao etal., 1991). 
Type I and III R-M systems also have separate promoters for the genes encoding the 
MTase (mod)  and the additional subunit that is required for restriction (Pres;  Loenen et 
al., 1987; Sharrocks and Hornby, 1991). Promoter fusion studies, with the lacZ 
operon, have found no evidence of differential gene expression with P e, and P.od  of 
the type I R-M system EcoKI (Loenen et al., 1987; Prakash-Cheng et al., 1991) or the 
type ifi system EcoPI (Sharrocks and Hornby, 1991). Experiments examining the 
restriction phenotypes of E. coli after conjugation, reveal that there is a delay in 
restriction activity when the hsd genes of EcoKJ are transferred (Prakash-Cheng and 
Ryu, 1993). It is not possible, from the results of Prakash-Cheng and Ryu (1993), to 
conclude whether modification activity is observed immediately upon transfer, but it 
seems probable. Promoter fusion studies show that both P,. and mod  are transcribed 
immediately upon transfer, and yet there is a delay before restriction is detected. A 
mutant has been isolated, termed hsdC, that can't act as a recipient of the EcoKI hsd 
genes in conjugation, presumably because restriction activity is not regulated, leading 
to auto-restriction (Prakash-Cheng et al., 1993). Further analysis of this mutant 
should identify a mechanism of controlling the R-M activity of type I systems. 
Restriction by EcoKI is reduced after cells have been irradiated with ultraviolet (uv) 
light (Day, 1977) or treatment with chemical agents that cause DNA damage (Efimova 
et al., 1988a). Kelleher and Raleigh (1994) examined the effect of uv-induced DNA 
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damage on the restriction activity of three R-M systems in E. coli K- 12, the type I 
system EcoKI and the modification-dependent systems McrA and McrBC. Restriction 
by McrA was alleviated by exposure to uv light, but this was because the genetic 
element that encodes it, e14, is rapidly lost (Hiom et al., 1991a; Kelleher and Raleigh, 
1994). The excision of e14 is probably analogous to parts of the lytic pathway of 
phages, where the phage repressor is cleaved by activated RecA (Roberts and Roberts, 
1975). Restriction by McrBC and EcoKI was also alleviated in these experiments; 
alleviation of McrBC restriction is dependent on the SOS response, whereas alleviation 
of EcoKI is dependent on actual DNA damage as restriction was not alleviated in 
strains that expressed SOS-regulated genes constitutively (Kelleher and Raleigh, 
1994). The mechanism of these activities, therefore, is likely to be different. 
Alleviation of McrBC restriction may be by the direct interaction with an SOS-induced 
protein. The ENase of EcoK1 is not turned-over after cutting DNA, but remains bound 
to the target site. Restriction by EcoKI may be alleviated, therefore, by titration of the 
enzyme with small DNA fragments containing unmodified target sites that are 
produced as a by-product of the E. coli DNA repair machinery (Kelleher and Raleigh, 
1994). This may also explain the alleviation of restriction in E. coli K-12 dam mutants 
(Efimova et al., 1988b); EcoKI could be titrated by the excess of unmodified targets 
generated by uncoordinated DNA replication (Boye and 14bner-Olesen, 1990; 
Kelleher and Raleigh, 1994). It is not clear why restriction need be alleviated in 
response to DNA damage or whether, in the case of EcoKI at least, it is merely a 
saturation of the restriction ability of the cell. 
Phage antirestriction mechanisms 
Many phages have methods of avoiding R-M systems (see Kruger and Bickle, 1983; 
Bickle and Kruger, 1993), however, like the host-encoded systems, there has been 
little work performed on the distribution of phage antirestriction systems in nature. 
One study has examined the restriction of a collection of phages, by R-M systems that 
may be expected in the phage host-range (Korona etal., 1993). Twenty four naturally 
occurring coliphage were tested for restriction by three type I and four type II R-M 
systems in vivo; 19 were restricted by at least one R-M system. Twenty one of the 24 
phages could also be tested for cutting by the four type II ENases in vitro; 16 of the 
phages that were not restricted in vivo were also not cut by the ENase in vitro. This 
may indicate that the targets for these R-M systems are not present in the phage 
genomes (Korona et al., 1993) or alternatively, that the phage DNA is modified so that 
the targets are not recognised as a substrate for the ENase. The remaining five phages 
that are not restricted in vivo, but are cut by the type II ENase in vitro, probably 
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encode antirestriction systems that interfere with the host's R-M system. In the well-
studied laboratory phages, most antirestriction systems are directed against type I R-M 
systems, although phage T5 does encode a function that makes it resistant to EcoRI, a 
type II R-M system (Eskridge et al., 1967). Unlike most other antirestriction systems, 
the antirestriction gene of T5 appears to encode an essential function as the only 
mutants that can be isolated sensitive to EcoRI are those that have additional target sites 
in the region of phage DNA first introduced into the cell during infection (Davison and 
Brunel, 1979a, 1979b; Brunel and Davison, 1979). 
A number of statistical analyses have been performed on the nucleotide sequence of 
phages. An examination of the nucleotide sequence of a total of 12 DNA phages, T7, 
X, OX174, G4, M13, fi, fd, IKe, 029, P1, PZA and T4, shows that six-base 
palindromes are significantly underrepresented in all but phage T4 (Sharp, 1986; 
Karlin et al., 1992). These sequences are not depleted in the RNA phage MS2 or 
viruses that infect eukaryotes, e.g. EBV, HSV, CMV or SV40, and strongly suggests 
a counter-selection for six-base palindromes in DNA phages. Fifty-five of the 64 
possible six-base palindromes are known to be targets for the type II R-M systems 
(Roberts and Macelis, 1993), and it seems probable that all possibilities do exist in 
nature. It is possible that a phage may encounter a type II system with any of 64 six-
base specificities, although there is some evidence to suggest that the range of DNA 
targets recognised by type II R-M system enzymes is limited within a species 
(Janulaitis et al., 1988). The underrepresentation of six-base palindromes in the 
genomes of DNA phages probably results from the selection against phages containing 
targets for host-encoded type II R-M systems (Sharp, 1986; Karlin et al., 1992). 
Phage T4 is not underrepresented in these sequences, but it is completely protected 
from restriction by most systems as it contains glucosylated hydroxymethylcytosine 
(hmC) in its DNA (Wyatt and Cohen, 1952). 
Modification of phage DNA 
Like phage T4, a number of other phages are protected from restriction by the 
modification of their DNA. This modification may be methylation, as with the Bacillus 
phage 43T (Noyer-Weidner etal., 1981), acetimidation, by phage Mu (Swinton etal., 
1983) or the glucosylation of hmC, as with phage T4 (Wyatt and Cohen, 1952). 
DNA methylation is an obvious mechanism to avoid restriction and a wide range of 
phages encode MTases, including the Bacillus phages 03T and SPR (Noyer-Weidner 
et al., 1981), the Shigella phage DDVI (Nikolskaya et al., 1979), phages T2 and T4 
(Hattman, 1970), and the Lactococcus phage 450 (Hill et al., 1991). The MTases of 
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the Bacillus phages are similar to the MTases of type II R-M systems, but often contain 
more than one TRD and recognise more than one DNA sequence (Lange etal., 1991). 
The host and phage-encoded MTases of Bacillus appear to be unrelated, but the MTase 
of the Lactococcus phage 50 is clearly derived from the host. The Lactococcus self-
transmissible plasmid pTR2030 encodes a type II R-M system, LlaI, and shares a 1.2 
kb region of sequence identity with 0 50 that encodes a functional MTase (Hill et al., 
1991). 
The DNA of phages Mu and D108 contain N acetamidoadenine instead of adenine, 
and the enzyme responsible is encoded by the mom gene (Swinton et al., 1983). The 
mom gene product is a sequence-specific modifying enzyme and phages are protected 
from restriction by those systems whose target overlaps this sequence (Kahmann, 
1984). The mom gene of phage Mu has been sequenced, and encodes a polypeptide of 
predicted molecular mass 28.3 kDa (Kahmann, 1984). Constitutive expression of 
mom is lethal to the host, and its expression is tightly regulated (Kahmann et al., 
1985). Transcription of the mom gene is dependent on the methylation of sites 
upstream from the promoter, by host-encoded Dam MTase (Hattmann, 1982), and the 
phage-encoded corn gene product is required for translational initiation (Wulczyn et al., 
1989). 
The presence of glucosylated hmC in the DNA of the T-even phages, and the Shigella 
phage DDVI, renders them totally resistant to most R-M systems (Wyatt and Cohen, 
1952). This modification also serves to differentiate between phage and host DNA, as 
phage-encoded nucleases rapidly digest host DNA upon infection by T-even phages 
(Warner and Snustad, 1983). The DNA of a T-even phage is replicated containing 
hmC, instead of cytosine, and then glucosylated at this position postsynthetically 
(Revel, 1983). Phages may be isolated that are not glucosylated, but these are still 
resistant to most R-M systems due to the presence of hmC. The modification-
dependent systems, McrA, McrBC and Mn, are able to restrict the growth of these 
phages, although the T-even phages do encode a gene, am, whose product disrupts the 
activity of McrBC (Dharmalingam and Goldberg, 1976; Dharmalingam et al., 1982). 
Am is not produced sufficiently quickly to protect its own DNA, but it is able to 
protect superinfecting phages from restriction by McrBC. T-even phages that contain 
cytosine instead of the modified base, hmC, are restricted by classical R-M systems. 
T-even phages, therefore, appear to have a number of redundant antirestriction systems 
as glucosylation of the DNA renders the phage totally resistant to restriction by most 
R-M systems. This may indicate a close evolutionary link between the phages and 
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their host, and am and hmC may be part of an evolutionary legacy (Kruger and Bickle, 
1983). 
The region of DNA that contains the hsd genes of the type I R-M system Ecoprrl also 
encodes a phage exclusion gene, prrC (Levitz etal., 1990; Tyndall etal., 1994). PrrC 
is activated by a T4-encoded peptide, Stp, and cleaves the host tRNALYS, blocking 
translation and phage development (Amitsur etal., 1987, 1992). The only known 
function of T4-encoded polynucleotide kinase and RNA ligase is to repair this damage 
and allow phage development to continue (Amistur etal., 1987). The PrrC protein and 
Ecoprrl are closely associated, as they can be co-precipitated using specific antibodies, 
and results indicate that the Ecoprrl complex masks the activity of PrrC (Amitsur et al., 
1992; Morad et al., 1993). The T4 Stp peptide may be an antirestriction mechanism 
that dissociates the ENase complex and in so doing releases, and activates, PrrC 
(Snyder, 1995). The PrrC exclusion system may be an RNA-based phage restriction 
system, and T4 polynucleotide kinase and RNA ligase a phage antirestriction 
mechanism (Bickle and Kruger, 1993). 
Inactivation of R-M systems 
The Bacillus phages 4ilrH and ONR2rH are not restricted by the type II R-M system 
BamNxI (Makino etal., 1979; 1980). DNA prepared from phage ONR2rH grown in a 
strain expressing BamNxI, is still cut by the ENase in vitro, suggesting that both 
enzymatic activities of the R-M system are inhibited (Makino etal., 1979). A 
polypeptide was isolated from cells infected with 0 1 rH, that specifically inhibited the 
BamNxI ENase in vitro, and this inhibitory protein probably forms a complex with the 
ENase that blocks its activity (Makino etal., 1980). 
Phages T3 and T7 encode a more general antirestriction system that blocks both 
restriction and modification by type I R-M systems (Studier, 1975; Studier and 
Movva, 1976; Spoerel etal., 1979; Kruger and Bickle, 1983). The T3 system is also 
active against type III R-M systems (Kruger etal., 1982; Bickle and Kruger, 1993), 
but both phages T3 and T7 are efficiently restricted by type II systems 
(Bandyopadhyay etal., 1985). The phage gene encoding this function is termed ocr or 
gene 0.3 (Studier, 1975; Kruger etal., 1977), and the molecular mechanism of T7 Ocr 
activity has been examined in detail; Ocr binds tightly to free ENase, either to the 
HsdM or HsdS subunit, and prevents the complex from binding DNA. This explains 
why both enzymatic activities are inhibited, and the phage is neither restricted or 
modified. If an ENase:DNA complex is formed before Ocr is added, then nuclease 
activity is still inhibited, suggesting that the binding site for Ocr is accessible after 
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DNA binding, but before cutting occurs. The MTase activity is strongly inhibited by 
Ocr added at any stage of the reaction (Bandyopadhyay etal., 1985). The T3 ocr gene 
product is also able to hydrolyse AdoMet, and mutants can be isolated that map to ocr 
and still retain the Ocr phenotype, but have lost the ability to hydrolyse AdoMet 
(Kruger et al., 1977). AdoMet stimulates the ENase activity of type ffi R-M systems 
(Haberman, 1974), so the hydrolysis of AdoMet by the phage T3 ocr gene product 
explains why these phages are resistant to restriction by type ifi systems. 
The ocr gene is in a region of the phage genome that is introduced into the cell at the 
start of injection of the phage DNA (Pao and Speyer, 1973). Moffatt and Studier 
(1988) followed the fate of 32p-labelled DNA of infecting T7 phages in hosts with 
different R-M systems, and concluded that the phage DNA was not susceptible to 
degradation until six or seven minutes after infection. The ocr gene product should be 
made just three to four minutes after infection (Studier, 1972), and can be visualised at 
about this time in experiments following the synthesis of phage proteins in cells 
infected with T7 (Moffatt and Studier, 1988). The first EcoKJ target site is in a region 
of the phage DNA that is introduced into the cell after ocr, but T7 phages containing a 
site before ocr are still protected from restriction by EcoKJ, although it is not clear if a 
single target at this position would be a substrate for the ENase. However, the 
evidence does indicate that transcription and translation of the early region of the T7 
genome occurs before the DNA can be degraded by host-encoded R-M systems, and 
the production of Ocr during this time would protect the phage DNA from cutting by 
type I ENases (Moffatt and Studier, 1988). 
The absence of potential target sites for type II R-M systems (Sharp, 1986; Karlin et 
al., 1992), the production of the Ocr function that blocks the activity of type I 
enzymes, and the underrepresentation of sites for the E. coli MTases Dam and Dcm 
(Schroeder et al., 1986), have lead Kruger and colleagues (1989) to suggest that these 
may be methods for phage T7 to avoid methylation. Apart from R-M systems, DNA 
methylation in prokaryotes has been linked to DNA replication and repair, regulation of 
gene expression and packaging of phage DNA (see Marius, 1987), but any relevance 
of undermethylation to the biology of phage T7 is unknown. 
Modulation of R-M activity 
Phage P1 encodes both a type III R-M system, EcoPI, and an antirestriction system 
that is encoded by the genes darA and darB (lida et al., 1987; Streiff et al., 1987). The 
Dar proteins are associated with the DNA when injected into the cell and block 
restriction by type I R-M systems. The darA gene product is sufficient to protect 
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against restriction by type lB family of R-M systems, but both the darA and darB gene 
products are required to protect against restriction by the type IA systems. 
Furthermore, any DNA packaged in a P1 phage head is protected from restriction, 
which allows efficient generalised transduction between hosts with different type I R-
M systems (lida et al., 1987). The DarA and DarB proteins are associated in the P1 
head and DarB does not seem to be present in the phages of a PldarA mutant, 
suggesting that DarA is required for the correct incorporation of DarB into the phage 
head. The Dar proteins probably bind DNA in the phage head and remain bound to the 
DNA after injection. Dar may alleviate restriction by blocking the DNA translocation 
required for cutting by the type I ENases (lida et al., 1987). The Dar proteins also 
stimulate methylation of unmodified DNA by the MTases of type IA R-M systems 
(lida et al., 1987). These enzymes are the only prokaryotic MTases shown to have a 
strong preference for hemimethylated DNA. DarA may be responsible for blocking 
restriction, and DarB for modification enhancement, but this can't be tested using 
PldarA mutants as these phages do not incorporate DarB into the phage heads. If 
DarA remains bound to the DNA and blocks restriction, the DNA would only be 
poorly methylated by the MTase of a type IA R-M system, and when DarA-mediated 
protection is lost, the DNA would be cut by the ENase. However in vivo, the MTases 
of other type I R-M systems do not have a strong preference for hemimethylated DNA 
and would methylate unmodified DNA protected from restriction by DarA. The DNA 
would not be cut, therefore, when DarA protection was lost and this may explain why 
PldarB mutants are only resistant to restriction by non-type IA R-M systems. 
The lambdoid phages X, Xreverse (Arev), 0 21 and P22 encode a very specialised 
antirestriction system, encoded by the genes rat (X, 021 and P22; Zabeau et al., 1980; 
Franklin, 1984; Semerjian et al., 1989), or lar (Xrev; Toothman, 1981). Most work 
has been performed on the rat gene of phage X. Zabeau and colleagues (1980) 
discovered that unmodified X phages can escape restriction upon coinfection with 
modified X helper phages, and mapped the gene responsible between N and clii. 
When this region of DNA was sequenced, a short open reading frame (orj) of 201 bp 
was assigned to ml (Ineichen etal., 1981; Sanger etal., 1982). A ml mutant, m118 
(Debrouwere et al., 1980a), was sequenced and shown to have two mutations in this 
orf(Loenen and Murray, 1986). Both Xmr and Arat phages are restricted efficiently 
by EcoKJ, however, after a single round of infection of a restriction-deficient, 
modification-proficient host, the progeny of the rar phages are fully modified, 
whereas those of the rat phages are only poorly modified (Zabeau et al., 1980). This 
effect may be seen even after multiple rounds of infection (Kelleher et al., 1991). Ral 
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is not itself a MTase, as the X phage only carries the modification pattern of the host in 
which it was last propagated (Toothman, 1981). 
The nil gene has been cloned in an expression plasmid, and the gene product visualised 
using both an in vitro transcription and translation system, and minicells transformed 
with the plasmid (Loenen and Murray, 1986). The only R-M systems in which 
restriction is alleviated, and modification enhanced by Ral, are the type IA. These are 
also the only systems whose MTase has a strong preference for hemimethylated DNA 
in vivo. Recombinant ?. phage that over-express the genes for the EcoKI MTase, do 
not efficiently methylate their DNA unless they also contain ral (Loenen and Murray, 
1986). An examination of the polypeptides produced by two phages, ral or nit, 
encoding the EcoKI MTase, concluded that Ral altered the ratio of HsdM and HsdS 
subunits produced, and that this explained the increase in de novo methylation activity 
with Ral (Zinkevich et al., 1986). However, the phages in these experiments are very 
different. Both phages contain the same region of DNA, encoding the MTase from 
EcoKI, but only in the rat phages are the hsd genes transcribed from the strong X 
promoter, PL . This fragment of DNA encodes most of hsdR, all of hsdM, hsdS, 
mcrBC and other downstream genes. McrB and HsdS comigrate by SDS PAGE (Sam 
and Murray, 1980) and these two products may have been confused in this work as 
Zinkevich and colleagues (1986) appear to have made no attempt to confirm their 
identification of the polypeptides produced. A favoured model to explain Ral activity 
is that Ral interacts directly with either HsdM or HsdS and changes the kinetics of 
methylation so that unmodified DNA is efficiently methylated (Loenen and Murray, 
1986). 
The ml gene appears to have no role in the life cycle of phage ?, as it is dispensable for 
normal phage development (Zabeau et al., 1980; Debrouwere et al., 1980a, 1980b). 
Debrouwere and colleagues (1980b) observed that E. coli strains in which ral was 
constitutively expressed were phenotypically similar to strains carrying a mutation in 
rho that encodes a transcriptional termination factor. They postulated that ral might 
have an antitermination function which modulated the activity of EcoKI. However, no 
evidence of antitermination activity was observed with cloned ral (Loenen and Murray, 
1986) and the activity observed by Debrouwere and colleagues (1980b) may be due to 
llz10; a single-strand binding protein of unknown function that is also expressed by 
the defective prophage used in this work. 
The ml gene of 021 has been identified by the nucleotide sequence analysis of a 
recombinant ? phage (Franklin, 1984). The ? and 021 rat genes are identical, and it 
may be that the gene identified as 021 ml is derived from ? sequence in the 
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recombinant phage that was sequenced. The ml gene of the Salmonella phage P22 has 
also been sequenced, and shares 75% identity with A. ral (Semerjian etal., 1989). The 
ml gene from phage P22 has been cloned in an expression plasmid, and used to 
transform both E. coli K-12 and S. enterica serovar lyphimurium LT2. Restriction by 
the E. coli strain is alleviated, demonstrating that the P22 ml gene encodes a functional 
protein, but restriction by the Salmonella strain is unaffected (Semerjian etal., 1989). 
S. enterica serovar typhimurium LT2 encodes three R-M systems, termed StyLTI, 
StyLTil and StyLTffi; only StyLTifi is a type IA R-M system (Barcus and Murray, 
1995). Therefore, although the P22 ml gene product is probably effective against 
StyLTifi, the two other R-M systems would still be active and restrict the test phage. 
The Ral-like antirestriction function of Xrev is encoded by the lar gene (Toothman, 
1981). Xrev arises by a recombination event between phage A. and the excised Rac 
prophage (Kaiser and Murray, 1979). The Rac prophage is a defective lambdoid 
prophage in the chromosome of many E. coli strains, and encodes genes that can serve 
the same functions as the early genes of phage A., including integration, recombination, 
immunity, and replication (Low, 1973; Gottesman et al., 1974; Diaz etal., 1979). E. 
coli sbcA mutants express the recE and recT genes, and A.rev relies on these genes to 
provide the general recombination functions normally encoded by A. exo and bet 
(Kushner etal., 1974; Gottesman etal., 1974; Clark et al., 1993). E. co!i sbcA 
mutants are also phenotypically Lar (Simmon and Lederberg, 1972), and the 
antirestriction activity of these mutants is functionally separable from the recombination 
functions encoded by recET (Toothman, 1981). 
Possible roles of R-M systems 
Recently, it has been proposed that the res and mod genes of the type II R-M systems 
may be a selfish symbiotic unit, that ensure the maintenance of the R-M system that 
they encode (Naito et al., 1995). Naito and colleagues (1995) examined the stability of 
plasmid-encoded type II R-M systems in E. coli, and found .  that plasmids encoding 
both the res and mod genes were maintained better than vector plasmid alone or those 
encoding just mod. They postulate that once a bacterium express an R-M system, loss 
of the genes encoding that system is fatal. Once the genes have been lost, R-M activity 
would continue with residual ENase and MTase present in the cell. However, the 
concentration of these enzymes would decrease through successive generations until 
the MTase activity is not sufficient to ensure that the host DNA is completely modified, 
and the host DNA then becomes a substrate for the ENase, leading to cell inviability. 
This hypothesis cannot be extended easily to R-M systems that have common subunits 
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in the ENase and MTase, like the type I and ifi systems, but may account, at least in 
part, for the maintenance of those R-M systems that have separate ENases and 
MTases. 
Traditionally, R-M systems have been described as primitive immune systems that 
protect against phage infection, although evidence is now accumulating that R-M 
systems influence the flux of genetic material between bacterial populations (for recent 
reviews see Arber, 1994; King and Murray, 1994; Barcus and Murray, 1995). R-M 
systems are certainly a barrier to phage infection, however studies with populations of 
bacteria and phages show that R-M systems only confer a transient advantage to the 
host. In the laboratory, a bacterial population that is challenged by phages quickly 
acquire mutations that make the host totally resistant to infection (Levin, 1988; Korona 
and Levin, 1993). Phage resistance was also acquired by the host in experiments 
where bacteria colonised an environment in which phages were already present, but a 
host-encoded R-M system increased the likelihood of the bacterial population 
becoming established (Korona and Levin, 1993). This colonisation selection may be 
important in the maintenance of R-M systems, but it also seems relevant that the 
maintenance of an R-M system affords protection to a range of phages simultaneously, 
unlike mutations conferring phage resistance. Mutations may also be disadvantageous 
as the products of the genes, changed to acquire phage resistance, are commonly 
involved in other processes in the cell and their disruption may compromise the fitness 
of the bacterium in nature. However, these mutations are rapidly acquired in 
laboratory studies (Korona and Levin, 1993). R-M systems are not a complete barrier 
to phage infection, and those phages that do escape restriction are likely to become 
modified. An R-M system, therefore, can only confer a transient advantage to the host 
as the phage becomes rapidly modified, although bacteria encode R-M systems with 
many different specificities. This diversity of recognition sequences may be explained 
by the frequency-dependent selection of rare specificities by phages (Levin, 1988). 
There are still a number of points which are perhaps inconsistent with R-M systems 
having evolved solely as a barrier to phage infection (Levin and Lenski, 1985). 
R-M systems are a leaky barrier to phage infection; the eop of phages vary, 
depending on the particular phage and R-M system challenged, but it is typically 
reduced to between 10 - ' and 10 5 by a single system. 
Many phages encode anti-restriction mechanisms. However, one study does 
suggest that a sufficient proportion of naturally occurring coliphages are sensitive 
to R-M systems to account for the maintenance of these systems by phage-
mediated selection (Korona et al., 1993). 
33 
R-M systems are a barrier to the transfer of any DNA molecule, however, the 
consequence of DNA cutting may be different for extra-chromosomal elements and 
chromosomal DNA. The cutting of a phage genome leads to the restriction of phage 
growth, and similarly, a plasmid that is cut is not maintained. It is interesting to note 
that a number of self-transmissible plasmids also encode an anti-restriction function, 
termed Ard, that is functionally similar to the T7 antirestriction function Ocr, and the 
two products share regions of sequence identity (see Wilkins, 1995; Belogurov et al., 
1995). The fate of bacterial DNA is likely to be different, however, as fragments may 
be rescued by homologous recombination with the host chromosome. 
Linear fragments of DNA, generated by R-M systems, are rapidly degraded in E. coli 
by the RecBCD nuclease (Simmon and Lederberg, 1972), the same enzyme that is 
required for the repair of DNA double-strand breaks and the promotion of homologous 
recombination (see Smith, 1988). Enzymes analogous to RecBCD are found in many 
bacterial species, and an eight nt asymmetric DNA sequence termed x. 5' 
GCTGGTGG, has been identified as a hotspot for RecB CD-promoted recombination 
(Smith et al., 1981). RecBCD is a multifunctional enzyme that has a number of 
enzymatic activities; a single-strand and double-strand DNA exonuclease, a single-
strand DNA endonuclease, a DNA helicase and a site-specific nuclease that nicks DNA 
when approaching a X site from the 3' direction. A model for RecBCD-promoted 
homologous recombination is that site-specific nicking of DNA at the X site and the 
subsequent unwinding of DNA produces a single-stranded end that may be used to 
initiate RecA-dependent strand exchange (Smith, 1988). The ss DNA end that is 
produced would normally be degraded by RecBCD, but this activity is lost after 
association with the X site (Dixon and Kowalczkowski, 1993; Kuzminov et al., 1994) 
possibly by dissociation of the RecD subunit (Dixon et al., 1994). The effect of this is 
to increase the survival of linear DNA that contains ax  site (Kuzminov et al., 1994). 
Thus, it is RecBCD and its interaction with X that determines the fate of linear DNA in 
the cell, and it seems relevant that X sites occur more frequently than expected, and 
have an orientation bias, in the E. coli genome (Burland et al., 1993). 
The ends generated by ENases can be used to initiate recombination, although most 
experiments have been performed in the absence of RecBCD (for example, Eddy and 
Gold, 1992). One experiment, in the presence of RecBCD, demonstrates that a 
fragment generated by cutting with the type II ENase, EcoRI, can be used to initiate 
recombination in vivo (Stahl et al., 1983). The overall level of recombination, 
however, is reduced in the presence of an R-M system. Experiments with conjugal 
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plasmids show that restriction, by type I and ifi systems, both reduce linkage and the 
acquisition of early genetic markers (Boyer, 1964; Pittard, 1964; Arber and Morse; 
1965). Similarly, the frequency of transduction mediated by phage Pldaf is severely 
reduced by the presence of a type I R-M system (lida et al., 1987). These 
observations seem inconsistent with the suggestion that the ends generated by ENases 
are recombinogenic (Endlich and Linn, 1985; Price and Bickle, 1986). Preliminary 
experiments, however, using the PCR to examine restriction fragment length 
polymorphisms, indicate that R-M systems may influence the transfer of DNA by P1-
mediated transduction (McKane and Milkman, 1995). McKane and Milkman (1995) 
examined the recombination patterns of a number of transductants, centred around a 
single allele, and showed that transduction between different strains of the ECOR 
collection (Ochman and Selander, 1984) could result in the replacement of multiple 
fragments much shorter than the entrant molecule. When the DNA from two of these 
transductants was transduced back into the parent, the substitutions were much longer, 
and no multiple replacements were observed suggesting an effect due to restriction by 
the host (McKane and Milkman, 1995). Further experiments, with hosts of known R-
M and recombination genotypes and P1 phages of known dar (anti-restriction) 
genotype, should help clarify the situation. The present results are consistent with the 
finding that the chromosomes of naturally occurring E. coli differ in short regions of 
DNA (Milkman and McKane-Bridges, 1993), and indicate a more general role for R-M 
systems in the flux of genetic material between populations. 
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Chapter two: Materials and methods 
Bacterial strains 
Bacterial strains are described in table 2.1. 
Phages 
Phages are described in table 2.2. 
Plasmids 
Plasmids are described in table 2.3. 
Synthetic oligonucleotides 
Synthetic oligonucleotides are described in table 2.4. 
Enzymes, isotopes, and chemicals 
Klenow DNA polymerase, type II ENases and T4 DNA ligase were purchased from 
Boehringer Mannheim Ltd.; VentR  DNA polymerase was from New England Biolabs 
Inc.; Lysozyme was from Sigma-Aldrich Company Ltd.; Sequenase was from 
Amersham International plc.; HK Phosphatase was purchased from Epicentre 
Technologies and Taq DNA polymerase and polynucleotide kinase (PNK) were kindly 
donated by D. Clark and S. Bruce, respectively. 
Stabilised aqueous solutions of [35S]dATPaS  (400 Ci mmol'), [7-32P]dATP (3000 Ci 
mmol') and S-adenosyl-L- [methyl- 3 H]methionine ([methyl- 3 H]AdoMet, -75 Ci mmoi 
1)  solubilised in hydrochloric acid, were purchased from Amersham International plc., 
and aqueous L- [3 5S]cysteine (600 Ci mmol') was from DuPont Ltd. Amplify and 
Hyperfilm MP, purchased from Amersham International plc., were used for 
fluorography; 35S was detected using Biomax film from IBI-Kodak Ltd., and Cronex 
film from DuPont Ltd. was used for other applications. 
Antibiotics (chioramphenicol, tetracycline and rifampicin) were purchased from Sigma-
Aldrich Company Ltd., and ampicillin (Penbritin) was from Beecham Research plc. 
Dialysis tubing was purchased from Spectrum Medical Instruments Inc. or MediCell 
International Ltd.; 0.2 pm syringe filters were from Whatman Scientific Ltd.; 0.45 pm 
(HV) filters, used for the filtration of organic solvents, and Immobilon-P 
polyvinylidene difluoride (PVDF) membrane, used in Western blotting, were from 
Strains§ 	 Relevant features 	 Source 
E. coli K-12 derivatives 
C600 r}( mJ( supE Appleyard, 1954 
5K C600hsdR Hubacek and Glover, 1970 
NM710 C600srl::Tn1OA(rac) King and Murray, 1995 
NM792 NM7 l0hsdRE4 This thesis 
AB 1157 rKmK 	(mc) Low, 1973 
JC8679 sbcA23 in AB 1157 Gillen et al., 1977 
NM5 19 JC8679hsdRE4 Lab collection 
W31 10 r ( m}( sup° C. Yanofsky 
W31lOtipC::Tnl0 trpC::TnlO C. Yanofsky 
NM679 W31 lOiX(mrr-hsd-mcr) King and Murray, 1995 
NM7771 W31 10zcj306l::TnlO(laf) King and Murray, 1995 
NM778 W31 10zcj3061::Tn1O(lar) Lab collection 
NM7941  NM777hsdRz4 This thesis 
Yme1 r}( m ( supF Lab collection 
NM5261 YmelhsdRA4 King and Murray, 1995 
NM787 YmeltipC::TnlO This thesis 
E. coli B derivatives 
BL21 rBmB sup °hsdS Studier and Moffat, 1986 
NM7931 BL21supF This thesis 
Table 2.1. Bacterial strains. §, NM refers to stock numbers in N.E. Murrays 
laboratory; t, lysogenic for XDE3, where indicated. 
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Phages§ Relevant features Source 
Plkc Lennox, 1955 
DE3 Xint::1acI1acUV5- Studier and Moffat, 1986 
T7gene] 1mm 2 ' 
NM22 XNam7Nam53cI26 Lab collection 
NM63 7c126 Lab collection 
NM75 Xb2red3imm' Lab collection 
NM 123 XcI857Sam7 Lab collection 
NM 144 2h82immcI Lab collection 
NM220 Xh80immcI Lab collection 
NM243 Xvir Lab collection 
NM324 Xbiol imm434cI Lab collection 
NM325 Xbio23 2E,(int-ral) imm434cI Lab collection 
NM435 XPa,n3c126 Lab collection 
NM507 Xb2imm 21cI Lab collection 
NM508 Xh80imm 21cI Lab collection 
NM891 ?recE Kaiser and Murray, 1979 
NM 1090 Xm118c160 Lab collection 
NM 1094 Xc160 Lab collection 
NM1 118 XhsdRA4cI857A(att) Lab collection 
Table 2.2. Phages. §, NM refers to stock numbers in N.E. Murrays laboratory. 
BE 
Plasmid Relevent features Source 
pUC 18 ColE 1 replicon, carrying bla, Piac  and Yanisch-Perron et 
multiple cloning sites (mcs). at., 1985 
pUC19 As pUC18, but mcs in opposite orientation. Yanisch-Perron et 
at., 1985 
pT7-6 Co1E1 replicon, carrying P, bla and mcs. Tabor, 1990 
pT7-7 Similar to pT7-6, also contains translational Tabor, 1990 
initiation region (tir) of T7 gene 1. 
pJLA503 CoIE1 replicon, carrying PL, 	R'  c1857, bla, Schauder et al., 1987 
tir atpE, and mcs. 
pET 16b Similar to pT7-7, also contains coding Novagen Inc. 
sequence for polyHis and factor X cleavage. 
pJF1 18 Co1E1 replicon, carrying bla, P, and mcs. Furste etal., 1986 
pACYC184 pl5A replicon carrying cat and tetA. Chang and Cohen, 
1978 
pPT7 (pJFMS) Genes encoding EcoKI MTase in pJFl 18. Dryden etal., 1993 
pJH 16 Genes encoding EcoRI MTase in Heitman et at., 1989 
pACYC 184. 
R-factor Genes encoding RI R-M system and bla. Yoshimori et al., 
1972 
pUCml 4.2 kb BamHI (?thio2l4) ml fragment Loenen and Murray, 
cloned in pCQV2. 1986 
pmlS 400 bp HaeIII-BamHI ml fragment in Loenen and Murray, 
pUC13. 1986 
pGK1 400 bp EcoRI-HindIll (pUCml) fragment in This thesis 
pT7-6. 
pGK3 270 bp blunt-ended ml fragment (amplified This thesis 
by the PCR) in pUC18. 
pGK4 220 bp NdeI-EcoRI (pGK3) mlfragment in This thesis 
pJLA5O3. 
pGK5 220 bp NdeI-EcoRI (pGK3) rat fragment in This thesis 
pT7-7. 
pGK6 7.6 kb Hindffl (XNM891) icr fragment in This thesis 
pUC18. 
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pGK8 3.5 kb BamHI (pGK7) lar fragment in This thesis 
pUC18. 
pGK9 1.4 kb EcoRI-ClaI (pGK8; blunt-ended) lar This thesis 
fragment in pUC18. 
pGK1O 500 bp XhoI-EcoRI (pGK9; blunt-ended) This thesis 
lar fragment in pUC 18. 
pGK1 1 500 bp HindIll-EcoRI (pGK1O) lar This thesis 
fragment in pUC19. 
pGK12 500 bp HindIll-EcoRJ (pGK1 1) lar This thesis 
fragment in pUC18. 
pGK15 290 bp HindIll-EcoRI lar fragment This thesis 
(amplified by the PCR) in pT7-6. 
pGK16 Similar to pGK15, encodes Las K42Am. This thesis 
pGK17 Similar to pGK15, encodes Lar MiT. This thesis 
pGK18 Similar to pGK15, encodes Lar MOT. This thesis 
pGK19 Similar to pGK15, encodes Lar M141. This thesis 
pGK20 Similar to pGK15, encodes Las M1Am. This thesis 
pGK21 Similar to pGK15, encodes Lar M1OAm. This thesis 
pGK22 Similar to pGK15, encodes Lar M14Am. This thesis 
pGK23 Similar to pGK15, encodes Lar M1OAm This thesis 
M141. 
pGK24 220 bp NdeT-BamHI (pGK5) nil fragment in This thesis 
pET 1 6b. 
pGK25 570 bp BgITI-BamHI (pGK5) ml fragment This thesis 
in pACYC 184. 
Table 2.3. Plasmids used in this work. 
Rol 
Designation Sequence (5'-3') Use 
755G GACTATCCATATGACTACG Amplification of nil using the 
PCR to introduce an NdeI target 
site (figure 4.3) 
642C G'IIII'CCCAGTCACGAC With 755G (40 primer) 
F799 ATAAGC11TGGGCTGCAGG T7 reverse sequencing primer 
T7 promoter TAATACGACTCACTATAGGG T7 promoter sequencing primer 
408L TGTCTAGATATCGGCCTAAC To create an EcoKI target used in 
CACGTGGTGCGTACGAGCT MTase assays and gel 



























GGGAA1TCTTCC'f IT! CAAT 
AGTGG 
GTFACACTACGCTCGGTA 








With 408L or 860L ('bottom' 
strand; figure 4.12) 
To create a modified EcoKI 
target, used in the MTase assay 
('top' strand, modified; figure 
4.12) 
With 860L or 408L ('bottom' 
strand, modified; figure 4.12) 
Amplification and mutagenesis of 
kir by the PCR (figure 5.3) 
Site-directed mutagenesis (SDM; 
Lar K42Am; figure 5.3) 
With G2370 (figure 5.3) 
With G2371 
SDM (Lar M141; figure 5.5) 
With G3788 (figure 5.5) 
SDM (Lar MiT; figure 5.5) 
With G5859 (figure 5.5) 
SDM (Lar MiOl; figure 5.5) 
With G7230 (figure 5.5) 
SDM (Lar M1Am; figure 5.5) 
With G8266 (figure 5.5) 
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H 1207 	TITIAGAGAAAAA11TATGAG SDM (Lar M1OAm; figure 5.5) 
H1208 CTCATAA1TITICFCTAAAA With H1207 (figure 5.5) 
H1831 	GTCATATCTCTAAA'! F! TIC SDM (LarMl4Am; figure 5.5) 
H1832 GAAAAAT[TFAGAGATATGAC With H1831 (figure 5.5) 
Table 2.4. Synthetic oligonucleotides. T7 promoter (sequencing) primer was 
purchased from Amersham International plc., all other oligonucleotides were from 
Oswel DNA service, Dept. Chemistry. 
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Millipore Corporation; 5 gm Acrodisc filters, used in-line during liquid 
chromatography, were from Gelman Sciences; Microsep concentrators were from 
Filtron Technology Corp. 
Benzamidine hydrochloride, phenylmethylsulfonyl fluoride (PMSF), 2-
mercaptoethanol, dithiothreitol (DTT), acrylaniide, N,N' -methylene-bis-acrylamide, 
N,N,N' ,N' -tetramethylethylenediamine (TEMED), keyhole limpet hemocyanin 
(KLH), 3-maleimidobenzoic acid N-hydroxysuccinimide ester (MBS), ethidium 
bromide, brilliant blue R, bromophenol blue, 1,3-diaminopropane, piperazine, 
ethanolamine, acetonitrile (HPLC grade), water (HPLC grade), and anti-rabbit IgG 
horseradish peroxidase conjugate, were purchased from Sigma-Aldrich Company Ltd; 
trifluoroacetic acid (TFA; HPLC grade) was from Fisons plc.; agarose was from 
Flowgen Instruments Ltd.; caesium chloride was from ICN Biomedicals Inc.; 2-
amino-2-(hydroxymethyl)- 1 ,2-propandiol (Tris) and urea were from Boehringer 
Mannheim Ltd.; high-purity isopropyl-3-D-thiogalactopyranoside (IPTG) was from 
Calbiochem-Novabiochem Corp.; 40% wlv acrylamide/bis-acrylamide (19:1) and 30% 
w/v acrylamide/bis-acrylamide (37.5:1) solutions were from NBL Gene Sciences Ltd., 
and the ECL detection reagents were from Amersham International plc. 
General laboratory supplies were purchased from Sigma-Aldrich Company Ltd., 
Fisons plc., or Merck Ltd. 
Standard solutions and buffers 
Ethidium bromide: 10 mg ml' in deionised water (dH 2 0), stored in the dark at 4°C. 
Ampicillin: stock solution 100 mg ml - 1 in dH2 0, 100 jig mP end concentration. 
Chioramphenicol: stock solution 34 mg ml' in ethanol, 25 jig mi' end concentration. 
Tetracycline: stock solution 25 mg ml' in dH2 0, 50 jig mV end concentration. 
Rifampicin: stock solution 100 mg mV in methanol, 200 jig ml- ' end concentration. 
Antibiotic solutions were sterilised by filtration, and stored at -20°C. 
PMSF: 20 mlvi in ethanol, stored at 4°C. 
Benzamidine hydrochloride: 10 mM in dH2 0, stored at 4°C. 
Tris-EDTA (TE): Tns base (10 mM) and ethylenediaminetetraacetic acid (EDTA; 1 
mM) adjusted to appropriate pH (usually 7.5) with concentrated HC1. 
Tris-Borate-EDTA (TBE) 20x: Tris base (1.78 M), boric acid (1.78 M) and EDTA 
(0.05 M). 
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Phage buffer: KH2 PO4 (3 g), Na2 PO4 (7 g), NaCl (5 g), MgSO4 .7H2 0 (1 ml of 0.1 
M), CaCl2 (10 ml of 0.1 M), gelatine (1 ml, 1 % w/v), and dH 2 0 to 11. 
M9 Salts (4x): Na2 HPO4 .7112 0 (64 g 1'), KH2 PO4 (15 g 1'), NaC1 (2.5 g I'), NH4 C1 
(5.0 g 11). 
18 aa mix: DL-alanine (10 mg m1 1 ), L-arginine.HCJ (2 mg ml'), L-asparagine (10 mg 
ml'), L-aspartate (10 mg ml'), L-glutamine (10 mg ml'), glycine (10 mg ml'), L-
histidine (2 mg ml'), L-isoleucine (2 mg ml'), L-leucine (2 mg ml'), L-lysine.HC1 
(10 mg nil'), L-phenylalanine (2 mg ml'), L-proline (3 mg ml'), DL-serine (10 mg 
ml'), DL-threonine (10 mg ml'), L-tryptophan (2 mg ml'), L-tyrosine (2 mg ml 1 ), 
DL-valine (4 mg m1 1 ), L-glutamate (10 mg m1 1 ). 
Acetate buffer (pH 5.0): 50 mM acetic acid, adjusted to pH 5.0 with 10 M NaOH. 
Tris-MES (pH 6.5 or 8.0): Tris base (20 mM), 2-[N-morpholino]ethanesulphonic acid 
(MES, 20 mM), MgCl2 (10 mM), EDTA (1 mM), adjusted to required pH with 
concentrated HC1 or 10 M NaOH. 
Piperazine buffer (pH 9.5): 20 mM piperazine, adjusted to pH 9.5 with concentrated 
HC1. 
Diamino propane buffer (pH 10.3): 20 mM 1,3-diamino propane, adjusted to pH 10.3 
with concentrated HC1. 
Phosphate buffer (50 mM, pH 6.0): Na2 HPO4 (6.0 ml, 1M), NaH2 PO4 (44 ml, 1M), 
dH2 0 (to 11). 
Phosphate buffer (10 mM, pH 7.2): Na2 HPO4 (6.8 ml, 1M), NaH2 PO4 (3.2 ml, 1M), 
dl-]2 O (to 11). 
Phosphate buffer (pH 11.9): Na 2 HPO4 (50 ml, 50 mlvi), NaOH (23 ml, 0.1 M), and 
dl- 2 O (to 100 ml). 
Phosphate-buffered saline (PBS): NaCl (8 g I'), KC1 (0.2 g I'), Na2HPO4  (1.44 g I'), 
KH2 PO4 (0.24 g 11), adjusted to pH 7.5 with concentrated HC1. 
Tris-buffered saline (TBS): Tris (10 mM), NaCl (150 mlvi) adjusted to pH 7.5 with 
concentrated HC1. 
Cracking buffer: Tris.HC1 pH 6.8 (50 mM), sodium dodecyl sulphate (SDS, 2% w/v), 
bromophenol blue (0.1% w/v), glycerol (10% vlv), 2-mercaptoethanol (10% v/v), 
DTT (100 mM) 
Sterile solutions were prepared by autoclaving at 15 lb in -2  for 15 mm, unless 
otherwise stated. 
Media 
Luria (L) Broth: Difco Bacto tryptone (10 g 1'), Difco Bacto yeast extract (5 g 1'), 
NaCl (10 g 1'), pH adjusted to 7.2 with NaOH before autoclaving. 
Minimal Broth: to sterile dl- 2 O (300 ml) was added 4x M9 Salts (100 ml), glucose (4 
ml, 20%), Mg504 (1 ml, 1M), CaC12 (50 pJ, 1M) and vitamin B  (100 jtl, 2 mg ml'). 
Luria broth and minimal broth were converted to solid media by adding 15 g 1' and 10 
g I' Difco agar respectively. 
Baltimore Biological Laboratory (BBL) Agar: trypticase (10 g I'), NaCl (5 g I'), Difco 
agar (10 g 1'; top layer 6.5 g I'). 
TY (2x): Difco Bacto yeast extract (10 g I'), Difco Bacto tryptone (16 g I'), NaCl (10 
g1 1 ). 
SOC: L broth (100 ml) supplemented with glucose (1.8 ml, 20% wlv), MgSO4 (1 ml, 
1 M) and MgCl2 (1 ml, 1 M). 
Media was sterilised by autoclaving at 15 lb in -2  for 15 mm. 
Manipulation of bacteria and phages 
Long-term storage of bacterial cells 
A single colony was grown overnight in liquid media, under appropriate conditions, 
and used to inoculate L-agar in a small bottle ('stab'). After overnight incubation, the 
bottle cap was sealed and the stab stored at room temperature. 
Preparation of plating cells 
An overnight culture was diluted 20-fold in L-broth, grown to mid-logarithmic phase 
(0D650 —0.6, —5 x 108  cfu ml'), and the cells harvested by centrifugation (3 000 x g, 5 
mm). The pellet was resuspended in the same volume of 10 mM MgSO 4 , as the 
culture the cells were harvested from, and stored at 4°C. 
Preparation of A. lysates 
A single plaque was picked using a toothpick and resuspended in 1 ml phage buffer 
containing a few drops of chloroform (10 pfu m1' of XcI). 0.1 ml of an appropriate 
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dilution of the phage, to give confluent lysis (-10 pfu), was mixed with an equal 
volume of plating cells, left for 15 min to allow phage adsorbtion, and 2.5 ml molten 
BBL soft agar was added before the mixture was poured on fresh L-agar in a petri dish 
('plate'). The plate was incubated until confluent lysis was observed (usually 7-8 hr) 
and placed at 4°C overnight with an overlay of L-broth (4 ml). The broth was 
decanted, remaining cells lysed with a few drops of chloroform, and clarified by 
centrifugation (3 000 x g, 5 mm). The phage lysate was transferred to a fresh bottle 
and stored at 4°C. 
Restriction alleviation tests 
Plating cells were prepared from a restriction-proficient strain transformed with the 
plasmid of interest, and infected with appropriate dilutions of modified and unmodified 
phages. After adsorbtion (15 mm), infective centres were assayed by plating in top-
layer (2.5 ml) on BBL agar. Plaques were counted after overnight incubation and the 
titre of unmodified phages was normalised against the titre of modified phages, to 
correct for variation resulting from factors other than restriction. 
Modification enhancement tests 
Plating cells were prepared from a restriction-deficient, modification-proficient strain, 
transformed with the plasmid of interest (if relevant), and infected with unmodified ? 
phages at a multiplicity of infection (moi) of 0.1 (normally, 100 p.l each in a 1.5 ml 
microcentrifuge tube). After adsorbtion of the phages (15 mm), cells were harvested 
by centrifugation (11 000 x g, 5 mm) to remove unabsorbed phages, resuspended in 
pre-warmed L-broth (10 ml in a 100 ml flask), and grown with aeration under 
appropriate conditions (normally 37°C). After the phages had undergone a single 
round of infection (70 mm), a sample (1 ml) of the lysate was removed and remaining 
cells lysed by the addition of a few drops of chloroform. The degree of phage 
modification was estimated by measuring the efficiency of plating (eop) of progeny 
phages on a restricting strain versus a non-restricting strain. Modified X phages were 
used as a control to ensure that the plating efficiencies of the indicator bacteria were 
comparable. 
Construction of strains carrying hsdRA4 
The hsdRM derivatives of NM7 10 (NM792), and NM777 (NM794) were made by 
transferring the deletion from an Ahsd phage to the bacterial chromosome (Gough and 
Murray, 1983). The host was infected with ?NM1 118 (A.hsdRA4cI857Mtt) and 
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grown in top-layer on BBL-agar overnight at 30°C. Lysogens were selected by 
streaking samples from the centre of lysis on L-agar seeded with homo-immune XcI 
phages of different host ranges (--10 pfu ANM63 and ?NM220 or ANM 144). Cells 
were purified and lysogens confirmed by their sensitivity to Xvir, but immunity to Ad 
phages. ANM1 118 has a deletion removing the attachment site and is only able to 
integrate efficiently into the host chromosome by homologous recombination, 
therefore, lysogens probably have the phage genome integrated in the hsd genes. 
The ANM11 18 lysogens were streaked on L-agar and grown overnight at 42°C. Of 
the surviving cells, a proportion will retain the hsdRA4 deletion after excision of the A. 
genome from the host chromosome. The cured-lysogens were purified and hosts that 
were no longer able to restrict unmodified phages were presumed to have acquired the 
hsdRA4 deletion. 
Preparation of WE3 lysogens 
Phage A.DE3 (Studier and Moffatt, 1986) contains T7 gene 1, encoding T7 RNA 
polymerase, inserted in the mt gene of a phage A vector (A.D69; Mizusawa and Ward, 
1982). In order for ADE3 to lysogenise its host, the mt gene product has to be 
provided in trans. ADE3 was isolated from a culture of BL21(DE3), by infecting 
plating cells (100 Pd)  with the helper phage XNM75 (moi —10; A.immintxi?) and 
selecting for ADE3 (imm 21) by growth on a Aimm lysogen (NM477immA).  Phages 
were plaque-purified and the immunity of phage 21 confirmed by their inability to 
grow on BL21(DE3). 
Lysogens of ADE3 were prepared by co-infecting cells with ADE3 and XNM75 (moi 
—10) in top layer on BBL-agar, and selecting for lysogens with the immunity of phage 
21 by streaking on L-agar seeded with two homo-immune AcT phages of different host 
ranges (-10 pfu A.NM507 and ANM508). Lysogens were purified and the immunity 
confirmed by their sensitivity to Avir, but not Aimm 2 ' phages. Monolysogens were 
confirmed by their sensitivity to AcT, and these imm 2 ' hosts were presumed to have 
been lysogenised by XDE3. 
P1 transduction 
Transduction using Plkc was achieved in two stages (Miller, 1992). A P1 lysate was 
made on the donor strain, resulting in the packaging of host DNA in a small proportion 
of phage heads, and the recipient transduced by growth with the phage and selection 
for recombinants. 
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P1 lysates were prepared in a similar way to X plate lysates. An overnight culture of 
the donor strain was diluted 20-fold in L-broth supplemented with CaCl 2 (5 mM) and 
grown to mid-logarithmic phase (0D 650 -0.6) with good aeration at 37°C. Cells were 
harvested (3 000 x g, s mm) and resuspended in a tenth volume of L-broth containing 
CaCl2 (5 mM). Dilutions of P1 kc (100 p1) were used to infect an equal volume of cells 
and allowed to adsorb for 20 min before the mixture was plated in top layer (2.5 ml) 
on L-agar. Lysates were harvested after overnight incubation at 37°C by adding L-
broth (4 ml) and transferring to 4°C, for a minimum of 6 hr, before decanting the 
phage lysate. Remaining cells were lysed by adding a few drops of chloroform, the 
phage lysate clarified by centrifugation and stored at 4°C. 
Cells from an overnight culture of the strain to be transduced were harvested by 
centrifugation (3 000 x g, 5 mm) and resuspended in an equal volume of an aqueous 
solution containing MgSO4 (10 mlvi) and CaCl2 (5 miVi). Samples (100 jil) of the 
P lkc phage lysate (grown on the donor strain and serially diluted) were mixed with an 
equal volume of cells, and incubated at 37°C for 20 min to allow phage adsorbtion. 
Sodium citrate (200 tl; 1 M, pH 8.5) was added, to prevent re-infection of the bacteria 
by the P1 phages, and infected cells were spread on solid selective media. After 
incubation (usually at 37°C, for 24 to 36 hr), transductants were purified and 
phenotypes confirmed or, in the case of co-transduction, transductants were screened 
for the required phenotype. 
Construction of NM793(DE3) 
NM793(DE3) was made by a series of P1 transductions. An efficient donor of supF, 
tagged with a closely linked transposon, was generated by the P1-mediated transfer of 
trpC::TnlO from a sup' strain (W31 lOtrpC::TnlO) to the supF strain, Ymel. 
Tetracycline-resistant transductants of Ymel were selected on L-agar supplemented 
with 10 pg ml tetracycline and screened for the retention of supF by their ability to 
suppress XSam7 (XNM123), but not XPa,n3 (XNM435). Phage P1 grown on this 
host (NM787) was used to transduce BL2 1 (DE3). Tetracycline-resistant transductants 
were selected for as before and screened for the presence of supF by their ability to 
suppress ?JJam7Nam53 (2NM22), a phage chosen to avoid complementation by the 
resident imm 2 ' prophage. Phage P1 was grown on the trpC host and used to 
regenerate a prototrophic strain (NM793). These were selected on M9-minimal agar 
and screened for the presence of the supressor mutation as described above. 
Manipulation of nucleic acids 
Large-scale preparation of plasmid DNA 
Large amounts of purified plasmid DNA were prepared by a modified method of 
Clewell and Helinski (1969). Cells transformed with the required plasmid were grown 
overnight (250 ml, usually at 37°C) and harvested by centrifugation (8 000 x g, 10 
mm). The pellet was resuspended in lysis solution (7 ml; 25 mm Tris.HC1 pH 8.0, 10 
mM EDTA pH 8.0, 1% w/v glucose), cells disrupted by the addition of lysozyme (10 
mg) and left on ice for 5 mm. Freshly prepared alkaline-SDS (14 ml; 0.2 M NaOH, 
1% w/v SDS) was added to the mixture and left for 10 min on ice before potassium 
acetate (3.5 ml; 3 M, pH 5.0) was added. After a further 5 min incubation on ice, the 
DNA solution was clarified by centrifugation (8 000 x g, 10 mm) and passed through a 
funnel stuffed with glass wool to remove any remaining debris. Nucleic acid was 
precipitated with isopropanol (15 ml) at 4°C (15 mm) and sedimented by centrifugation 
(8 000 x g, 10 mm). The pellet was washed with 70% ethanol, dried under vacuum (5 
mm), and resuspended in dl- 2 O (9 ml) containing ethidium bromide (0.5 ml, 10 mg 
m1'). CsC1 (9.5 g) was dissolved in the DNA solution, transferred to a Sorvall 
Ultracrimp tube (DuPont Ltd.) and a density gradient formed by centrifugation (130 
000xg, 48 hr). 
The DNA was visualised with uv-light and two bands were normally distinguished. 
The upper band contains chromosomal DNA, linearised and nicked plasmid DNA, 
whereas the lower band should contain only supercoiled plasmid DNA and this was 
collected using a hypodermic needle and syringe to puncture the side of the tube. 
Ethidium bromide was extracted in isopropanol saturated with TE and NaCl, by 
vigorously mixing the two solutions and leaving the phases to separate before 
removing the solvent layer. The solution was diluted in two volumes of dH 2 O and the 
DNA precipitated by adding a further two volumes of ice-cold ethanol. The CsCl, 
removed with the DNA from the gradient, was not usually precipitated using this 
method, but if it was thought necessary, excess salt was removed by dialysis. The 
DNA was sedimented by centrifugation (29 000 x g, 15 mm), rinsed with 70% ethanol 
and dried under vacuum. The DNA was resuspended in dH 2 O (500 .il), any 
remaining protein removed using phenol and precipitated with ethanol (see below). 
Removal of proteins with phenol 
Proteins were removed from solutions containing DNA by vigorously mixing equal 
volumes of DNA and buffered phenol solutions, separating the two phases by 
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centrifugation (11 000 x g, 3 mm) and removing the aqueous, DNA-containing, layer 
to a fresh tube. Buffered phenol solutions were prepared from either solid or water-
saturated phenol (Hastings and Kirby, 1966). Tris.HC1 pH 7.8 (110 ml, 1 M), m-
cresol (14 ml), 2-mercaptoethanol (500 tl), and hydroxyquinoline (0.28 g) were 
added to the phenol (250 g solid and 14 ml dH2 0 or 241 ml water-saturated phenol) 
and mixed using a magnetic stirrer-bar for 30 min at 20°C. The buffered phenol 
solution was transferred to a polypropylene bottle and stored in the dark at 4°C 
Precipitation of DNA with ethanol 
DNA in solution was precipitated by the addition of a tenth volume of sodium acetate 
(3 M, pH 5.3), two volumes of ice-cold ethanol, and left at -20°C for 20 mm. The 
DNA was sedimented by centrifugation (11 000 x g, 20 mm), rinsed with 70% 
ethanol, dried under vacuum and resuspended in an appropriate volume of dH 0 or TE 
buffer. 
Small-scale preparation of plasmid DNA 
Cells transformed with the plasmid were harvested by centrifugation (11 000 x g) from 
a culture (1.5 ml) grown overnight and plasmid DNA isolated by a method based on 
those of Holmes and Quigley (1981) and He et al. (1990). The pellet was resuspended 
in TELT buffer (400 il; 50 mM Tris.HC1 pH 7.5, 62.5 mM EDTA pH 7.5, 2.5 M 
LiC1, 0.4% v/v Triton X100), and left at 20°C (2 mm) after the addition of lysozyme 
(40 t1 of 100 mg ml' in TELT). The mixture was heated to 100°C (2 mm) to denature 
proteins, then cooled on ice (10 mm) and clarified by centrifugation (11 000 x g, 15 
mm). Plasmid DNA in the supernatant was precipitated by adding isopropanol (200 
p1) at 4°C (2 mm) and the DNA was sedimented by centrifugation (11 000 x g, 20 
mm). The pellet was rinsed with 70% ethanol, dried under vacuum, resuspended in 
dl- 2 O or TE buffer (20 tl) and stored at -20°C. 
Small-scale preparation of phage A. DNA 
Phage DNA was prepared by a method devised by A. Titheradge (unpublished). A 
culture of an appropriate host was diluted 40-fold in L-broth (4 ml), supplemented 
with MgSO4 (10 mlvi), infected with the required phage at a moi —5 (_108  pfu) and 
grown with aeration until lysis (normally, 37°C for 4 hr). Remaining cells were lysed 
by the addition of chloroform (100 t1), cell debris was removed by centrifugation (3 
000 x g, 10 mm), and nucleases (5 p1, 10 mg ml' RNase and DNase) added to the 
supernatant in a fresh tube. The lysate was incubated at 37°C for 30 mm, and the 
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phage precipitated by the addition of polyethylene glycol (PEG) and salt (4 ml; 20 g 
6K PEG, 11.7 g NaCl, 78 ml phage buffer). The mixture was left overnight at 4°C, 
and the phage particles sedimented by centrifugation (13 000 x g, 20 mm, 4°C). Care 
was taken to remove most of the PEG, and the phages were resuspended in phage 
buffer (500 p.1). Chloroform was added (500 p.1) to remove any remaining PEG, the 
mixture clarified by centrifugation (5 000 x g, 3 mm) and the aqueous phase 
(containing the phage particles) transferred to a tube containing phenol (500 pJ) and TE 
buffer (100 p.1). The two phases were separated by centrifugation (11 000 x g, 3 mm), 
and the aqueous phase transferred to a tube containing phenol (250 p.1) and chloroform 
(250 p.1). The aqueous phase, containing naked phage DNA, was separated as before, 
mixed with an equal volume of chloroform and the aqueous phase collected. To 
remove some of the excess salt carried over from the stages with phage particles, the 
DNA in solution was precipitated with ethanol twice, resuspended in TE (100 p.1) and 
stored at -20°C. 
Cutting of DNA, with type II ENases 
DNA was cut by type II ENases in buffers recommended and provided by the 
supplier. Digests were normally done with 1 to 2 p.g DNA, and 5 units of enzyme in 
lx buffer (10 p.1), and incubated at the recommended temperature (normally 37°C) for 
a minimum of 1 hr. 
Removal of 5'-phosphates 
The phosphates were removed from the 5' end of vector DNA to aid the recovery of 
recombinant molecules, as these ends are not a substrate for DNA ligase. The reaction 
was done in the buffer supplied with the enzyme (TA buffer), generally with 1 to 2 p.g 
DNA, CaCl2 (5 mM) and 1 unit of HK phosphatase. The mixture was incubated at 
30°C for 1 hr, and the enzyme inactivated by heating to 65°C for 30 mm. 
Generation of blunt-ended fragments 
Recessed 3'-ends were filled using Kienow DNA polymerase, to generate blunt-ended 
fragments. Kienow polymerase (1 unit in 20 p.1) and dNTPs (0.4 MM) were added to 




Ligation of DNA 
DNA was ligated using T4 DNA ligase (Murray et al., 1979), in buffer supplied with 
the enzyme (66 mM Tris.HC1 pH 7.5, 5 mM MgCl2 , 1 mM DTT, 1mM ATP). The 
ligation reaction was normally done in a final volume of 10 t1 buffer, with 50 to 100 
ng vector DNA, 0.5 units enzyme and incubated at 16°C overnight. 
Agarose gel electrophoresis 
DNA fragments were separated by electrophoresis through horizontal agarose gels 
submerged in lx TBE containing ethidium bromide (0.8 mg ml'). The concentration 
of agarose varied, depending on the size of DNA fragments, but was generally 
between 0.7 and 1.5% w/v. Samples containing DNA were mixed with Ficol-loading 
dye (30% w/v; 40% w/v Ficol 400, 0.05% w/v bromophenol blue in TE buffer), 
applied to the gel and electrophoresis done at 5 Vcm'. The DNA was visualised over a 
uv-light transilluminator and photographed with a video copy processor (Mitsubishi 
Electronics Corp.). ? DNA (XSam7cI857) cut with Hindu, or a 123 bp ladder (Life 
Technologies Ltd.) were routinely used as standards. 
Recovery of DNA from agarose gels 
The region of the gel containing the required fragment of DNA was isolated using a 
scalpel and placed in dialysis tubing closed at one end. The piece of gel was covered 
with lx TBE, any air removed and the tubing sealed. The dialysis tubing was 
submerged in lx TBE and the DNA eluted from the agarose by electrophoresis (5 V 
cm', 30 mm). The DNA was released from the sides of the tubing by reversing the 
direction of electrophoresis (10 sec), and the DNA solution removed to a 
microcentrifuge tube. Ethidium bromide was extracted with dH 2 0-saturated 
isobutanól, protein removed with phenol, the DNA precipitated with ethanol and 
resuspended in an appropriate volume of dH 2 0 or TE buffer. 
Transformations 
Cells were made competent by electroporation (Heery and Dunican, 1989). An 
overnight culture was diluted 20-fold in 2x TY media and grown to mid-logarithmic 
phase (0D650  -0.6), the cells harvested by centrifugation (3 000 x g, 5 mm, 4°C) and 
washed three times in ice-cold dH2 0. The pellet was resuspended in an equal volume 
of dH2 0 (normally 100 p1) and samples (40 p1) added to dilute DNA solutions (usually 
5 to 20 ng in 5 p1). The mixture was placed in an electroporation cuvette (0.2 cm) and 
pulsed (4.8 msec) with an electric field (12.5 kV cm') using a Gene Pulser 
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electroporator (BioRad Laboratories Ltd.; settings, 25 pF, 2.5 kV, 200 Q). Soc 
media (1 ml) was immediately added to the mixture, transferred to a small bottle and 
incubated under appropriate conditions to allow expression of genes whose products 
confer the selective advantage (normally, 37°c for 20 mm). Samples (10 and 100 tl) 
were spread on selective agar and incubated overnight. 
The polymerase chain reaction 
DNA was amplified using the polymerase chain reaction (PCR) essentially as 
described by Saiki et al. (1988) using either Taq or VentR  DNA polymerase and the 
buffers supplied with the enzymes. The reaction mixture contained oligonucleotide 
primers (200 nM), dNTPs (50 jiM), buffer (20 mM (NH4 )SO4 , 75 mM Tris.Hcl pH 
8.8, 0.1% v/v Tween 20, 2.5 mM MgCl2 ), template and 50 U ml' Taq DNA 
polymerase, or primers (400 nM), dNTPs (200 jiM), buffer (10 mM KC1, 10 mM 
(NH4 )SO4 , 20 mM Tris.HCI pH 8.8, 0.1% v/v Triton X100, 2 mM MgCl 2 ), template 
and 20 U m14  VentR  DNA polymerase. The template was usually phage DNA 
(approximately 1 ng RI -1 ) although phage lysates, colonies, plasmids or products of a 
primary PCR, were also used as a source of the DNA template. In general, 
amplification with VentR  DNA polymerase required more template than Taq. 
Amplification was performed in an OmniGene thermal cycler (Hybaid Ltd.) and a 
general program profile consisted of three stages. The DNA was denatured for 5 mm 
to provide single-stranded template, followed by multiple cycles of denaturation (1 
mm), annealing (40 sec) and extension (40 sec), with the last extension stage increased 
to 10 mm. 
DNA denaturation was at 96°C for VentR,  but 94°C for the less thermo-tolerant 
enzyme, Taq. The choice of annealing temperature is dependent on the DNA 
sequence, and was estimated to be 5°C lower than the melting temperature of the 
sequence. The melting temperature Tm  was estimated using the equation: 
Tm  4[G+C] + 2[A+T] 
The choice of annealing temperature was the factor that appeared to have the greatest 
influence on the amount of product obtained. Extension from the primers was done at 
72°C, and the final incubation of the reaction at 72°c for 10 min assured that most of 
the products were full-length. The denaturation-annealing-extension stage was 
generally repeated 30 times, although this was reduced to 20-25 times when the fidelity 
of replication was considered important, e.g. site-directed mutagenesis. 
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End-labelling of oligonucleotides 
Oligonucleotides were labelled for use in gel retardations by using T4 polynucleotide 
kinase (PNK) to transfer a labelled-phosphate from [y- 32P]dATP to the 5' end of the 
DNA (Midgley and Murray, 1985). The oligonucleotide was mixed in buffer (20 p1 
reaction volume; 500 mM Tris.HC1 pH 7.5, 100 mM MgCl2 , 50 mM DY1') with [7-
32P]dATP (1 p1, -3 000 Ci mmol') and T4 PNK (50 fold dilution in 25 MM Tris.HC1 
pH 7.5, 10 mM 2-mercaptoethanol, 50% v/v glycerol), and incubated at 37°C for 45 
mm. The enzyme was inactivated by heating to 68°C for 10 mm, and the 
unincorporated label removed using a NuTrap probe-purification push column 
(Stratagene Ltd.). The oligonucleotide was eluted in TE buffer (70 p1) and annealed to 
an unlabelled, complimentary oligonucleotide to generate double stranded DNA for gel 
retardation. 
Products of the PCR reaction were 'end-labelled' using 'cold' dATP if they were 
cloned as blunt-ended fragments. The reaction conditions were similar, but 30 mM 
ATP was substituted for [°y- 32P]dATP and the products were not column-purified. 
Nucleotide sequence analysis 
Nucleotide sequence was determined by chain-termination sequencing (Sanger et al., 
1977) using Sequenase 2.0, and the method described is based on the recommended 
procedure (Amersham International plc.). Double-stranded DNA template (3 to 5 pg 
in 10 p1) was mixed with an oligonucleotide primer (1 to 50 pmoles) and denatured by 
heating to 100°C for 4 mm, followed by rapid freezing in dry ice. A reaction mix was 
made by combing DTT (2 p1, 0.1 M), Sequenase labelling mix (0.7 .1l; 1.5 pM dGTP, 
1.5 p,M dCTP, 1.5 .tM dTTP), Sequenase reaction buffer (2 p1; 200 m Tris.HC1 pH 
7.5, 100 mM MgCl2 , 250 mlvi NaCl), [35S]dATPCcS (0.5 p1; 400 Ci mmot') and 
Sequenase 2.0 T7 DNA polymerase diluted eight-fold in enzyme dilution buffer (2.5 
p1; 10 mM Tris.HC1 pH 7.5, 5 mM DTT, 0.5 mg m1' bovine serum albumin). The 
reaction mixture was added to the thawed template-primer and incubated at 20°C for 4 
mm. Samples (4 p1) were added to each of 4 ddNTP termination mixes (each 
termination mix contained 80 jiM dGTP, dATP, dCTP and dTTP in 50 MM NaCl with 
8 jiM of either ddGTP, ddATP, ddCTP, or ddTTP) and incubated at 37°C before the 
reaction was halted by the addition of stop solution (4 pI;  95% v/v formamide, 20 MM 
EDTA, 0.05% w/v bromophenol blue, 0.05% w/v xylene cyanol FF). The DNA 
solutions were denatured by heating to 100°C for 3 mm, and the products separated by 
polyacrylamide gel electrophoresis (PAGE) in the presence of urea. 
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When reactions used template DNA amplified by the PCR, dimethyl suiphoxide 
(DMSO) was added to each stage of the reaction (10% v/v) to help prevent problems 
related to secondary structure formation (Winship, 1989). 
DNA-denaturing PAGE 
The products of the nucleotide sequencing reactions were separated on a 6% 
polyacrylamide gel using SequiGen apparatus (BioRad). A stock solution was made 
containing acrylamide/bis-acrylamide (21 ml; 40% w/v, 19:1), urea (59.5 g), TBE 
buffer (3.5 ml, 20x), dl- 2 O (to 140 ml) and stored in the dark at 4°C. The base of the 
gel plates was sealed with a small volume (10 in]) of the urea-acrylamide mix 
polymerised with ammonium persulphate (AMPS; 125 jtl, 10% w/v) and TEMED (50 
.tl), and the gel formed by pouring a solution of urea-acrylamide mix (30 ml), AMPS 
(125 p1, 10% wlv), and TEMED (50 p1) between the two plates. The acrylamide was 
allowed to polymerise and electrophoresis done in lx TBE buffer at a constant power 
of 40 W. The gel was pre-warmed to 55°C and the samples heated to 100°C (3 mm), 
prior to loading. After electrophoresis, the gel was soaked in a solution containing 
methanol (10% v/v) and acetic acid (10% v/v) for 20 mm, to fix the DNA and remove 
urea from the gel. The gel was dried at 80°C under vacuum for 90 mm, and labelled-
DNA visualised by autoradiography. 
A utoradiography 
Autoradiography was used to detect DNA labelled with 35  in sequencing reactions, 
32P for gel retardations, and proteins from cells grown in the presence of 
[3  5S]cysteine. 
Gels dried on filter paper were placed in direct contact with BioMax (detection of 35S) 
or Cronex (detection of 32P) X-ray film, and stored at 20°C (355)  or -70°C (32P) until 
developed using an automatic film processor (X-Ograph Ltd.). 
Fluorography 
Fluorography was used to detect [methyl- 3 H]DNA, methylated by the EcoKI MTase in 
the presence of labelled-AdoMet. DNA was separated from AdoMet by non-
denaturing PAGE, and the DNA fixed in the gel by soaking in a solution of methanol 
(10% v/v) and acetic acid (10% v/v) for 30 min with agitation. After fixing, the gel 
was covered in Amplify (Amersham International plc.), soaked for a further 30 nun as 
before, and dried on a piece of blotting paper under vacuum at 80°C for 2 hr. The 
dried gel was placed in direct contact with Hyperfilm MP and stored at -70°C until the 
film was developed using an automatic film processor. 
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Manipulation of proteins 
Liquid chromatography was carried out using a modular system purchased from either 
Pharmacia Biotech Ltd. or ISCO Inc., and high performance (high pressure) liquid 
chromatography (HPLC) used a modular system from Gilson Medical Electronics Inc. 
Spectroscopy was done on a Perkin Elmer Lambda 5 spectrophotometer, and proteins 
were further analysed by N-terminal sequence analysis (A. Cronshaw, Dept. 
Biochemistry) and matrix-assisted laser desorption ionisation, time of flight (MALDI-
TOP) mass spectroscopy (K. Shaw, Dept. Chemistry). 
Columns and media 
The Resource S (1 ml, cation exchanger), Resource Q (1 ml, anion exchanger), Hi-
Load 16/60 Superdex 200 (gel filtration), PD-l0 (gel filtration), and Hi-Trap NHS 
activated (1 ml, affinity chromatography) pre-packed columns were purchased from 
Pharmacia Biotech Ltd.; The Econo-Pac Q (5 ml, anion exchanger) column was from 
BioRad Laboratories Ltd., and the Vydac C 18 (110 x 4.6 mm, HPLC) column was 
from Anachem Ltd. 
Diethylaminoethyl- (DEAE-) Sepharose (anion exchanger), Carboxymethyl- (CM-) 
Sepharose (cation exchanger) and Heparin-agarose were purchased from Sigma-
Aldrich Company Ltd.; Sephadex G-50 was from Pharmacia Biotech Ltd, and 
Hydroxyapatite-BioGel was from BioRad Laboratories Ltd. When required, the resin 
was packed in a modular-system C-column from Pharmacia Biotech Ltd. 
Determination of protein concentration in solution 
The concentration of proteins in solution was estimated, from measurements of uv-
light absorption, using the equation (Harris, 1987): 
protein (mg ml') - 1.55 Ab280 - 0.76 Ab260 
The concentration of Ral and the EcoKI MTase was calculated from the absorbance at 
280 rim. (Ab280), using the molar extinction coefficient (E) estimated from the sum of 
values of the absorbance (Mihalyi, 1970) of tyrosine, tryptophan and phenylalanine 
residues in the proteins (, at 280 nm of a 1 mg ml' solution, EcoKJ MTase = 0.842, 
Ral = 1.62). 
The absorption spectrum between 240 and 340 nm was routinely used to examined 
purity and aggregation of proteins in solution. The purity was estimated by taking the 
ratio of absorbance at 280 nm and 250 nm; aromatic residues, e.g. tryptophan, absorb 
at 280 nm whereas nucleotides, in particular, absorb at 250 nm. Particles in the 
solution, e.g. protein aggregates, scatter light that is seen as a deviation in the base line 
at higher wavelengths. 
Coupling of Rai to keyhole limpet hemocyanin 
Peptides used as immunogens are usually coupled to a carrier protein to enhance the 
immune response to the peptide (Gnann et al., 1989). Synthetic Ral may be 
sufficiently large not to require a carrier protein to stimulate an immune response, but it 
was coupled to the carrier keyhole limpet hemocyanin (KLH) as this was unlikely to 
decrease its immunogenic properties. KLH was activated with maleimidobenzoic acid-
N-hydroxysuccinimide ester (MBS). An KLH solution was made in phosphate buffer 
(pH 7.2), dialysed overnight, and adjusted to a concentration of 20 mg ml'. A sample 
(250 j.fl) was removed, 55 pJ phosphate buffer (10 mM, pH 7.2) added and mixed 
with 85 i1 MBS (6 mg ml' in dimethylformamide, DMF). MBS was added dropwise 
to ensure that local concentrations of DMF did not cause precipitation of the KLH, and 
the mixture was stirred for 30 min at 20°C. A column packed with Sephadex G-25 
(PD- 10)was washed with phosphate buffer, pH 6.0 (50 mM), and the protein solution 
applied to separate the activated KLH from free MBS. The eluted protein (-1.5 ml) 
was mixed with an equal volume of synthetic Ral, dissolved in phosphate-buffered 
saline (PBS pH 7.5; —2 mg unpurified synthetic Ral), and was left, with stirring, at 
20°C (3 hr). The coupled KLH-Ral mixture was divided in two, and used to inoculate 
rabbits (R707 and R708; G. Ledbetter, Dept. Medical Microbiology; first inoculation 
mixed with Freund's complete adjuvant). 
Coupling of Rai to NHS-activated Sepharose 
Synthetic Ral (Brown et al., 1993) was covalently coupled to agarose using a HiTrap 
N-hydroxysuccinimide- (NHS-) activated Sepharose column (1 ml). The column was 
washed with 6 volumes of HC1 (1 mM, 4°C) and synthetic Ral (0.6 mg; AB72B and 
AB80B) applied in 1 column volume of a solution containing NaCl (0.5 M) and 
NaHCO3 (0.2 M, pH 8.3) at 1 ml min - '. The column was sealed and left at 4°C (4 hr) 
to allow coupling of the ligand. The NHS-Sepharose was deactivated, and excess 
ligand eluted from the column, by washing with 2 buffers alternately, buffer A (0.5 M 
ethanolamine, 0.5 M NaCl, pH 8.3) and buffer B (0.1 M acetic acid, 0.5 M NaCl, pH 
4.0). Six column-volumes of buffer were passed through the column sequentially at 1 
ml min- ' (A, B, A, left 30 mm, B, A, B), neutralised with 2 column-volumes of 
Tris.HC1 pH 8.0 (100 mM) and stored in 20% ethanol. 
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Gel retardation 
Gel retardations were done essentially as described by Powell et al. (1993). The 
cofactor AdoMet (100 j.tM) was incubated separately with 32P-labelled DNA and 
protein (0.2 nM DNA; 100 nM purified EcoKI MTase and 2 mM Ral) for 10 min at 
4°C in buffer containing 20 mM Tris.HCJ pH 8.0, 100 mM NaCl and 5% glycerol. 
Equal volumes of protein and DNA mixtures were combined and incubated for 10 mm 
at 4°C, followed by the addition of purified Ral antibodies (10 jfl). After 20 min at 
4°C, complexes were separated by non-denaturing PAGE (5% w/v polyacrylamide) 
and labelled-DNA visualised by autoradiography. 
Non-denaturing PAGE 
Non-denaturing PAGE was used for gel retardations (5% w/v polyacrylamide) and for 
the separation of labelled-DNA and [methyl- 3 H]AdoMet in MTase assays (12% w/v 
polyacrylamide). AMPS (100 jil, 10% w/v) and TEMED (40 jil) were added to a 
mixture of acrylamide (10.1 ml for a 12% gel, 4.2 ml for a 5% gel; 30% w/v 
acrylamide/bis-acrylamide [37.5:1]), TBE (2.5 ml, 20x) and dH2 0 (made-up to 25 ml) 
and poured between two glass plates sealed with the spacer (1 mm; ATTO Corp.) held 
together with bulldog clips. After polymerisation, samples were applied to the gel in 
glycerol (10%) and electrophoresis done in lx TBE buffer at a constant current of 30 
mA. The gel-front was marked by applying a sample (5 j.il) of Ficol loading buffer to 
an empty well. 
Labelling of proteins 
Proteins encoded by genes under the control of the T7 promoter were labelled with 
[3 5S]cysteine essentially as described by Tabor (1990). Rifampicin specifically inhibits 
E. coli RNA polymerase, and genes under the control of T7 RNA polymerase are still 
expressed in the presence of the antibiotic. These gene products may be specifically 
labelled after addition of the antibiotic. BL2 1 (DE3), or NM794(DE3), was 
transformed with the plasmid of interest and grown at 37°C with good aeration to an 
0D650 —0.4 in L-broth supplemented with ampicillin (100 jig ml'). Cells from 1 ml of 
culture were harvested by centrifugation (11 000 x g, 5 mm) and resuspended in M9-
minimal media. The cells were harvested, as before, and resuspended in 1 ml M9-
minimal media supplemented with 18 aa mix (5% v/v) and ampicillin. The culture was 
incubated, with aeration at 37°C for 60 mm, and expression of the T7 RNA 
polymerase gene induced by the addition of 0.6 mM IPTG. After 20 mm, cultures 
were warmed to 42°C and, 10 min later, rifampicin added (200 jig ml'). Cells were 
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incubated with rifampicin for 10 min at 42°C, as the antibiotic efficiently inhibits 
expression of host-encoded proteins at this temperature, and the culture was shifted to 
37°C for 20 mm, a temperature suitable for efficient labelling. A sample (500 pA) was 
removed, [35S]cysteine added (10 pCi), and cells incubated for a further 5 min at 
37°C. Cells were harvested by centrifugation (11 000 x g, 5 mm), resuspended in 
'cracking' buffer (100 .tl) and heated to 100°C (5 mm). Polypeptides were separated 
by Tris-tricine SDS-PAGE and labelled proteins visualised by autoradiography. 
Tris-tricine SDS-PA GE 
SDS-PAGE with a buffer containing tricine was used (Schagger and von Jagow, 
1987), instead of the usual Tris-glycine buffer system (Laenmili, 1970), to achieve 
good separation of proteins in the 5 to 20 kDa range. This discontinuous method uses 
three gels, a stacking, spacer and separating gel. SDS is used to ensure a similar 
charge to mass ratio for each protein, hence, proteins are separated on the basis of 
molecular mass. To get good resolution, it is important that proteins in the sample 
reach the separating region of the gel at the same time, and this is achieved by the 
stacking of proteins in the stacking gel. The spacer gel also helps to stack low 
molecular weight proteins, although if high resolution was not thought to be a critical 
factor then this gel was omitted. tricine, instead of the usual glycine, also aids the 
stacking of proteins under 30 kDa. 
The stacking gel contained 4% acrylamide (1 ml; all gels used a 49.5% w/v 
acrylamide/bis-acrylamide [32:1] stock solution), gel buffer (3.1 ml; 3 M Tris.HC1 pH 
8.45, 0.3% w/v SDS), and dH2 O (to 12.5 ml). The spacer gel contained 10% 
acrylamide (6.1 ml), gel buffer (10 ml) and dH2 O (to 30 ml). The separating gel. 
contained 16.5% acrylamide (10 ml), gel buffer (10 ml), glycerol (4 ml) and dH 2 0 (to 
30 ml). 
The acrylamide solutions were polymerised by the addition of AMPS (100 il, 10% 
w/v) and TEMED (10 pA) and poured between two sealed glass plates (ATTO Corp., 
or Hoffer Scientific Instruments for minigels). The stacking and spacer gels were 
made approximately twice the thickness of the wells, although the spacer gel was 
usually omitted when using minigels. A flat interface between different gels was 
achieved by overlaying each gel with butan-2-ol until polymerised, and removing the 
solvent before applying the next layer. Samples were mixed in 'cracking' buffer, and 
heated to 100°C (5 mm) before applying to the gel. Electrophoresis was done with 
different anode and cathode buffers (0.2 M Tris.HC1 pH 8.9 and 0.1 M Tris 0.1 M 
tricine pH 8.25, respectively), initially at a constant voltage of 30 V, until the sample 
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had completely entered the stacking gel, and then increased to 85 V overnight (150 V 
for a minigel, 4°C, 4 hr). Low molecular weight markers (Sigma-Aldrich Ltd.) were 
used as standards. 
Staining of proteins with coomassie 
Proteins were stained in an aqueous solution of ethanol (250 ml 1- '), formaldehyde (10 
ml 1', 35%) and brilliant blue R (1.2 g 1 - '), and the stain removed from the gel by 
soaking in a solution of methanol (10% v/v) and acetic acid (10% v/v). The destain 
was changed periodically and timings were arbitrary. 
Western blotting 
Proteins were transferred from a polyacrylamide gel to PVDF membrane by wet 
elecrophoretic transfer (Towbin et al., 1979) using a TransBlot Cell (BioRad 
Laboratories Ltd.). Six pieces of blotting paper, PVDF membrane wetted with 
methanol, support pads from the cell ; and the gel itself were soaked in transfer buffer 
(3 1; 25 mM Tris, 190 mlvi glycine) to remove any air bubbles, and assembled in a 
'sandwich' while submerged in buffer. The gel and membrane were placed on 3 
pieces of filter paper on top of a support pad, and the remaining 3 pieces of filter paper 
were placed on top of this. The other support pad was then placed on the top and the 
'sandwich' placed in the buffer tank and covered with transfer buffer. The proteins 
were transferred by electrophoresis, taking care that the membrane was on the correct 
(positive) side of the assembled cell, at a constant voltage of 30 V overnight or, for a 
minigel, 40 V, 1.5 hr. 
After electrophoresis, the apparatus was dismantled and the membrane used for 
immunodetection. When required, the transferred protein was visualised by coomassie 
staining using solutions suitable for the PVDF membrane (stain: 50% v/v methanol, 
10% v/v acetic acid, 0.1% w/v brilliant blue R; destain: 50% v/v methanol, 10% v/v 
acetic acid). The membrane was blocked, to prevent non-specific adsorption of the 
antibodies during immunodetection, with a solution made from non-fat dried milk 
(10% w/v in Tris-buffered saline; TBS) for 1 hr at 37°C. The block was removed, and 
primary antibody (usually sera from R707 at 1:1000 in block) incubated with agitation 
at 20°C. After an hour, the primary antibody mixture was removed, the membrane 
washed 4 times in TBS and the secondary antibody added. The secondary antibody 
was anti-rabbit IgG labelled with horseradish peroxidase, and was used at 1:5000 in 
block. After incubation at 20°C (1 hr) with agitation, the antibody mixture was 
removed and the membrane washed as before. The secondary antibody was detected 
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using ECL reagents (Amersham International plc.); the conjugated enzyme causes 
oxidation of luminol, emitting light that may be detected with X-ray film. Equal 
volumes of the two ECL solutions were mixed and incubated with the membrane for 1 
mm. The membrane was blotted briefly, wrapped in Saranwrap (Dow Chemical 
Corp.), placed in direct contact with Hyperfilm and developed between 10 sec and 20 
min later. 
Analysis of DNA and protein sequences 
DNA and protein sequences were analysed using the University of Wisconsin Genetic 
Computer Group package 8.0 (UWGCG 8.0, 1994). 
Isoelectric 
The Isoelectric program calculates the overall charge of a protein at different pH values 
and generates a plot of the net charge as a function of pH. The net charge of a protein 
is calculated on the basis of protonated (positively-charged) residues (K, L, H), the 
protonated amino terminus, deprotonated (negatively-charged) residues (Y, C, E, D), 
and the deprotonated carboxyl terminus. The isoelectric point is the pH at which the 
protein has no overall charge. 
Compare and DotPlot 
The Compare program compares two sequences and produces a file that may be plotted 
using DotPlot (Maizel and Lenk, 1981). Two sequences are compared and a point 
added to the file when a given number of matches (stringency) are found within a 
given range of the sequence (window). This comparison is repeated such that all 
regions are compared between the two sequences, and DotPlot creates a graph with 
points of similarity plotted against their position within each sequence. 
Gap 
The Gap program compares two sequences and creates an alignment with the largest 
number of matches. A penalty is specified for both a gap introduced in the alignment 
(gap weight), and the length of the gap (length weight). The penalty is such that, for 
any gap, the specified number of extra matches must be made (Needleman and 
Winsch, 1970). 
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Chapter three: Rai activity in vivo 
Introduction 
Restriction of unmodified X phages by E. coli K-12 may be overcome at high 
multiplicities of infection (moi). Heip etal. (1974) observed two phenomena, a 
multiplicity effect and a rescue effect. The multiplicity effect was observed when cells 
were infected with unmodified 'helper' phages (X.0) and the 'test' phage (?vir.0) was 
added after adsorption of the helper phage. It was concluded that the multiplicity effect 
was due to an inactivation of the restriction complex and this conclusion is now 
understood at a molecular level. The EcoKI ENase does not turn-over after DNA 
cutting (Meselson and Yuan, 1968) and the multiplicity effect results from a saturation 
of the hosts restriction potential. The alleviation of restriction reaches a maximum at a 
moi of 12, therefore, on average, 12 unmodified phages are able to inactivate the host-
encoded EcoKlI ENase. There are five EcoKI target sites in the DNA of the helper 
phage, and binding of EcoIU ENase to each of these sites presumably removes that 
molecule from the pool of the free ENase in the host. It has been calculated that if 12 
phages, each with five sites, saturate the restriction ability of E. coli K- 12, there are 
approximately (12 x 5 =) 60 molecules of EcoKI ENase in each cell (Kelleher and 
Raleigh, 1994). 
The rescue effect observed by Heip et al. (1974) has a different basis, as alleviation of 
restriction by EcoKE was only observed when the helper phage was modified (X.K). 
Furthermore, this effect was dependent on expression of phage genes as restriction by 
EcoKI was unaffected by the addition of chloramphenicol, an antibiotic that inhibits 
protein synthesis. The gene product responsible for the rescue effect was termed Ral, 
for restriction alleviation (Zabeau et al., 1980). Zabeau et al. (1980) used different 
helper phages to map the ml gene to between cffi and N in the phage X genome. 
Mutagenesis and mapping of the mutants located ml between 70.6 and 70.9% on the 
physical map of ? (Debrouwere et al., 1980a) and when this region was sequenced an 
open reading frame encoding a polypeptide of 66 aa was assigned to ml (Ineichen et 
al., 1981). The nucleotide sequence of one of the ml mutants, ml 18, isolated by 
Debrouwere et al. (1980a) has been determined, and it contains two missense 
mutations (Loenen and Murray, 1986). A transversion from G to T changes the 
predicted translational initiation codon from ATG to ATT. There is also a change from 
G to A at base 73 that would cause an aa substitution, Glu to Lys, at this position 
(note: there is a typographical error in Loenen and Murray (1986) that reads a change at 
base 72. The laboratory notes of W. Loenen, and my own nucleotide sequence 
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analysis, confirm that base 73 is changed). The ral gene and the mutant allele, rall 8, 
have been cloned in an expression vector. Minicells transformed with the plasmids 
and an in vitro transcription-translation system have been used to detect the ml gene 
product. A polypeptide of suitable size may be detected with the cloned wild-type ml, 
but no corresponding protein is detected with the mutant, m118 (Loenen and Murray, 
1986). 
The effect of Ral on restriction by a number of different R-M systems has been 
examined, including the type I systems EcoKI, EcoBI (IA), EcoAJ (IB) and EcoR 1241 
(IC), the type II systems EcoRI and EcoRll, and the type ifi system EcoPI (Zabeau et 
al., 1980; Loenen and Murray, 1986). Ral only alleviates restriction by the type IA R-
M systems. These screens are rather limited, but there is no evidence to suggest that 
Ral affects any systems other than the type IA. The type IA R-M systems are also the 
only systems to have a strong preference for hemimethylated DNA in vivo. After a 
single round of infection of either an rl3mB  or r ( m}( host by unmodified phages, the 
progeny of Xm1 phages are efficiently modified, whereas the progeny of Xml phages 
are only poorly modified (Zabeau etal., 1980). Similar results have been obtained 
with the cloned ml (Loenen and Murray, 1986). 
DNA methylation has been examined in vitro, under conditions where DNA cutting is 
blocked, for EcoKI, EcoBI (type IA; Vovis etal., 1974), EcoM ( type IB; Suri and 
Bickle, 1985), EcoR124I and EcoR124II (Price etal., 1987a). The type IA ENases 
are the only prokaryotic enzymes that have a strong preference for hemimethylated 
DNA in vitro, although the type IC ENases also show some differences in the rate of 
methylation of an unmodified substrate versus a hemimethylated substrate. The 
MTases of EcoKlI (Suri etal., 1984; Dryden etal., 1993) and EcoR124I (Taylor etal., 
1993) show similar results. The conclusion of this work is that the type lB (e.g. 
EcoAI) R-M systems methylate an unmodified target as efficiently as a hemimethylated 
substrate, the type IA (e.g. EcoKI) systems have a strong preference for 
hemimethylated DNA and the type IC systems (e.g. EcoR12411) are somewhat 
intermediate between the type IA and 18 systems. It seems relevant that the type IA are 
the only systems to have a strong preference for hemimethylated DNA and are also the 
only systems affected by Ral. 
Unmodified ml phages (Xrat' .0) are restricted as efficiently as rat phages (Xrat.0) 
presumably as Ral is not produced sufficiently quickly to protect its own DNA (Zabeau 
et al., 1980; Toothman, 1981). It has been suggested that Ral activity is advantageous 
to the progeny of phages that escape restriction (Zabeau et al., 1980; Loenen and 
Murray, 1986). The progeny of unmodified rat phages (Xmt.0) that escape restriction 
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by a type IA R-M system will only be poorly modified, whereas the progeny of nit 
phages (Arar .0) will be efficiently methylated and protected from restriction by 
bacteria with an R-M system of the same specificity. This hypothesis has been 
investigated with strains proficient for restriction by EcoKI using unmodified nit and 
nit phages, and monitoring modification following a single round of infection. 
Single round of infection with unmodified phages 
The degree of modification of progeny phages was examined after a single round of 
infection of a restriction-proficient host by unmodified nit and rat phages (A..0). 
Unmodified phages are restricted, therefore, only a small number of progeny phages 
were expected after a single round of infection. Unless unadsorbed phages were 
discounted from the subsequent measurements of the degree of phage modification, 
these residual, unmodified, phages could potentially mask any effect of Ral. 
Traditionally, antiserum to X phage particles has been used to inactivate unadsorbed 
phages, but the only antisera available were ineffective, possibly due to a low titre of 
X-specific antibodies. Therefore, a genetic method was used based on the observation 
that Ral does not affect EcoRI (Kelleher et al., 1991; A. Titheradge, unpublished). 
The host cells were transformed with a plasmid, pJHl6, that encodes the EcoRI 
MTase (Heitman et al., 1989) and the test strains used to titre the progeny phages were 
transformed with a plasmid that encodes the EcoRI R-M system (Yoshimori et al., 
1972). Only phages that have been passaged through the host strains will be modified 
against EcoRI, and unadsorbed, hence unmodified, phages will be efficiently restricted 
by EcoRI encoded by the test strains. Two test strains were used, r r 1 and r rR, 
therefore, the degree of EcoKI-modification of progeny phages was examined for 
those phages that had been through an infective cycle on the rKmK r 1 m 1 host. 
Preliminary experiments were done using three different strains of E. coli K- 12, C600, 
NM710 and Ymel. These strains were transformed with pJH16, to make them rmK 
rRImRI, and infected (100 .tl, moi of 1) with unmodified 2n2l' (?NM324.0) or ?nit 
(ANM325.0) phages. After 10 min the infected cells were harvested by centrifugation 
(11 000 x g, 5 mm), to remove some of the unadsorbed phages, and resuspended in 
pre-warmed L broth (10 ml) supplemented with chioramphenicol to select for hosts 
that maintain the plasmid, pJH16. The culture was incubated to allow a single round 
of infection (70 mm, 37°C with aeration) and a sample removed (1.5 ml). Cells were 
lysed by the addition of chloroform, and the titre of progeny phages determined on two 
test strains. The test strains were transformed with a plasmid encoding EcoRI, to 
make them either rK  r7 (C600 RI) or r r (5K RI). The degree of K-specific 
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modification of the progeny phages was estimated by comparing the titre of phages on 
C600 RI versus that on 5K RI (the efficiency of plating, eop). The eop of progeny 
phages varies depending on both the phage and strain used (table 3.1). After an sri of 
NM710 or Ymel, transformed with pJH16, the progeny of XnzltO phages are 
modified against restriction by EcoKI more than the those of Xmt.0 phages. 
However, little difference is detected in the modification of the progeny of ?ni14 .0 and 
Xn-it.0 phages after an sri of C600. The results with NM710 and Ymel support the 
hypothesis that the progeny of an unmodified ral phage are more likely to become 
modified against restriction by a type IA R-M system than a nit phage. The results 
with C600, however, do'not support this hypothesis as the progeny phages are well 
modified irrespective of the rat genotype of the phage. 
Many strains of E. coli K- 12, including C600, contain a defective prophage termed 
Rac (Kaiser and Murray, 1979), but Ymel and NM710 have a deletion removing this 
element (G. King and N.E. Murray, unpublished). The Rac prophage is known to 
encode a Ral-like antirestriction function, termed Lar (Toothman, 1981). In the 
prophage, lar would not be expressed, however, Rac will excise in a small proportion 
of the hosts allowing expression of lar and this may be responsible for the masking of 
the Ral effect in C600. The cells that contain the excised Rac prophage, and hence 
express lar, will be phenotypically 	and efficiently methylate unmodified DNA. 
NM7 10 is a Rac derivative of C600 and the results with these strains, and phages of 
different ml genotype, indicate an effect of both Ral and Lar. The difference in the 
modification of progeny phages after an sri of NM710 and Ymel is difficult to explain, 
the Ral effect appears to be more pronounced after an sri of Ymel than NM7 10, and 
there are probably factors influencing the modification of phages other than Ral or Lar. 
To further examine the activities of Ral and Lar, experiments were done using strains 
differing only in the region of the Rac prophage, and phages differing only with 
respect to nil. The E. coli K-12 strains used were NM777 and NM778, made by P1 
transduction using CAG12081 (Singer etal., 1989) as the donor ofJhr5OlA(fiir-lar) to 
transduce W31 10 and selecting for the presence of a linked transposon zcj-
3061::TnlO. NM777 and NM778 both contain the transposon, but only NM777 is 
Lar (King and Murray, 1995; N.E. Murray, unpublished). These two isogenic strains 
were transformed with pJH16 and modification was monitored after a single round of 
infection as described above, but using two test phages which differ only with respect 
to ml (Xc160 and Xm118c160; table 3.2). Phages modified to protect against restriction 
by both EcoKI and EcoRI were used to ensure that the plating efficiencies of the test 
strains were comparable (table 3.3). The results with these isogenic strains and phages 
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(table 3.2) are similar to those obtained before (table 3.1) and demonstrate a role for 
both Ral and Lar. In a Lar host (NM777), the progeny of nit phages are better 
modified than ml phages. The effect of Ral is masked in a La? host (NM778). The 
effect of Ral after a single round of infection of NM777 (table 3.2) is only about a four 
fold increase in the modification of ra1 progeny phages, whereas the Ral effect after an 
sri of NM710 and Ymel is about 18 fold and 140 fold respectively. Therefore, there 
are probably other factors influencing the modification of progeny phages other than 
Ral and Lar. The E. coli chromosome does contain defective prophages and elements 
other than the Rac prophage (Campbell, 1977) and it is conceivable that one of these 
encodes a Ral-like function. Alternatively there may be a host-encoded function that 
influences modification. Regardless of the strain-specific differences, this work 
supports the hypothesis that the progeny of phages that escape restriction by a type IA 
R-M system are more likely to become modified if the phages are ra1 than rat. This 
enhanced modification would be advantageous, as the progeny of rat' phages would 
be protected from restriction in a subsequent round of infection of a host with a R-M 
system of the same specificity. 
Host 	Phage 	 Plaques per plate (no dilution) eop 
rKmK rm 	 rKrRI (C600 	rK rM (5K RI) 
RI) 
C600pJH16 	Anit.0 	133, 117, 145, 203, 211, 173, 7.3x10' 




YmelpJHl6 	?rat4 .0 
XmL 0 
131, 149, 178, 248, 289, 210, 6.2 x 10 1 
160 	 243 
49, 46, 46, 46 581, 625, 586, 8.1 x 10 2 
510 
4, 1, 5, 2 	616, 627, 704 4.6 x iO 
42, 32, 48, 30 	192, 163, 190, 2.1 x 10' 
171 
0' 0 ' 0' 0 	184, 153, 186, <1.5 x io 
149 
Figure 3.1. The modification of progeny phages after a single round of infection 
(sri) of an EcoKT restriction-proficient host. See text for details. The rat phage was 
Xbiol imm 434cI (XNM324) and the nit phage was Xbio232imm 434cI (XNM325). The 
E. coli K-12 strains Ymel and NM710 are lar, whereas C600 is lark. The plasmid 
pJH16 encodes the EcoRI MTase and the test strains, C600 and 5K, were transformed 
with a plasmid that encodes the EcoRI R-M system. 
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Host 	Phage 	 Plaques counted (no dilution) 	eop 
rKmK rjm 	 (C600 	rKrRI (5K RI) 
RI) 
NM777 pJH16 A.nir.0 	685, 724, 690, 743, 705, 696, 9.7 x 10' 
717 	 766 
A rat. 0 	146, 157, 165, 663, 672, 642, 2.3 x 10.1 
136 	 657 
NM778 pJH16 krar.0 	730, 751, 737, 722, 754, 751, 1.0 
736 	 738 
594, 632, 616, 666, 667, 648, 9.3 x 10.! 
617 	 654 
Table 3.2. The modification of progeny phages after a single round of infection (sri) 
of an EcoKI restriction proficient host. See text for details. The nzt phage was Xc160 
(A,NM1094) and the rat phage was Anil18cI60 (ANM1090). The E. coli K-12 strains 
NM777 and NM778 are lot and respectively, but otherwise isogenic. 
Phage 	 C600 RI (rK rRI ) 	5K RI (rKrRI) 
A,m1.KRI 	 2.9 x 1010 	 2.2 x 1010 
2rat.KRI 	 2.0 x 1010 	 1.5 x 1010 
Table 3.3. Titre of raP (XNM1094) and rat (XNM1090) phages, modified against 
EcoKJ and EcoRI, on the test strains C600 RI (r K rR ) and 5K RI (rKr);  a control to 
ensure that the plating efficiencies of the test strains were comparable. 
Chapter four: The Rai protein 
Overexpression of the ral gene of bacteriophage X 
The ml gene of phage X has been cloned in two plasmid expression vectors by Loenen 
and Murray (1986). pUCml is a derivative of pUC13 (Messing, 1983), that contains 
an 400 bp HaellI-BamHI insert including ml (figure 4.1 a), and pml5 is a derivative of 
pCQV2 (Queen, 1983) that contains an 4.2 kb BamHI fragment from Xbio214 (figure 
4. lb). The ml gene product was visualised using an in vitro transcription-translation 
system and in minicells transformed with pml5, however, the product is present only 
as a very small proportion of the total cellular protein (Loenen and Murray, 1986). 
To increase the level of ral expression, alternative expression vectors were tried. The 
—400 bp EcoPJ-Hindffl fragment from pUCml was cloned in the plasmid vector pT7-6 
(Tabor, 1990), to make pGK1 (figure 4.2), and the nucleotide sequence of ral in 
pGK1 was confirmed by double-strand sequencing using Sequenase. Transcription of 
ml in pGK1 is driven from the T7 promoter, and T7 RNA polymerase is encoded by a 
?DE3 prophage, but translational initiation is dependent on the ribosome binding site, 
and other DNA sequences, cloned with ml. Cell extracts were prepared from 
BL21(DE3) transformed with pGK1, proteins separated by SDS-PAGE and visualised 
with coomassie stain, however, no overexpression of ral could be detected. 
Vectors that combine both a strong promoter and sequences required for translational 
initiation upstream of the cloned gene, have been successful in overexpression studies 
(Studier and Moffatt, 1986; Schauder et al., 1987; Tabor, 1990). These vectors 
normally contain an NdeI target site to place the ATG start codon of the cloned gene in 
the correct position for maximal expression; the NdeI recognition sequence is 5' 
CATATG. An NdeI target site was introduced at the start of nil by using the PCR, 
with a primer containing an NdeI site overlapping the start codon (figure 4.3a). The 
template used in these reactions was pUCnil and the other primer annealed to the -40 
region in the vector (figure 4.3b). The 270 bp fragment amplified by the PCR was 
partially sequenced, by direct sequencing using Sequenase, to confirm that the 
fragment contained ml, converted to a blunt-ended fragment with Kienow DNA 
polymerase and 5'-end phosphates added using polynucleotide kinase (see chapter 2). 
This 270 bp fragment including ml was ligated to pUC18 cut with SmaI, to generate 
pGK3 (figure 4.3c). The ral gene was then transferred to each of two vectors that 
provided a strong, well-controlled, promoter and an efficient translational initiation 
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Figure 4.1. Plasmids constructed by Loenen and Murray (1986). (a) pUCml (3.1 
kb). (b) pra15 (9.5 kb). See text for details. bla, gene encoding ampicillin resistance; 
P 1 , lac promoter; PL, 2 promoter; c1857, temperature sensitive allele encoding X 





Figure 4.2. Plasmid pGK1. See text for details. bla, gene encoding ampicillin 
resistance; P.r, T7 gene 10 promoter. 
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Figure 4.3. Generation of plasmid pGK3. (a) Nucleotide sequence at the start of 
the ml gene, the deduced aa sequence of its product, and the oligonucleotide, 755G, 
used to introduce an NdeI target site overlapping the translational initiation codon of 
ml. (b) The region of pUCml amplified by the PCR using oligonucleotide primers 
755G and a primer (642C) that anneals to the plasmid -40 region. (c) pGK3 (3 kb) 
containing the ml fragment amplified by the PCR. See text for further details. bla, 
gene encoding ampidillin resistance; P 1 , lac promoter; target sites in brackets, lost in 




GACTATCCATATGACTACG 	 755G 
CCAGGACTATCCGTATGACTACGACGACTATT 	 ral 


















1987) to generate pGK4 (figure 4.4a), and pT7-7 (Tabor, 1990) to generate pGK5 
(figure 4.4b). pJLA503 contains the 2 promoters P L and PR , upstream of the 
translational initiation region of alpE, and the X gene c1 857 . Transcription is repressed 
at 30°C by the product of c1857 , and induced by a temperature shift to 42°C (Schauder 
et al., 1987). pT7-7 contains the promoter and upstream sequence of T7 gene 10 
(Tabor, 1990). Transcription relies on T7 RNA polymerase, that is frequently 
provided by a XDE3 prophage (Studier and Moffatt, 1986). ?DE3 was generated by 
cloning the genes lad, and T7 gene 1 downstream of an IPTG-inducible lacUV5 
promoter, in the BamHI site of the ? vector D69 (Mizusawa and Ward, 1982; Studier 
and Moffatt, 1986). Insertion in the BamHI site disrupts the 2 mt gene, that is 
required for both integration and excision, but lysogens may be made using a helper 
phage to provide the mt gene product in trans. Therefore, stable lysogens may be 
made with ?DE3 and transcription of T7 gene 1, encoding T7 RNA polymerase, is 
induced by adding IPTG to the media. Overexpression of ml was examined as before, 
a product was detected in cell extracts of both BL21(DE3) pGK5, and NM522 pGK4, 
although the cells transformed with pGK5 appeared to give the higher level of 
expression. The complete nucleotide sequence of the insert in pGK5 was determined, 
by double-strand sequencing using Sequenase, and was identical to the published 
sequence (Ineichen et al., 1981). To test whether the product of the cloned ml gene 
was active, a restriction-deficient modification-proficient host, NM526(DE3), was 
transformed with pGK5 and infected with an unmodified nit phages. After a single 
round of infection, the degree of phage modification was estimated by measuring the 
efficiency of plating of progeny phages on a restricting host versus a non-restricting 
host. The progeny phages are efficiently modified after a single round of infection of 
the host transformed with pGK1, showing that the cloned nil gene encoded an active 
polypeptide (table 4.1). 
Overexpression of nil and the solubility of its product were examined by growing 
BL21(DE3) pGK5 at 28, 37 or 42°C, and taking samples at various times after 
induction. The highest proportion of Ral in the soluble fraction appeared to be after 
three hr induction, with cells grown at 28°C (figure 4.5). 
Vectors that produce a fusion polypeptide have been successful in increasing the level 
of expression of cloned genes, and in aiding the purification of the fusion proteins (for 
example, Smith and Johnson, 1988). The pET 16b vector has a T7 promoter upstream 
of a translational initiation region and coding sequence for poly-histidine and a factor 
Xa proteolytic cleavage site. Immediately downstream of the coding sequence for the 
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Figure 4.4. Plasmids that overexpress ml. (a) pGK4 (5.1 kb). (b) pGK5 (2.7 kb). 
bla, gene encoding ampicihin resistance; P L and PR , promoters; c1857, temperature 
sensitive allele encoding X repressor; tir, translation initiation region. 
Host (sri X325.0) 	 eop 
526(DE3) pT7-7 1.3 x iO 
526(DE3) pGK5 	 8.8 x 10 
Table 4.1. Modification enhancement by pGK5. A restriction-deficient, 
modification-proficient strain of E. coli K-12 lysogenic for XDE3 , NM526(DE3), was 
transformed with pT7-7 or pGK5 and infected with unmodified Xrat phages 
(2NM325.0). After a single round of infection, the degree of phage modification was 
estimated by measuring the efficiency of plating (eop) of progeny phages on a 
restricting strain (C600) relative to that on a non-restricting strain (5K). See chapter 2 
for details. 
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Time (hr) 1.5 3 4.5 
Fraction D S P S P S 
RaI= 
Figure 4.5. Overexpression of nil, and visualisation of its product. Cell extracts 
were prepared from BL21(DE3)pGK5, grown at 28°C for 1.5, 3, or 4.5 hours, and 
clarified by centrifugation (20 000 x g, for 20 min at 4°C). The insoluble (pellet) and 
soluble (supernatant) fractions were separated by Tris-tricine SDS-PAGE and 
visualised by coomassie staining of the gel, see chapter 2. P, pellet; S, supernatant; 
migration of Ral is indicated by the arrow. 
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The 220 bp NdeI-BamHT fragment from pGK5 was cloned in pET 16b, to generate 
pGK25 (figure 4.6a), however no overexpression of ml was detected and Ymel(DE3) 
transformed with pGK25 remains restriction-proficient (results not shown). The DNA 
of pGK25 gives the expected fragments when cut with a number of type II ENases, 
but the nucleotide sequence of the insert was not determined and there may be some 
subtle rearrangement or mutation. The fusion pollypeptide contains an extra 21 aa 
residues and this may disrupt the activity of Ral. 
One other plasmid was made that would allow the overexpression of both ml and the 
hsdMS genes of EcoKI in the same cell. The plasmid used to overexpress the EcoKI 
MTase, pPT7, is a derivative of pJF118 (FUrst et al., 1986; Dryden et al., 1993; P. 
Thorpe, unpublished) and contains the origin of replication from plasmid ColE 1. 
pACYC184 contains the origin from plasmid pl5A, and is compatible with Co1E1-
based plasmids (Chang and Cohen, 1978). The 560 bp BglII-BamHI ml fragment 
from pGK5 was ligated to pACYC 184 cut with BamHI, to generate pGK24 (figure 
4.6b). pGK24, therefore, contains the same arrangement of promoter, translational 
initiation region and ml gene as pGK5, but in a vector that will be maintained with 
pPT7. Modification of Xrat.0 enhanced by NM526(DE3) transformed with pGK24 
and pPT7 (table 4.2, see comments in the legend), showing that an active Ral 
polypeptide is produced. 
Production and purification of Ral Abs 
The complete Ral protein has been made by solid-phase peptide synthesis, as part of a 
study on the synthesis and purification of polypeptides (Brown et al., 1993). One of 
the problems of chemically synthesising a protein like Ral, is that a range of truncated 
peptides accumulate during the synthesis which makes it difficult to purify the full 
length product. Brown and colleagues (1993) have developed a method of attaching a 
large organic compound (Thfmoc) to the N-terminus of the peptide, on the last cycle of 
synthesis, and this changes the elution time of the full length polypeptide by reverse-
phase high performance (high pressure) liquid chromatography (HPLC). Thus, the 
complete peptide is easily purified and the Thfmoc group cleaved to generate the full 
length protein. During the development of this system, a number of partially purified 
preparations of Ral were made that have been used to produce Ral anti-sera and to 
affinity purify specific antibodies (Abs). 
Peptides are normally coupled to a carrier protein to enhance the immune response to 
the peptide, and synthetic Ral was coupled to keyhole limpet hemocyanin (KLH) using 




















Figure 4.6. Other piasmids that overexpress ml. (a) pGK25 (5.9 kb). (b) pGK24 
(4.5 kb). See text for details. bla, gene encoding ampidihin resistance; cat, gene 
encoding chioramphenicol resistance; P, T7 gene 10 promoter; factor Xa, proteolytic 
cleavage site; tir, translation initiation region; ori pl5A, origin of replication from 
plasmid pl5A. 
Host (sri 2325.0) 	 eop 
526(DE3) pPT7 pACYC 184 	8.3 x iO 
526(DE3) pPT7 pGK24 	3.5 x 10' 
526(DE3) pJFll8 pGK24 1.1 
Table 4.2. Modification enhancement by pGK24. See text, section 'In vitro 
methylation with cell extracts' for details. The degree of phage modification after a 
single round of infection (sri) of unmodified, ml, phage (?NM325) was estimated by 
measuring the efficiency of plating (eop) of progeny phages on a restricting strain 
(C600) relative to that on a non-restricting strain (NM679). Phages were titred by 
spotting 10 d of diluted phage on a lawn of cells in BBL top layer, and the 
measurement of eop is not as accurate as the method described in chapter 2. However, 
this assay, based on sampling small volumes, is sufficiently accurate to indicate the 
enhancement of modification. 
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cysteine residues (Gnann et al., 1989). Two rabbits (R707 and R708) were 
immunised with the Ral-KLH antigen, at days 0, 30, and 60. Test bleeds were taken 
from the pre-immunised rabbits and 10 days after each immunisation. The final test 
bleeds were used to detect Ral in Western blot analyses of the synthetic peptide and 
extracts from cells expressing ml. The third test bleeds were found to contain 
antibodies that recognised Ral, so the rabbits were sacrificed and sera collected (G. 
Leadbetter, Dept. Medical Microbiology). The Ral anti-sera and pre-immune sera 
contain a lot of other proteins, including other Abs that cross-react to E. coli proteins 
(figure 4.7). The Ral-specific Abs were purified by affinity chromatography (Harlow 
and Lane, 1988); a one ml Hi-Trap N-hydroxysuccinimide-activated Sepharose 
column was used to cross-link synthetic Ral to a solid support (see chapter 2). 0.1 ml 
of 1 M Tris.HC1 pH 8.0 was added to 0.9 ml of Ral anti-sera (R707), and this was 
applied to the Ral-affinity column, pre-equilibrated with 100 MM Tris.HC1 pH 8.0. 
The column was washed with 20 volumes 100 mM Tris.HC1 pH 8.0, then 10 volumes 
10 mM Tris.HC1 pH 8.0. The Ral-specific Abs were eluted with 100 MM glycine pH 
3.0, and 0.5 ml fractions were collected in tubes containing 56 g 1 M Tris.HC1 pH 
8.0. One fraction was found to contain most of the eluted Ab, about 0.4 mg of protein 
estimated from the uv adsorption spectrum, and was stored in 50% v/v glycerol at - 
20°C. 
The pre-immune sera, Rai anti-sera, the Abs that did not bind to the Ral-affinity 
column, and the affinity-purified Abs from R707, were compared by western blot 
analysis of cell extracts; extracts were prepared from induced cultures of BL2 1 (DE3) 
transformed with pT7-7 or pGK5. Abs from the pre-immune sera cross-react to many 
E. coli proteins, but not to Ral, whereas the Ral anti-sera also recognised Ral (figure 
4.7). The Abs that did not bind to the Ral-affinity column gave similar results to the 
pre-immune sera, but the Abs that bound to the column specifically recognised Ral and 
little else (figure 4.7). The other band seen with the Ral-specific Abs may be another 
protein that cross-reacts, or Ral that has not been fully reduced-denatured and is 
migrating anomalously by SDS-PAGE. 
Purification of the ral gene product 
Preliminary experiments were performed to identify which conditions and resins may 
be suitable to purify Ral. Chromatography columns were made from one ml syringes, 
blocked with glass wool and filled with a variety of different media. Depending on the 
media, different buffers and pHs were used: 
0 Diethylaminoethyl- (DEAE-) Sepharose with Tris-MES buffer, pH 8.0 and 6.5 
W. 
Pre- Rai Non- Affinity 
Antibodies immune anti-sera specific purified 
sera 
pGK5 + - +1- + - +- 
pT7-7 - + - + - + - + 
Rai c 	 o 
Figure 4.7. Cross-reactivity of antibodies to cell extracts. Cell extracts were 
prepared from BL21(DE3) transformed with pGK5 or p17-7, separated by Tris-tricine 
SDS-PAGE, and analysed by Western Blot. See text for details. Arrow indicates 
migration of Ral. 
79 
• Carboxymethyl- (CM-) Sepharose with Tris-MES buffer, pH 8.0 and 6.5 
• Heparin-agarose with Tris-MES buffer, pH 8.0 
• Hydroxyapatite-BioGel with Piperazine buffer, pH 9.5 
BL21(DE3) pGK5 or NM522 pGK4 were grown to an 0D 650 of 0.6, induced with 1 
mM IPTG and harvested after three hr. For each column, 0.5 g of cells were 
resuspended in 1.5 ml of the relevant buffer, sonicated and the cell debris removed by 
centrifugation. The soluble cell extract was applied to the column, pre-equilibrated 
with buffer, and bound protein removed with buffer containing 1 M NaCl. Samples of 
the flow-through and bound fractions were separated by Tris-tricine SDS-PAGE, and 
analysed by Western blot with Ral antisera. Ral did not bind to heparin, 
hydroxyapatite, or DEAE, but some Ral did bind to CM at pH 6.5. 
DEAE- and CM-Sepharose are anion and cation exchange resins respectively, and 
proteins bind by electrostatic interactions. The charges on the exchange media are 
balanced by counterions, e.g. Cl - or Na, that are displaced by the protein, and usually 
the protein binds with an overall charge the same as the counterion it displaces. Anion-
exchangers, like DEAE, are positively charged so a protein should bind if it has an 
overall negative charge, conversely cation-exchangers, like CM, are negatively 
charged. The isoelectric point of a protein is the pH at which the protein has no overall 
charge. Ion-exchange chromatography is generally performed one to 1.5 pH units 
above (anion-exchange) or below (cation-exchange) the isoelectric point of the protein, 
to ensure an overall negative or positive charge on the protein. The ion-exchanger 
remains ionised over a broad pH range, and bound proteins are eluted by increasing 
the ionic strength of the solution, thereby weakening the strength of the electrostatic 
interaction (Scopes, 1988). The isoelectric point of Ral was calculated to be 8.5 using 
the Isoelectric program of the UWGCG 8.0 package (figure 4.8). 
The preliminary experiments with DEAE-Sepharose were probably performed at too 
low pH, and further attempts were made during the course of this work to bind Ral to 
an anion-exchanger. However, attempts at pH 9.5 (piperazine buffer, Econo-Pac Q 
column), pH 10.3 (diamino propane buffer), or pH 11.9 (phosphate buffer, Resource 
Q column) were unsuccessful, as approximately half of Ral in the sample only ever 
bound and did not give a clear elution profile. This may be due to the instability of Ral 
at these pHs or non-specific interactions with the media. Cation-exchange 
chromatography, however, has been extremely useful in the purification of Ral. Ral 
should be positively charged below pH 8.5, but it does not completely bind CM at pH 














Figure 4.8. The predicted net charge of Ral plotted as a function of pH. The overall 
charge was calculated on the degree of protonation of positively-charged residues (K,R 
and H) and negatively-charged residues (Y, C, E and D) at a particular concentration of 
hydrogen ions (pH), using the Isoelectric program of the UWGCG 8.0 package. 
proteins, Ral does bind to CM-Sepharose at pH 5.0, and this was used as the first step 
in the purification of Ral. 
Ral bound to CM-Sepharose may be eluted using a salt gradient, which separates Ral 
from some other proteins, but the protein is then diluted. A simple method of 
concentrating protein is by ammonium sulphate precipitation, but for this to work the 
protein must already be at a concentration of approximately one mg MY'. Therefore, 
protein bound to the CM-Sepharose column was eluted in a step gradient of one M 
NaCl so that the protein concentration was suitable for Ral to be precipitated with 
NH4 (SO4 )2 . The salting out of proteins using high concentrations of salt is dependent 
on the surface charge distribution and polar interactions with the solvent. Water 
molecules are normally ordered around hydrophobic patches in proteins, and as the salt 
concentration increases, water molecules are attracted away from the protein to hydrate 
salt ions. Exposed hydrophobic regions will then cause aggregation of the proteins, 
and this precipitate may be harvested by centrifugation and dissolved in a small volume 
of low salt buffer. 
Ral does not bind to heparin, hydroxyapatite, or a cation-exchanger so gel filtration 
was chosen as the next step in the purification of Ral. Gel filtration chromatography 
separates proteins according to size; smaller proteins are retarded in the molecular pore 
structure of the packed beads and elute later than large molecules which are retarded 
less and flow through the column faster. The separation achieved by gel filtration 
depends on loading a small sample volume, normally no more than 3% of the column 
volume (Scopes, 1988). 
Two types of media have been used for gel filtration, that have different molecular 
mass separation ranges; Superdex 200, 10-300 kDa and Sephadex G-50, 1.5-30 kDa. 
On the basis of the working ranges, a column packed with Sephadex G-50 would be 
the better choice to purify Ral, however a Hi-Load (factory-packed) Superdex 200 
column was available that provided better separation than the Sephadex column. 
Fractions containing Ral were collected from the Superdex 200 column and further 
purified using hydrophobic adsorbtion, reverse phase HPLC. HPLC uses columns of 
homogeneous small-beaded particles that can operate at high pressures. Hydrophobic 
adsorption chromatography, as its name suggests, relies on hydrophobic interactions 
between proteins and immobilised aliphatic chains, and reverse phase refers to the 
elution of bound macromolecules with organic solvents. 
A generalised procedure for the overexpression of ml and the purification of its product 
is outlined below. 
M. 
BL21(DE3) was transformed with pGK5 and a single colony grown for eight hr. 
at 37°C with good aeration, in an 20 ml bottle containing five ml of L broth 
supplemented with 100 jig m11 ampicillin. 
Three ml of this culture were used to inoculate 100 ml L broth, supplemented with 
ampicillin, in a one 1 flask, and grown overnight at 37°C with good aeration. 
10, two 1 flasks containing 250 ml L broth, pre-warmed to 37°C and supplemented 
with ampicillin, were inoculated with eight ml of the overnight and grown at 28°C 
to an 0D650 of 0.6. 
Expression of m/ was induced by adding IPTG to a final concentration of 0.6 MM. 
Cells were harvested by centrifugation three hr after induction, and resuspended in 
30 ml buffer (50 mM acetic acid pH 5.0) supplemented with 7mM 13-
mercaptoethanol, 20 jiM benzamidine and 10 jiM phenylmethylsulfonyl fluoride 
(benzamidine and PMSF are protease inhibitors). 
The cell suspension was sonicated at 4°C and clarified by centrifugation at 37 000 
x g for one hr. 
The supernatant, i.e. soluble cell extract, was applied to a column packed with 40 
ml CM-Sepharose, that had been pre-equilibrated with buffer. 
The column was washed with buffer until no protein was detected in the flow 
through, and the bound protein eluted with a step gradient of one M NaCl, in 
buffer, at 60 ml hr (figure 4.9). 
Protein eluted from the CM-Sepharose column was precipitated by adding 
NH4 (SO4 )2 to 80% saturation, and the precipitate was collected by centrifugation at 
13 000xg for 20 mm. 
The pellet was dissolved in 1.5 ml buffer, passed through a filter with a 0.2 gm 
pore size, and applied to a Hi-Load 16/60 Superdex 200 column pre-equilibrated 
with buffer. 
Ral was eluted in buffer (figure 4.9b) and applied to a Vydac C 18 (5 gm) column to 
further purify Ral by HPLC. The column was equilibrated in 0.1% v/v aqueous 
trifluoroacetic acid (TFA), 10% v/v acetonitrile and the protein was eluted with a 
gradient of 10 to 90% v/v acetonitrile in 0.1% v/v TFA over 30 min at a flow rate 
of 1 ml min- ' (figure 4.9c). 
Fractions containing Ral were frozen in liquid nitrogen and dried under vacuum. 
The most abundant protein in the sample applied to the C 18 column elutes at the same 
place as synthetic Ral, and this fraction was further analysed by 'MALDI-TOF' mass 
spectroscopy (K. Shaw, Dept. Chemistry) and N-terminal peptide sequencing (A. 
Cronshaw, Dept. Biochemistry). The mass of the protein is 7464 kDa which is the 
Figure 4.9. Elution profiles of Ral. (a) CM-Sepharose at pH 5.0, with a step 
gradient of 1 M NaCl. % Transmission (%T) at 280 nm is plotted as a function of salt 
concentration. (b) HiTrap Superdex 200 at pH 5.0. %T is plotted as a function of the 
elution volume. (c) Vydac C 18 (HPLC) 10-90% v/v acetonitrile + 0.1% v/v TFA over 
30 mm. Absorbtion at 214 nm is measured as a function of time. The elution of Ral is 
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mass expected for Ral if the N-terminal methiomne is missing, and a small peak is seen 
at 7605 kDa that corresponds to the mass of full-length Ral (figure 4.10). The loss of 
this methionine is a common postranslational modification in prokaryotes, and peptide 
sequencing confirmed that the N-terminal sequence started at the second residue of Ral 
(sequence obtained TTTID). 
Analysis of Rai activity in vitro 
The EcoKI MTase has been purified, and the protein efficiently modifies 
hemimethylated oligonucleotides containing the EcoKI target sequence, but only 
poorly modifies unmodified substrates in vitro (Dryden et al., 1993). However, the 
binding affinities of the MTase for specific oligonucleotides are similar, irrespective of 
the methylation state of the DNA. The preference of the MTase for hemimethylated 
DNA, therefore, must be due to differences in catalysis and not binding affinity 
(Powell et al., 1993). DNA footprinting of MTase:oligonucleotide complexes, by 
methylation interference, correlates differences in the protein:DNA interface with DNA 
of different methylation states. Without AdoMet, the methyl donor and cofactor, 
interference is detected for all substrates in the two halves of the recognition sequence 
and also at adjacent bases in the spacer region. The interference patterns do not change 
for hemimethylated or fully modified substrates when a complex is formed in the 
presence of AdoMet, but the footprints change with unmodified substrates; interference 
is restricted to bases in the recognition sequence (Powell and Murray, 1995). 
Methylation of the target sequence, therefore, changes the conformation of the 
protein:DNA interface and this conformational difference, in the presence of AdoMet, 
may be important in determining whether the DNA will be methylated or restricted 
(Powell and Murray, 1995). 
Ral could both alleviate restriction and enhance modification of EcoKJ if it altered the 
ENase so that an unmodified target was recognised as hemimethylated. Restriction 
would be alleviated, as hemimethylated targets are not a substrate for restriction, and 
modification would be enhanced, as EcoKII efficiently modifies hemimethylated DNA. 
If this is true, then the MTase should methylate an unmodified target as efficiently as a 
hemimethylated site in the presence of Ral, and the methylation interference footprint 
with Ral, MTase, AdoMet, and an unmodified substrate may look like the footprint of 
MTase with a modified substrate. Alternatively, Ral could enhance methylation to 
such an extent that restriction doesn't have time to occur or, if Ral blocked restriction, 
a small stimulation of methylation may explain the Ral phenotype. Modification is 
Figure 4.10. 'MALDI-TOF' (matrix-assisted, laser desorbtion ionisation, time of 
flight) mass spectrum of Ral, with ionisation plotted as a function of mass. Main 
peak, 7464.5; shoulder, 7605.5; two other peaks at approximately 15 000 and 22 000 
may be oligomers that have not been completely ionised. 
M. 
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enhanced by Rat even in the absence of HsdR, the subunit required for restriction, and 
consequently Rat activity was studied in vitro with purified Rat and the EcoKI MTase. 
Purified EcoKl MTase was kindly donated by D. Dryden and L. Cooper (Dryden et 
al., 1993). The elution of proteins with organic solvents, in reverse phase HPLC, can 
denature or inactivate proteins and, therefore, Rat activity was examined in vitro using 
Rat eluted from the Superdex 200 column. Typically, the total amount of protein 
eluted from the Superdex column, that contained Ral, was 4.3 mg (from a three 1 
culture) at a concentration of 55 pM. The ratio of the absorbance at 280 nm to 250 nm 
was typically 2.3 (figure 4.11) and, from the HPLC elution profile, this sample 
contains greater than 90% Rat (figure 4.9c). 
In vitro methylation 
An in vitro methylation assay has been developed (Dryden et al., 1993; Wiltcock et al., 
1994) based on the transfer of a 3 H-methyl group from radiolabelled AdoMet to a 
synthetic oligonucleotide substrate. Two complementary oligonucleotides were 
annealed to generate both an unmodified and hemimethylated EcoKI target site (408L 
and 409L and 860L:409L, respectively). The sequence of the oligonucleotides, and 
the position of the modified bases used to generate methylated targets, are included in 
figure 4.12 (Powell et al., 1993; oligonucleotides were annealed by mixing equimolar 
quantities together, heating to 100°C for five minutes in a water bath and leaving to 
cool gradually to 25°C). The EcoKJ MTase was applied to a PD-10 gel filtration 
column and eluted with 100 mM NaCl, 100 mM Tris.HC1 pH 7.9 ('reaction buffer'), 
to remove glycerol and salt in the MTase storage buffer. The Rat storage buffer could 
not be changed in a similar way, as Rat is too small to be separated from the glycerol 
and salt using a PD-10 column, so Rat was diluted to the required concentration in 
reaction buffer. The components for the assay were typically 0.1 tM MTase, 0.5 JIM 
Rat (if present), 15 mM -mercaptoethano1, 200 .tCi ml' [3 H]AdoMet (Amersham, 
specific activity approximately 75 Ci mmol'1 ), and 2.25 p.M annealed oligonucleotide 
(408L:409L or 860L:409L) in reaction buffer. AdoMet and DNA were mixed together 
in the reaction buffer and then added to the other components, as the order of addition 
can drastically affect the results of the assay (M. Winter and D. Dryden, unpublished). 
The assay mixture was incubated at 37°C, five p.1 samples removed at different time 
points and heated at 65°C for 10 minutes to stop the reaction and disrupt the 
protein:DNA complex. The oligonucleotides were separated from [3 H]AdoMet by 
PAGE (three p1 of 20% v/v glycerol in reaction buffer was added to each tube, and 
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Figure 4.11. UV absorbtion spectrum of Ral between 240 nm and 340 nm. 
860L 
408L 5' TGTCTAGATATCGGCC TAACCACGTG GTGCGTACGAGCTCAGGCG 
409L 3' ACAGATCTATAGCCGG ATTGGTGCAC CACGCATGCTCGAGTCCGC 
861L 
Figure 4.12. Oligonucleotides used to generate an EcoKI target site. Arrows, bases 
methylated by EcoKlI and substituted with N6  -methyl adenine in 860L and 861L; bold, 
half-sites of the EcoKI recognition sequence. 
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visualised by fluorography (see chapter 2). No effect of Ral on methylation by EcoKI 
was detected (figure 4.13), although the assay is probably not sensitive enough to 
detect small differences in methylation activity. 
Gel retardation 
Gel retardation is used to show the interaction of proteins and DNA, and Powell et al. 
(1993) have used this method to calculate binding affinities of the EcoKJ MTase for 
oligonucleotides of different methylation states. MTase bound to DNA causes a shift 
in the migration of the DNA by PAGE, that may be detected by autoradiography if the 
DNA is labelled with 32P. if Ral interacts with the MTase a further shift may be 
expected, however, Ral is a small protein and the change in mobility of the complex 
probably would not be detected. Using Abs to Ral, it was hoped that a 'supershift' 
could be produced with a DNA:MTase:Ral:Ab complex. Gel retardations were 
performed essentially as described by Powell et al. (1993), with 50 nM MTase, 1 mM 
Ral and 0.1 nM unmodified 32P-labelled DNA (annealed oligonucleotides, 
408L:409L). The protein:DNA complexes were formed for 10 minutes at 4°C before 
10 jd of the purified Ral Abs were added, and incubated for a further 15 mm. 
Complexes were separated by PAGE and visualised by autoradiography (see chapter 
2). A shift in the migration of the DNA was seen with MTase, but no extra shift was 
detected with Ral and the Abs (figure 4.14). 
In vitro methylation with cell extracts 
The purified Ral may be inactive, or some factor required for activity may be missing 
from the reaction mixtures, so methylation activity was examined in cell extracts of 
strains overexpressing the genes encoding the EcoKJ MTase and Ral. BL21 is hsdR 
and a ENase complex may be made if the cloned hsdMS genes are expressed, and this 
host is also lark which may influence the methylation results (see chapter 3). 
Therefore, an hsdRz.4laf strain, NM526(DE3), was transformed with pairs of 
compatible plasmids, pPT7 and pACYC 184, pPT7 and pGK24, or pJF1 18 and 
pGK24; pPT7 is the derivative of pJF1 18 that expresses hsdMS (Dryden etal., 1993), 
and pGK24 is the derivative of pACYC 184 that expresses ml (this chapter). Five ml L 
broth, supplemented with 100 pg ml' ampicillin and 40 ig m1 1 chloramphenicol, were 
inoculated with a single colony and grown at 37°C to an 0D 650 of 0.6. Transcription 
of the cloned genes was induced by adding IPTG to a final concentration of 0.6 MM, 
and the cells were harvested after two hr. 
!J1 
Figure 4.13. In vitro DNA methylation with purified proteins. EcoKI MTase 
activity was followed with unmodified (408L:409L) or hemimethylated (860L:409L) 
DNA substrate, over a range of times (1 min to overnight, o/n) with (+) or without (-) 
Ral. The labelled-DNA was separated from the [3 H]AdoMet by non-denaturing 
PAGE, and visualised by fluorography. See text for further details. 
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Figure 4.14. 'Supershift' gel retardation. See text for details. The migration of 
free DNA and DNA:MTase complex is indicated with arrows. 
A sample of each culture was used to examine the Ral phenotype of the clones, 0.5 ml 
of culture was harvested by centrifugation and the cells resuspended in 100 pJ 10 mM 
MgSO4 . Modification enhancement activity was examined after a single round of 
infection (see chapter 2) and the transformants gave the expected phenotypes (table 
4.2, see comments in the legend). As the host is hsdMS, a strain containing the 
cloned ml gene always enhanced modification, but a host overexpressing hsdMS, in 
the absence of ml, does not have this phenotype. 
The remaining cultures were used to make cell extracts; pellets were resuspended in 
200 p1100 mM NaCl, 100 mM Tris.HC1 pH 7.9, 7 mM 3-mercaptoethanol, sonicated 
at 4°C and clarified by centrifugation at 20000 x g for 30 min at 4°C. Methylation 
assays were performed as described previously, but using 40% (vlv) cell extract 
instead of purified protein. An additional DNA substrate was used that had a 
completely modified EcoKlI target site (oligonucleotide pair, 860L:861L; figure 4.12) 
to confirm that the methylation of the oligonucleotides observed was due to EcoKI 
MTase activity. The hemimethylated targets were the only substrates to be efficiently 
methylated. Comparisons cannot be made between different cell extracts, as the 
concentration of MTase will vary, but Ral did not appear to have any effect on MTase 
activity (figure 4.15). 
Discussion 
The ml gene of bacteriophage X has been overexpressed and its product purified, using 
a combination of ion exchange and gel filtration liquid chromatography, and reverse 
phase HPLC. The purified protein has the molecular mass and N-terminal sequence 
expected from the nucleotide sequence of ml (Ineichen et al., 198 1) without the N-
terminal methionine. The first aa residue, incorporated at the initiation of translation, is 
always N-formyl-methionine, although the first codon is not always an ATG codon for 
methionine, and this residue is commonly removed post-translationally in E. coli 
(Hershey, 1987). Most of the Ral produced by cells overexpressing the gene at 37°C, 
is insoluble. Attempts to increase the solubility of Rai, by growing cells at lower 
temperatures, have been partially successful; more Ral appears in the soluble cell 
extract from cultures grown at 28°C than those grown at higher temperatures. 
Incubation temperatures lower than 28°C were not tried as no equipment was readily 
available that could aerate cultures in flasks below this temperature. Expression of ml 
at lower temperatures, however, may further increase the solubility of its product. The 
production of fusion polypeptides can increase the solubility, and aid the purification, 
of expressed gene products and further investigations with pGK25 or similar plasmids 
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Figure 4.15. In vitro DNA methylation with cell extracts. See text for details. 
MTase + Ral, protein from cells overexpressing both the genes encoding the MTase 
and Ral; MTase + Ral (mix), protein from cells overexpressing the genes encoding the 
MTase and cells expressing ml were mixed together after the extracts were made. =, 
unmodified target (408L:409L); ±, hemimethylated target (860L:409L); 1:, fully 
modified target (8601-:409L). 
MTase + Rai 
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may increase the yield of Ral. The present purification procedure provides ample 
protein for biochemical studies, but a higher yield would be useful for structural 
studies. In particular, Ral is sufficiently small to be amenable to analysis by nuclear 
magnetic resonance (NMR), although approximately 20 mg of protein would be 
required to attempt a full structural determination. These quantities of synthetic Ral are 
available, but attempts to solve the structure by 2D NIVIR have been unsuccessful (P. 
Barlow and A. Brown, unpublished). The Ral purified from cell extracts may be 
useful for comparisons with the synthetic Ral, to determine whether they have the 
same biochemical and structural properties. Larger quantities of Ral could be purified 
if the insoluble protein was denatured before purification, e.g. with urea. However, 
the denatured protein would have to be renatured, and it would be necessary to 
determine if the renatured protein had refolded correctly, although similar studies could 
be performed to those envisaged for the synthetic Ral. 
The main reason for purifying Ral was to examine its molecular mechanism of action 
and its interaction with the EcoKI MTase. Large quantities of the EcoKJ MTase have 
been purified (Dryden et al., 1993) and a variety of biochemical techniques have been 
used to examine its activity (Powell et al., 1993; Powell and Murray, 1995; Chen et 
al., 1995). The EcoKI MTase has a strong preference for hemimethylated DNA in 
vivo and in vitro (Zabeau et al., 1980; Suri et al., 1984a; Dryden et al., 1993) and may 
be regarded as a maintenance MTase, as it maintains the methylation patterns of the 
host after semi-conservative DNA replication. Mutants have been isolated and mapped 
to hsdM that no longer have this preference for hemimethylated DNA and efficiently 
methylate an unmodified substrate, consistent with de novo methylation activity 
(Kelleher etal., 1991). An hypothesis to explain the Ral phenotype, is that Ral 
interacts directly with the MTase to stimulate MTase activity (Loenen and Murray, 
1986), and the maintenance MTase of EcoK]I could be changed to a de novo MTase. 
Preliminary experiments with gel retardations using the EcoKI MTase, Ral, labelled 
oligonucleotides and affinity purified Ral Abs were unable to show an interaction 
between Ral and the MTase associated with its target. This technique relies on Ab 
binding to cause a 'supershift', and the extra shift will not occur if the epitopes, 
recognised by the Ab, are masked. Other methods have been used to try and show an 
interaction between Ral and the MTase, including PAGE of glutaraldehyde-crosslinked 
complexes and gel retardation followed by Western blot analysis, however, the results 
were inconclusive and more work would be required to refine the techniques before 
any conclusions could be drawn. Another method that may be useful is liquid 
chromatography, either gel filtration or affinity chromatography with immobilised 
protein that would be similar to the method used for the purification of the Ral Abs. 
Gel retardation and chromatography techniques rely on a stable association during 
PAGE or on the column, whereas crosslinking of the MTase and Ral merely requires a 
close association in solution. Therefore, glutaraldehyde-crosslinking and detection of 
Ral by Western blot analysis, may be the most suitable technique to further analyse 
possible interactions between Ral and the MTase. Purified HsdM subunit is also 
available (M. Winter and D. Dryden, unpublished) that could be used to further define 
possible interactions. 
Methylation assays, with purified MTase and synthetic oligonucleotide substrates, did 
not show any increase in de novo methylation when purified Ral was present. The in 
vivo observations clearly demonstrate that the modification of unmodified phage DNA 
is enhanced in the presence of Ral, and the lack of increased methylation in vitro could 
be due to a number of factors: 
A component is missing. 
Subunit rearrangements are required that do not take place in vitro. 
The purified Ral is inactive, or the purified MTase has lost the activity required to 
interact with Ral. 
Oligonucleotides are not a suitable substrate. 
Impurities in the Ral preparation interfere with Ral. 
The enhanced methylation is not sufficient to be detected in this assay. 
Methylation assays with extracts from cells expressing the genes encoding the EcoKI 
MTase and Ral were designed to overcome problems associated with the first three 
points. Immediately before the extracts were made, bacteria were able to enhance the 
methylation of unmodified ni phages, however, enhanced methylation of unmodified 
DNA was not detected in vitro. Hemimethylated oligonucleotides are substrates for the 
EcoKJ MTase, but in case the substrate did make a difference, attempts were made to 
examine the methylation of plasmids with cell extracts. Hemimethylated substrates 
could be made by annealing two linearised plasmids isolated from strains with different 
modification phenotypes, however the plasmids were not labelled sufficiently to be 
visualised by fluorography (results not shown). The concentration of EcoKlI targets 
used in the MTase assay with oligonucleotides was 2.25 pM, and to achieve this 
concentration of sites with the plasmid (pRH3; Sain and Murray, 1980) would require 
approximately 4.5 pg .tl 1 DNA in the reaction (the molecular mass of pRH3 is 
approximately 4 x 106,  and it contains 2 EcoKlE sites). The concentration of plasmid 
DNA actually used was 0.2 tg tl' and this could be increased, although technical 
considerations would soon limit the amount of DNA in the reactions. If these 
experiments were continued it may be preferable to use a different method of 
separating the labelled DNA from AdoMet, e.g. gel filtration, and then detect the 
tritiated DNA in scintillant using a scintillation counter. 
The purified Ral, and cell extracts, used for these experiments do contain other 
proteins and it is possible that one of these interferes with Ral activity in vitro, but not 
in vivo. The Ral protein could be further purified by liquid chromatography using 
DEAE, Heparin and Hydroxyapatite; Ral does not bind to these resins, but other 
proteins probably will, and Ral would be collected in the flow-through. HPLC using a 
cation-exchange column and elution with an aqueous salt gradient may also be useful, 
although attempts to separate Ral using a Resource S column have been unsuccessful 
as Ral elutes over a large salt concentration. The measure of methylation enhancement 
in vivo is much more sensitive than these in vitro experiments, and more extensive 
studies, possibly using techniques of greater sensitivity should indicate that Ral does 
have a stimulatory effect on methylation in vitro. 
If Ral only slightly stimulates methylation, then it must also block DNA cutting. Small 
quantities of the purified EcoKT ENase are available (L. Cooper and D. Dryden, 
unpublished), but preliminary experiments indicate that purified Ral added to the 
ENase does not stop the cutting of unmodified plasmids in vitro. However, for similar 
reasons outlined for the methylation assays with purified proteins, an examination of 
DNA cutting with extracts from cells overexpressing the genes encoding the EcoKI 
ENase and Ral may be more informative. Other host-encoded exonucleases and 
endonucleases would be a problem in these experiments, although the circular plasmid 
DNA would be resistant to degradation, and non-specific cleavage could be detected 
with appropriate controls e.g. plasmid DNA prepared from a host expressing the genes 
encoding EcoKI. 
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Chapter five: The Lar activity of bacteriophage 
Xre verse 
Introduction 
The Ral function of bacteriophage X is able to modulate the activity of the type IA R-M 
systems, both alleviating restriction and enhancing modification (Zabeau etal., 1980). 
A number of lambdoid phages are known to encode a Ral-like function, including P22, 
4)21, and the recombinant phage ?reverse (Azev; Toothman, 1981; Semerjian etal., 
1989). The nucleotide sequences of the ml genes of phage ? and 4)21 are identical 
(Franklin, 1984). The nucleotide sequence of 021 in the region including ml is from 
an Aimm 2 ' hybrid phage, and the sequence identified as the ml gene of 4)21, may be 
sequence from X. The ml genes of phages ? and P22 also share a high degree of 
sequence identity, approximately 75% at the nucleotide and predicted an level 
(Semerjian etal., 1989). As the predicted aa sequences of the three identified ml genes 
are so similar, little information may be gleaned about individual residues that may be 
important for structure and/or function. The gene encoding the Ral-like activity of 
Arev has been termed lar (Toothman, 1981). This chapter describes the identification 
and characterisation of lar and its product. 
To understand the nature of Xrev, and lar, it is necessary to explain a little about the 
development of phage ? and how this recombinant phage was isolated. Phage A. DNA 
enters the cell as a linear molecule with complementary, single-stranded ends that are 
circularised by the activity of host-encoded DNA ligase to form a double-stranded cos 
site. DNA replication initiates on the supercoiled circular DNA molecule and proceeds 
bi-directionally to create monomeric daughter DNA circles (9 replication). Packaging 
of A. DNA requires two cos sites, therefore, monomeric circles are not packaged, 
although homologous recombination mediated by the host-encoded RecA function or 
phage-encoded Red function, can form multimeric molecules that may be used to 
package DNA. The DNA normally forms concatemers by rolling-circle (a) replication 
and is packaged after cutting at two suitably-spaced cos sites. For the phage to 
replicate by a replication, the RecBCD nuclease must be inactivated by the phage-
encoded Gam protein, presumably because RecBCD would degrade phage DNA from 
the unprotected single-stranded cos site (figure 5.1; Furth and Wickner, 1983; Murray, 
1991). 
The Fec (feckless) and Spi (sensitive to P2 interference) phenotypes are important in 
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may be appreciated with the information outlined above. Xredgam phages are unable 
to grow on a recA host, the Fec7 phenotype (Manly et al., 1969), as concatemeric DNA 
molecules cannot be formed. Wild-type X is unable to grow on a P2 lysogen, the Spi 
phenotype (Lederberg, 1957), and this is only partially understood. Xredgam phages 
are Spi and phage P2 cannot lysogenise a recB mutant (Sironi, 1969), suggesting that 
the inactivation of RecBCD nuclease by Gam is responsible for the Spi phenotype. 
Xredgani phages are also Spi and the Fec/Spi phenotypes, therefore, would appear 
to be mutually exclusive. However, Zissler and colleagues (197 1) isolated reverse 
mutants of Fec phages that were Fec, but Spi; these phages, termed Xreverse, could 
both grow on a recA host and a P2 lysogen. Heteroduplex mapping and genetic 
analysis has identified a region in the genome of Xrev that is substituted with DNA 
from E. coli that serves the same functions encoded by the early genes of phage A, 
including integration, recombination, immunity and replication (Low, 1973; 
Gottesman et al., 1974; Diaz et al., 1979). Southern blot analysis of Xrev and 
different strains of E. coli (Kaiser and Murray, 1979), confirmed the hypothesis that 
the region of host DNA substituted in Xrev was derived from the E. coli Rac prophage 
(Low, 1973; Gottesman et al., 1974). E. coli sbcA mutants (Templin et al., 1972) 
express the recE and recT genes of the Rac prophage (Kushner et al., 1974; Clark et 
al., 1993), and the exonuclease activity encoded by &rev and Rac is indistinguishable 
(Gillen et al., 1977). The Red activity of bacteriophage Xis encoded by two genes, 
redcx (exo) and redfl (bet). RecE exhibits a double-strand DNA exonuclease activity 
similar to Reda (Kushner et al., 1974), and RecT, like RedI3, catalyses the 
renaturation of single-stranded DNA (Kolodner et al., 1994). E coli sbcA mutants are 
unable to restrict the growth of unmodified phages, although they are genotypically 
hsdRMS (Simmon and Lederberg, 1972), and it seems probable that Xrev and sbcA 
hosts express the same gene, termed lar, whose product is responsible for the 
alleviation of restriction (Toothman, 1981). 
Identification of the lar gene 
To identify the region of the Rae prophage that encodes lar, a 7.6 kb Hindffl fragment 
from XNM891 (Kaiser and Murray, 1979), that includes DNA common to the E. coli 
sbcA8 mutant and Xrev, was cloned in pUC18 (Yamsch-Perron et al., 1985) to 
generate pGK7 (figure 5.2a). An EcoKI restriction-proficient strain (NM710) was 
transformed with pGK7 and the restriction alleviation activity of the plasmid was 
examined by comparing the titre of Xv.0 on this strain versus a non-restricting strain 
(NM792). In this screen, a similar titre indicates restriction alleviation. pGK7 
alleviated restriction, and the lar gene was further localised by cloning segments of the 
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Figure 5.2. Localisation of the region encoding 1w-. (a) Origin of &rev, XNM89 1 
and the Rac prophage integrated in the chromosome of the E. coli strain C600 and an 
sbcA mutant (sbcA8; JC5412). The DNA common to &rev and the sbcA8 mutant is 
contained in XNM89 1. (b) The 7.6 kb Hindffl fragment from ANM89 1 was cloned in 
pUC18 (Yanisch-Perron et al., 1985) to generate pGK7. Segments of this 7.6 kb 
Hind ifi fragment were cloned and screened for restriction alleviation activity. The 
BamHI fragment was cloned in pUC18 to generate pGK8. The MI-EcoRI fragment 
was excised from pGK8, converted to a blunt-ended fragment using Klenow 
polymerase, and ligated to pUC18 cut with Smal, to generate pGK9. pGK1O was 
similarly made with the 500 bp XhoI-EcoRI fragment from pGK9. Thick line, E. coli 
chromosome; thin line, pUC18 DNA; open box, Rac DNA; PB', hybrid Rac 
attachment site; open triangles, Hindffl target sites; P1w , 1acUV5 promoter in pUC18; 


































7.6 kb Hindffl fragment in pUC18 and screening for restriction alleviation activity 
(figure 5.2b). The BamHl fragment was cloned in pUC18 to generate pGK8. The 
ClaI-EcoRI fragment was excised from pGK8, converted to a blunt-ended fragment 
using Kienow polymerase, and ligated to pUC18 cut with Smal, to generate pGK9. 
pGK10 was similarly made with the 500 bp XhoI-EcoRI fragment from pGK9, and 
this 500 bp insert was the smallest DNA fragment that conferred restriction alleviation 
activity. 
The region of the Rac prophage in pGK1O has been sequenced (Clark etal., 1993; 
GenBank accession number L23927) and contains four open reading frames (orfs), 
orfG and orJH' (truncated) in one orientation (figure 5.3a), and froR and froS in the 
other (figure 5.3b). All of the clones that had Lar activity contained a plasmid insert 
oriented such that orfG should be transcribed from the lac promoter. In order to 
examine the orientation dependence of the restriction alleviation phenotype, the 500bp 
EcoRI-Hindffi fragment from pGK1O was cloned in pUC19, to generate pGK1 1, then 
removed and recloned in pUC18, to generate pGK12. pGK1 1 and pGK12, therefore, 
differ only in the orientation of the 500 bp insert relative to the lac promoter. 
Restriction alleviation activity was unaffected by the orientation of the insert (table 5.1) 
suggesting that there is sufficient lar expression to alleviate restriction even when 
transcription of the gene is opposed by that from the lac promoter. In these 
experiments, transcription was neither enhanced nor opposed by activation of the lac 
promoter. 
A 290 bp fragment including oifG (figure 5.3a/b) was amplified by the polymerase 
chain reaction (PCR) and cloned in pT7-6 to generate pGK15. This plasmid was 
found to both alleviate restriction and enhance modification by EcoKI (tables 5.2 and 
5.3). orfG is the only complete orf transcribed from the T7 promoter in pGK15, 
although froR and froS are read in the opposite orientation. To test whether orfG 
encoded Lar, an amber codon was generated within orfG that would have no effect on 
the predicted aa sequence of froS. Site-directed mutagenesis was performed using the 
PCR with four oligonucleotide primers, two flanking primers and two complementary 
internal primers that overlap the codon to be changed and contains the nucleotide 
sequence required for the aa substitution (Higuchi, 1990). Amplification by the PCR 
was performed separately with each pair of correctly oriented flanking and internal 
primers, with a wild-type DNA template, to generate two products. The DNA template 
and excess primers were removed by separation through an agarose gel and the full-
length fragment, containing the required substitution, was amplified by a second round 
of the PCR using the products of the first PCR as the template and the two flanking 
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(a) 	 Hindlil 
GGAAGCTTCAGAGGAATAATTCAGC 	 G2370 
Cia I 
3875 5' ATCGATAATTCAGAGGAATAATTCAGCCTGGCGGTGTAATG 
I D N S E E * 	 RecT 
M OrfG 
3916 CACCGCCAACTTGAAATATTTTTTATGAGAAAAATTATGAGAT 
H R Q L E I F F M R K I M R 	OrfG 
3959 ATGACAATGTTAAACCATGTCCATTTTGTGGTTGTCCATCAGT 
Y D N V K P C P F C G C P S V OrfG 
TACCGAGCGTAGTGTAAC G2371 
4002 AACGGTGAAAGCCATTTCAGGATATTACCGAGCGAAGTGTAAC 
T V K A I S G Y Y R A K C N OrfG 
4045 GGATGCGAATCCCGAACCGGTTATGGTGGAAGTGAA.AAAGAAG 
G C E S R T G Y G G S E K E 	OrfG 
4088 CACTCGAAAGATGGAATAAACGAACCACTGGAAATAATAATGG 
ALE RW -N K - R T TG.N N NG OrfG 
GGTGATAACTTTTCCTTCT G2372 
4131 AGGTGTTCATGTATAAAATTACCGCCACTATTGAAAAGGAAGG 
G V H V * 	 OrfG 
MY KIT A TIE KEG OrfH 
EcoRI 
TAAGGG 	 G2372 
4174 TGGCACTCCTACTAACTGGACAAGATATTC.AAAATCTAAACTA 
G T P T N W T R Y S K S K L OrfH 
4217 ACGAAATCAGAATGCGAAAAAATGCTCTCAGGTAAAAAAGAAG 
T K S E C E K M L S G K K E 	OrfH 
4260 CAGGCGTTTCCAGAGAGCAGAAAGTAAAACTGATAA.ATTTTAA 
A G V S R E Q K V K L I N F N OrfH 
XlioI 
4303 TTGCGAGAAACTTCAGTCCTCGAG 3' 
C E K L Q S S 	 OrfH 
Figure 5.3. Nucleotide sequence of the ClaI-XhoI fragment encoding lar, and the 
predicted aa sequence of possible gene products. (a) Sequence in the orientation co-
directional with recET, containing oifG and orjT-I. (b) The complementary sequence, 
in the 5'-3' orientation, containing froS and froR. 'flanking' primers used for the 
PCR and one of the internal primers used to generate the K42Am substitution (codon 
in bold) are shown. Target sites for type II ENases are underlined. 
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(b) 	XhoI 






GG 	 G2372 
4156 GGCGGTAATTTTATACATGAACACCTCCATTATTATTTCCAGT 
M N T S I I I S S FroS 
4113 GGTTC.GTTTATTCCATCTTTCGAGTGCTTCTTTTTCACTTCCA 
G S F I P S F E C F F F T S 	FroS 
CAATGTGATGCGAGCCA G2371 
4070 CCATAACCGGTTCGGGATTCGCATCCGTTACACTTCGCTCGGT 
T I T G S G F A S V T L R S V FroS 
T 	 - 	 G2371 
4027 AATATCCTGAAATGGCTTTCACCGTTACTGATGGACAACCACA 
I S * 
	
	 FroS 
M A F T V T D G Q P Q FroR 
3984 AAATGGACATGGTTTAACATTGTCATATCTCATAATTTTTCTC 
N G H G L T L S Y L I I F L FroR 
CGA G2370 
3941 ATAAAAAATATTTCAAGTTGGCGGTGCATTACACCGCCAGGCT 
1K N IS SW R C I T PP G 	FroR 
Hindlil 
CTTAATAAGGAGACTTCGAAGG 	 G2370 
Cl al 
3898 GAATTATTCCTCTGAATTATCGAT 3' 
* 	 FroR 
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Host 	 Titre X.0 
NM794 4.5 x 1010 
NM777 pUC18 	2.4 x 107 
NM777 pGK11 2.1 x 1010 
NM777 pGK12 	3.8 x 1010 
Table 5.1. Orientation dependence of Lar activity. Restriction alleviation activity 
was determined for each host by measuring the titre of unmodified 2mt phages 
(?NM325.0) normalised against the titre of modified X (XNM325.K). This corrects 
for variation resulting from factors other than restriction, see chapter 2. 
Host 	 eop of progeny phages 
NM526(DE3) pT7-6 	4.6 x iO 
NM526(DE3) pGK15 1.0 
Table 5.2. Modification enhancement activity of lar. A restriction deficient, 
modification proficient strain (NM526) was transformed with the plasmid of interest 
and infected with unmodified X phages (XNM325.0). After a single round of 
infection, the degree of phage modification was estimated by measuring the efficiency 
of plating (eop) of progeny phages on a restricting strain (Ymel) relative to that on a 
non-restricting derivative (NM526), see chapter 2. 
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Host Lar Titre X.0 
NM777(DE3) pT7-6 3.3 x 107 
NM777(DE3) pGK15 Wild-type 4.0 x 1010 
NM777(DE3) pGK16 K42Am 2.5 x 107 
NM777(DE3) pGK17 Mil 3.1 x 1010 
NM777(DE3) pGK18 MiOl 2.8 x 1010 
NM777(DE3) pGK19 M141 1.5 x 1010 
NM777(DE3) pGK20 M1Am 3.6 x 1010 
NM777(DE3) pGK21 M1OAm 2.8 x 1010 
NM777(DE3) pGK22 M14Am 1.1 x iO 
NM777(DE3) pGK23 M1OAmM14I 2.6 x i07 
Ymel(DE3) pT7-6 1.7 x 107 
Ymel(DE3) pGK15 Wild-type 2.7 x 1010 
Ymel(DE3) pGK16 K42Am 2.2 x 10' 0 
Ymel(DE3) pGK22 M14Am 2.1 x iO 
Ymel(DE3) pGK23 M1OAm M141 8.9 x 106 
Table 5.3. Restriction alleviation activity of kir mutants. Restriction alleviation 
activity was determined for each host by measuring the titre of unmodified ?nit phages 
(?NM325.0) normalised against the titre of modified X (A.NM325.K), see chapter 2. 
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primers (figure 5.4). The flanking and internal primers used for the site-directed 
mutagenesis of o,fG, described below, are shown in figure 5.3 and 5.5, and an 
example of the separation of the products generated by the first and second round of 
the PCR is shown in figure 5.6. The DNA fragments generated by the PCR were 
cloned in pT7-6 using the Hind HI and EcoRI sites in the flanking primers, and the 
nucleotide sequence determined using Sequenase (figure 5.7, see comments in the 
legend). To test whether orfG encoded tar, codon 42 of orfG was changed from AAG 
to TAG (K42Arn; figure 5.3a) and this is a synonymous change infroS (the codon for 
L35 changes from CTT to CTA; figure 5.3b). The resulting plasmid (pGK16; 
K42Am) was examined for restriction alleviation activity in both a sup° (NM777) and 
supF (Ymel) host (table 5.3). Restriction alleviation was quantified by measuring the 
titre of unmodified X on a restriction-proficient host transformed with the plasmid of 
interest, and the ability to enhance modification was examined by a single round of 
infection of rat phages on restriction-deficient, modification-proficient transformants. 
Ymel (rK,  supF), NM526 (rKmK derivative of Ymel) or NM777 (rK , sup 
0),  lysogenic 
for 2DE3, was the host in these experiments, and the phage was XNM325 that 
contains a bio substitution that removes a region of phage DNA including both the mt 
and nil genes. It is important that the phage is rat, as the progeny of a rat phages 
would be efficiently modified in a single round of infection, and the phage is inf to 
ensure that it does not act as a helper phage to allow XDE3 to excise from the host 
chromosome. Restriction was not alleviated in a sup' host transformed with pGK1 6, 
but was alleviated in a supF host. The open reading frame orfG, therefore, encodes a 
Ral-like antirestriction activity that is almost certainly the Lar activity identified by 
Toothman (1981). 
Examination of the DNA sequence at the start of tar identified a number of possible 
translational start codons (figure 5.3a). The DNA codon ATG encodes the most 
common translational initiation codon (Gold, 1988; McCarthy and Gualerzi, 1990), 
and there are three of these close to the start of oifG at positions 1, 10, and 14. To 
identify which ATG was the translational initiation codon, each ATG codon was 
mutated individually to one for isoleucine; the first ATG codon was changed to ATA 
(pGK17) and codons 10 and 14 to ATC (pGK18 and pGK19 respectively; figure 5.5). 
It was anticipated that a mutation to the ATG codon required for translational initiation 
would abolish Lar activity. However, all three mutants retained restriction alleviation 
activity (table 5.3) indicating that a single ATG codon was unlikely to be wholly 
responsible for translational initiation. 
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PCR 




Figure 5.4. Site-directed mutagenesis using the PCR. See text for details. Primers 
are drawn as short lines, arrows indicate 5'-3' orientation and a 'bulge' indicates base 
mismatches; parallel lines, the DNA template. 
- 	 - 	 - 	 - 
 
112 
Figure 5.5. The primers used to generate mutations at the start of the 1w- gene. The 
nucleotide and predicted aa sequence at the start of 1w- are shown. Bold type indicates 
the codons changed, and primer designations in brackets are the complementary 
oligonucleotides used in the PCR. 
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CTGGCGGTGTAATGCACCGCCAACTTGAAATATTTTTTATGAGAAAAATTATGAGATATGACAATGTA Ia! 
M H R Q L E I F F N R K I M R Y D N V aa 
Isoleucine substitutions 
G5859 GTGTAATACACCGCCAAC (G5860) 
G7230 
Amber codons 
G8267 GTGTATAGCACCGCCAAC (G8266) 
H1207 
TTTATCAGAAAAATTATGAG (G7231) 
G3789 GAAAAATTATCAGATATGAC (G3788) 
TTTTAGAGAA.AAATTATGAG (H1208) 
H1832 GAAAAATTTAGAGATATGAC (H1831) 
Lane 1 1 1 2 	3 
	
302 bp 	 OW 
242 bp 
79 bp 	4I 
Figure 5.6. Site-directed mutagenesis using the PCR - an example of the three 
products. Lane 1, 123 bp ladder; lane 2, fragment amplified using primers G7231 and 
G2370; lane 3, fragment amplified using primers G2372 and G7230; lane 4, fragment 
amplified using primers G2372 and G2370 with DNA purified from lanes 2 and 3 as 
the template. Arrows indicate the size of the fragments amplified by the PCR. 
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Figure 5.7. The nucleotide sequence of the codons changed by site-directed 
mutagenesis. (a) pGK15 (wild-type) and pGK16 (K42Am). (b) pGK15 (wild-type), 
pGK17 (Mu) and pGK20 (M1Am). (c) pGK15 (wild-type), pGK18 (MiOl) and 
pGK21 (MlOArn). (d) pGK15 (wild-type), pGK19 (M141) and pGK22 (M14Am) (e) 
pGK15 (wild-type) and pGK23 (M1OAm M141). In all parts, sequence is read 
GATC, the bases changed are indicated with an arrow and the codon is written at the 
side. Note, the sequence is of the reverse strand to lar. The nucleotide sequence of 
each fragment amplified by the PCR was determined using Sequenase. pGK17 and 
pGK20 both contain an additional mutation (G-A), outside any ORF, immediately 5' 
to the primers used in the PCR. Mutants could not be isolated that did not contain an 
additional mutation at this position. All other plasmids contain the expected sequence. 
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To identify the minimum coding sequence required for restriction alleviation activity, 
each of the three ATG codons was mutated to an amber codon (figure 5.5). An amber 
codon is recognised as a translational 'stop' codon in a sup' host whereas, in a supF 
host, a tyrosine residue is substituted at this position. An amber mutation in either the 
first (Ml; pGK20) or second (M 10; pGK21) ATG codons did not affect activity, but a 
change to the third ATG codon (M14; pGK22) abolished activity, both in a sup' and 
supF host. This showed that translation of the DNA sequence upstream of the second 
ATG codon was not required for restriction alleviation. To ascertain whether the third 
ATG codon could be mutated to one for isoleucine (ATC) when no translation 
occurred upstream of the second methionine codon, a double mutant was made 
(M1OAm M141; pGK23). The double mutant was generated by site directed 
mutagenesis using the PCR, with the same primers used to generate pGK19 (M141; 
figure 5.5) but with pGK21 (M1OAm) as the template. This double mutant is unable 
to alleviate restriction in either a sup° or supF host (table 5.3). To further the 
interpretation of these results, the polypeptides produced by each of the lar clones were 
examined. 
Identification of the lar gene product 
The products of the lar clones were visualised by the selective labelling of proteins 
encoded by genes under the control of the T7 promoter (Tabor, 1990). E. coli RNA 
polymerase, but not T7 RNA polymerase, is inactivated by the antibiotic Rifampicin, 
and the products of genes transcribed by T7 RNA polymerase may be selectively 
labelled if cultures expressing the T7 gene 1 are first treated with Rifampicin and then 
35S-labelled aa added to the media (see chapter 2). Different sized polypeptides were 
detected depending on both the plasmid and the suppressor genotype of the host 
(figure 5.8). The host strains alone, BL21(DE3)sup° or BL21(DE3)supF, produced 
no labelled protein (data not shown), nor did pT7-6 in either the sup °(NM777, lane 1) 
or supF host (Ymel, data not shown). pGK15 (wild type 1w-; lanes 2 and 5) produced 
2 main products, with estimated molecular mass 8.8 kDa, and 8.3 kDa. The smaller of 
these is the more abundant. 
The proteins produced by the 1w- mutants were similarly examined. In a sup' host, 
pGK16 (K42Am) produced no polypeptides of an appropriate size for Lar (lane 4), 
although a number of smaller products were seen, consistent with truncated forms of 
Lar. In contrast, in a supF host (lane 3) both the 8.8 kDa and 8.3 kDa proteins were 
produced by pGK16. This correlates well with the observed phenotype; pGK16 does 
not alleviate restriction in a sup° host, but does in a supF host. 
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Figure 5.8. Visualisation of the lar gene products. (a) Lane 1, BL2 1 (DE3) pT7-6 
(vector); lane 2, BL21(DE3) pGK15 (wild-type); lane 3, NM793(DE3) pGK16 
(K42Am); lane 4, BL21(DE3) pGK16. (b) Lane 5, BL21(DE3) pGK15 (wild-type); 
lane 6, BL21(DE3) pGK17 (Mil); lane 7, BL21(DE3) pGK20 (M1Am); lane 8, 
NM793(DE3) pGK20; lane 9, BL21(DE3) pGK18 (MiOl); lane 10, BL21(DE3) 
pGK21 (M1OAm); lane 11, NM793(DE3) pGK21; lane 12, BL21(DE3) pGK19 
(M141); lane 13, BL21(DE3) pGK22 (M14Am); lane 14, NM793(DE3) pGK22; lane 
15, BL21(DE3) pGK23 (M1OAm M141); lane 16, NM793(DE3) pGK24. (c) A 
longer exposure of the autoradiograph showing the 10 kDa Lar polypeptide in lanes 5-
8. 
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Long exposure 
Both pGK18 (MiOl; lane 9) and pGK21 (M1OAm), in a sup' (lane 10) or supF host 
(lane 11), produced only the 8.3 kDa polypeptide, from which it is concluded that the 
second ATG (M 10) is the initiation codon for the 8.8 kDa protein. 
The third ATG codon (M14) is the major translational start of lar, encoding the 8.3 
kDa protein, as this polypeptide was not detected in either a sup' or supF host when 
the third ATG codon was mutated to an amber codon (M14Am; pGK22; lanes 13 and 
14 respectively). Nevertheless, pGK19 (M141; lane 12) and pGK23 (M1OAm M141; 
lanes 15 and 16) both produced small quantities of the 8.3 kDa protein. The ATC 
codon in pGK19 and pGK23, therefore, appears to be used as a poor translational start 
in these mutants. It seemed unlikely that the codons between the second and third 
ATG codons could encode the translational start of the 8.3 kDa protein as this 
polypeptide was not visualised in a supF host transformed with pGK22 (M14Am), 
and yet the 8.8 kDa polypeptide (starting at MlO) was detected (lane 14). 
A 10 kDa polypeptide, specific to the jar clones, can be visualised after longer 
exposures of the autoradiograph (figure 5.8c). The initiation codon for this low 
abundance polypeptide must precede the first ATG codon since, in a supF host, 
pGK20 (M1Am) produced the 10 kDa, 8.8 kDa and 8.3 kDa proteins (lane 8) but, in a 
sup' host, this clone only produced the two smaller polypeptides (lane 7). pGK17 
(Mu) did not affect the polypeptides produced (lane 6). 
In vitro methylation with cell extracts 
Lar activity was examined in vitro using cell extracts of NM5 19 transformed with 
pPT7 to methylate oligonucleotides. NM519 is a derivative of E. coli K-12 that 
constitutively expresses tar (sbcA23), and experiments were conducted as described 
for cells expressing ml and the genes cloned in pPT7 that encode the EcoKI MTase 
(chapter 4). The in vivo results show that NM519 cells exhibit enhanced methylation, 
but no evidence of this is found in vitro (table 5.4; comments in legend); a 
hemimethylated oligonucleotide is efficiently modified whereas an unmodified 
oligonucleotide is only poorly methylated (figure 5.9). It may be that Lar, like Ral, 
only has a slight stimulatory affect on MTase activity that would not be detected in this 
assay (see chapter 4 for discussion). 
Comparisons between the predicted aa sequences of Rai 
and Lar 
The minimum an sequence required for Lar activity starts at the methionine encoded by 
the third ATG codon (M14). The nucleotide and predicted an sequences of the tar 
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Host 	 eop of progeny phages 
NM519pPT7 	 4.5x10' 
NM519pJF118 9.8x 10 
Table 5.4. Modification enhancement by E. coli sbcA23. The degree of 
modification after a single round of infection (sri) of unmodified phages (?325.0) was 
estimated by measuring the efficiency of plating (eop) of progeny phages on a 
restricting strain (C600) relative to that on a non-restricting strain (NM679). Phages 
were titred by spotting 10 j.tl of diluted phage on a lawn of cells in BBL top layer, and 
the measurement of eop is not as accurate as the method described in chapter 2. 
However, this assay, based on sampling small volumes, is sufficiently accurate to 
indicate the enhancement of modification. 
Protein Lar Lar + MTase 
DNA - + + - + + 
Time 1 1 5 115 5 1 1 5 115 5 
.4 
Figure 5.9. In vitro DNA methylation with cell extracts. See text for details. =, 
unmodified target (408L:409L); ±, hemimethylated target (860L:409L); 1, fully 
modified target (860L:409L). 
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gene, starting at the third ATG codon, were compared to those of ml using the 
UWGCG Compare and DotPlot programs (figure 5.1OaIb). The two proteins are 
much more dissimilar than X Ral and P22 Ral (Semerjian et al., 1989), although a 
number of regions do align. The lack of similarity at the an level cannot be explained 
by a frame-shift mutation in one of the genes as no diagonal offset lines are seen on the 
DotPlot of the nucleotide sequences (figure 5. lOb). The predicted aa sequences of Ral 
and Lar were also compared using the UWGCG Gap program (figure 5. lOc) and this 
alignment may indicate an important structural and/or functional role for the residues 
CNGC and W--RTT in the two polypeptides. The region of far encoding W--RTT is 
aligned in both nucleotide and aa sequence. 
Discussion 
The lar gene, responsible for restriction alleviation and modification enhancement 
activity of the E. coli Rae prophage, has been identified and although it has been 
sequenced previously, its function was unknown and it was termed orfG (Clark etal., 
1993). The far gene, cloned in an expression plasmid, has three translation initiation 
codons producing polypeptides of estimated molecular mass 10 kDa, 8.8 kDa and 8.3 
kDa. pGK2 1 (Ml OAm) alleviates restriction in a sup' host and yet only produces the 
8.3 kDa protein; demonstrating that this is the only form of Lar that is required for 
activity. The translational initiation codon for this protein appears to be codon 14 
(ATG). However, when codon 14 is changed to an ATC (pGK19 and pGK23) the 
8.3 kDa polypeptide is still produced, although as is apparent from the labelling 
experiments with pGK19 (M141; figure 5.8b, lane 12), the amount of the 8.3 kDa 
polypeptide is much reduced relative to the 8.8 kDa protein. It has been shown that 
ATC can be used to initiate protein synthesis (Romero and Garcia, 199 1) and results 
would indicate that, in pGK19 and pGK23, this codon can be used as a poor 
translational initiation codon. Restriction was not alleviated by pGK23 (M1OAm 
M141). It is likely that insufficient Lar was produced to alleviate restriction in the 
absence of providing T7 RNA polymerase to induce expression of the far gene. The 
restriction alleviation and modification enhancement assays provided clear phenotypes 
with uninduced, wild-type far (pGK1 5; tables 5.2 and 5.3). It seemed preferable to 
use these conditions to examine Lar activity rather than those in which the cell 
physiology is perturbed by the gross overproduction of Lar dependent upon T7 RNA 
polymerase. The initiation codon for the 10 kDa form of Lar appears to be before the 
first ATG codon (Ml), and that for the 8.8 kDa polypeptide is the second ATG codon 
(Mb). The 8.3 kDa protein is the most abundant, although it is not possible to predict 
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Figure 5.10. Comparisons between the ml and lar genes and products. (a) The 
predicted aa sequences of Ral and Lar (starting at M14) were compared using the 
UWGCG Compare program (window size, 30; stringency, 9) and plotted using 
DotPlot. (b) The nucleotide sequences of ml and liii (starting at codon 14) were 
compared using the UWGCG Compare program (window size, 21; stringency, 14) 
and plotted using DotPlot. (c) The predicted an sequences of Ral and Lar (starting at 
M14) were compared using the UWGCG Gap program (gap weight, 3.0; length 
weight, 0.1; lines indicate identity; dots indicate similarity; % similarity, 52%; % 
identity, 25%). See text for further details. 
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what forms would be produced from the Rac prophage and whether the different forms 
have any biological significance. 
The Rac prophage includes genes that can serve the same functions as the early genes 
of phage ?, including integration, recombination, immunity and replication (Low, 
1973; Gottesman et al., 1974; Diaz etal., 1979). The recE and recT genes from Rac 
can substitute for the general recombination genes of X, exo and bet respectively 
(Kushner et al., 1974; Clark et al., 1993). In X, ml is upstream of the recombination 
genes, whereas in the Rac prophage, lar is immediately downstream of recT. The ml, 
exo and bet genes are all transcribed from PL  in X and it is logical to expect that they 
are also cotranscribed in Rac. Other genes in this transcriptional unit include those 
required by ? for excision (xis) and integration (int); analogous genes in the Rac 
prophage may be encoded in the DNA sequence downstream of lar (figure 5.11). 
Despite the rearrangement of gene order in Rac compared to ?, the DNA sequences of 
nil and lar show a 47% identity suggesting that the two genes have a common origin. 
Rai and Lar are both able to alleviate restriction and enhance modification of the type 
IA R-M systems in vivo and an examination of their predicted an sequences may, 
therefore, help identify key residues involved in structure and/or function. Cysteine 
residues are commonly used to stabilise the structure of proteins, either forming 
disulphide bridges or associating with divalent metal ions (Branden and Tooze, 1991). 
Lar contains a sequence of cysteine residues, Cys - X 2 - Cys - X 17 - Cys - X2 - Cys, 
that resembles a zinc-binding motif. Ral does not contain the same motif but it does 
contain a symmetrical sequence, Cys - X 5 - Cys - X2 - Cys - X5 - Cys, which may 
serve a similar role. When the aa sequences of Ral and Lar are compared a number of 
regions align. The identities CNGC and W--RTT may be relevant. The cysteines in 
the sequence CNGC may be of structural relevance, whereas the W--RTT residues 
may indicate a region of functional importance. The best conservation at the nucleotide 
level is seen in the region encoding W--RTT. Ral is amenable to structural analysis by 
nuclear magnetic resonance, and polypeptide produced by solid-phase synthesis 
(Brown etal., 1993) or in vivo from the cloned gene (chapter 4) could be used for this 
purpose. Given the structure of Ral, the motifs identified should help to further 
distinguish important residues and define targets for site-directed mutagenesis. 
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att in t xis 	reda red 
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Rac 	
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Figure 5.11. The early region of phage X and the similar region from the Rac 
prophage. See text for details. In brackets, the products of the genes from phage ? 
that are functionally similar to those encoded by the Rac prophage; ?, unknown or 
predicted. 
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Chapter six: Conclusions and general discussion 
Conclusions and general discussion 
The Rail function of bacteriophage 2 is able to alleviate restriction and enhance 
methylation by type IA R-M systems (Zabeau et al., 1980; Loenen and Murray, 1986). 
Ral is not produced to protect its own DNA, but unmodified phages that do escape 
restriction are more likely to become methylated if they are mr (see chapter 3). 
Therefore, the progeny of Xr2t 4 phages that escape restriction are efficiently 
methylated, whereas the progeny of Xmt phages are only poorly modified. This 
would confer an advantage as the progeny of a rat phage would not be restricted by a 
host with an R-M system of the same specificity. A number of hypotheses have been 
proposed to explain the activity of Ral at a molecular level. 
Debrouwere et al. (1980b) concluded, from experiments performed with defective 
prophages, that Ral had an anti-termination function and antagonised the transcription 
termination factor Rho. They suggested that Rho may form a complex with EcoKI and 
that this complex was dissociated by Ral bound to either Rho or EcoKII. The EcoKI 
MTase has been purified to homogeneity (Dryden et al., 1993) and only the hsdM and 
hsdS gene products are required to form a MTase that modifies hemimethylated DNA 
efficiently but only methylates unmodified DNA poorly. Rho, therefore, is not 
required for the 'maintenance' methylation activity of EcoKI. Rho is involved in 
transcriptional termination, and Ral could antagonise this activity (Debrouwere et al., 
1980b). However, Loenen and Murray (1986) found that the cloned nil gene did not 
make a strain phenotypically Rho, and it has been suggested that another gene, Ea 10, 
expressed in the defective rat' prophage used by Debrouwere et al. (1980b), is 
responsible for the observed anti-termination activity (Court and Oppenheim, 1983). 
Ea 10 encodes a single-strand binding protein of unknown function, although the 
single-strand binding protein of E. coli plays a central role in DNA metabolism and is 
involved in DNA replication, repair and recombination (Meyer and Lame, 1990). 
Zinkevich et al. (1987) suggest that Ral affects transcription or translation so that 
production of one of the subunits of the MTase is increased. It is difficult to see why 
an increase in only one of the subunits required to form the MTase should lead to an 
increase in methylation. Overexpression of the genes encoding the EcoKI MTase does 
not enhance methylation (Loenen and Murray, 1986; also see table 4.2) and the only 
form of EcoKlI MTase shown to be active is HsdM2S 1 (Dryden et al., 1993; L. Cooper 
and D. Dryden, unpublished). Zinkevich et al. (1987) specifically labelled proteins 
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from mr and nit phages that encoded the EcoKJ MTase, and concluded that rat greatly 
stimulated synthesis of the HsdM protein, as this subunit could only be detected from 
the nif phage. However, the authors do not indicate how HsdM and HsdS were 
identified, and other proteins are known to migrate with HsdS on SDS-polyacrylamide 
gels which do not appear to be resolved in this work. In particular, the region cloned 
includes mcrB whose product co-migrates with HsdS (Sain and Murray, 1980). 
Critically the nit and mr phages used by Zinkevich et al. (1987) rely on different 
promoters for the transcription of hsdMS. Transcription of hsdMS in the rat phage is 
driven by the promoter present in E. coli K-12, Pm.dl  whereas transcription of hsdMS 
in the nil phage may also be driven by the X promoter, PL. The protein identified as 
HsdS, therefore, may be a number of unresolved proteins, including McrB, and the 
higher level of expression of hsdM in the mt phage may be due to transcription from a 
strong ? promoter. 
An attractive explanation for the molecular mechanism of Ral activity, is that Ral 
interacts directly with the R-M complex (Zabeau et al., 1980; Toothman, 1981; Loenen 
and Murray, 1986). If Ral changed the ENase so that unmodified DNA was 
recognised as hemimethylated, then this would explain both phenotypes. 
Hemimethylated DNA is not a substrate for the ENase so the DNA would not be cut, 
but it is a good substrate for the MTase so the DNA would be efficiently methylated. 
Ral cannot only block restriction as Ral is required for efficient methylation of 
unmodified DNA, even in the absence of HsdR, the subunit required for restriction 
(Loenen and Murray, 1986). The nil gene has been overexpressed and its product 
purified (chapter 4). The purified EcoKT MTase (Dryden et al., 1993) and Ral have 
been used to examine methylation enhancement in vitro and similar experiments have 
been done with extracts from cells expressing hsdMS and ml. Preliminary results, 
following the transfer of a [3 H]methyl group from AdoMet to a DNA substrate, do not 
show any effect of Ral; Rai does not appear to greatly enhance MTase activity, and 
unmodified DNA is only methylated poorly. This is inconsistent with Ral changing 
EcoKI so that unmodified DNA is recognised as hemimethylated. Ral may only 
slightly stimulate methylation and this probably would not be detected in the assay 
used. It is not at all clear how much Ral would need to stimulate methylation to 
produce the observed phenotypes, but presumably if methylation was not greatly 
enhanced then DNA cutting must be actively blocked by Ral. This could be achieved 
in a number of ways; Ral could block the formation of the ENase complex, 
HsdR2M2 S 1 , or prevent a process required specifically for restriction, e.g. DNA 
translocation. To examine restriction alleviation in vitro, experiments could be 
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performed with purified EcoKiI ENase, a small quantity of which is available (L. 
Cooper and D. Dryden, unpublished), although the use of cell extracts would 
overcome some of the problems associated with using purified proteins, not least the 
possible inactivation of the proteins during purification. 
The work described has done little to explain the molecular mechanism of Ral activity, 
but the identification of the lar gene that encodes the Ral-like activity of the E. co/i Rac 
prophage (chapter 5), has identified a number of conserved residues in the proteins that 
may be important for structure and/or function. The nil genes of phage ? and P22 
show 75% identity (Semerjian etal., 1989), whereas lar shows only 47% identity with 
the nil gene of X. The predicted aa sequences of Ral and Lar share only 25% identity, 
52% similarity, and only two short regions align. In particular, the identity W--R'Ff 
may indicate residues important for function. Site-directed mutagenesis could be 
performed on these residues, although this may be a little presumptuous in the absence 
of any supporting structural or biochemical evidence. The identification of other genes 
that encode Ral-like activities would be useful to see if the regions of identity between 
nil and Jar were present, and confirm their possible importance. A collection of 
lambdoid phages are available that could be screened for Ral activity (Highton et al., 
1990), and the most interesting genes would be those that shared little overall identity 
with either ml or Jar. Southern analysis of DNA prepared from the collection of 
lambdoid phages, with probes from the ml and 1w- genes, would identify phages with 
similar DNA sequence. Those phages that encoded a Ral-like function, but did not 
contain DNA that hybridised to probes from ral or Jar, would probably be the most 
interesting. The genes encoding the function that alleviated restriction could be cloned 
by a similar method to the one employed in the isolation of kir (see chapter 5). 
Fragments from the phage DNA cut with a type II ENase, e.g. Sau3A, would be 
cloned in a plasmid expression vector and used to transform a strain proficient for 
EcoKiI restriction. Clones would be screened for the ability to restrict unmodified 
phages (Xvir.0), and the plasmids purified from the hosts that are phenotypically r 1 . 
Further analyses, including the modification phenotype, should identify genes 
encoding Ral-like functions and the determination of the nucleotide sequence would 
provide more information on important residues. Another approach to identify 
important residues is random mutagenesis. A modified PCR has been used, that 
reduces the fidelity of replication by Taq DNA polymerase, to saturate regions of DNA 
with changes (Leung et al., 1989; Zhou et al., 1991; Spee et al., 1993). A method 
could be optimised to ensure one or two aa substitutions for every ral clone. 
Phenotypic and sequence analyses of each clone, would give information both on 
130 
important residues and those that could be changed without effecting Ral activity, If 
the alleviation of restriction and modification enhancement phenotypes of Ral involve 
distinct molecular interactions, then some very interesting mutants may also be isolated 
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REVIEWS 
Restriction enzymes in cells, 
not eppendorfs 
Gareth King and Noreen E. Murray 
Restriction enzymes are essential reagents 
to molecular biologists, but their relevance 
to bacterial populations is less obvious. 
Most bacteria encode restriction and 
modification systems and these are 
commonly considered to be a barrier to 
phage infection. Current evidence also 
supports a more general role for them 
in genetic recombination. 
G. King and N.E. Murray are in the Institute of Cell 
and Molecular Biology, University of Edinburgh, 
Edinburgh, UK EH9 3JR. 
B acterial restriction systems are often likened to the vertebrate 'immune' sys- 
tem because both distinguish 
'self' from 'non-self' and both 
attack molecules that they des-
ignate as foreign. Restriction 
systems, unlike immune sys-
tems, confine their attack to 
DNA, and their mode of dis-
tinction between 'self' and 
'non-self' relies on sequence-
specific modification. The ab-
sence of specific modification 
can identify DNA as foreign and lead to its restric-
tion. The diversity of restriction and modification 
(R—M) systems provides a battery of tools for modern 
molecular biology and many varied substrates for 
analysing key aspects of molecular recognition, par-
ticularly protein—DNA interactions. Recently solved 
structures of DNA—protein co-crystals for both re-
striction and modification enzymes have consider-
ably aided our understanding of the DNA sequence 
specificity and catalytic mechanisms of both en-
zymes". The DNA sequence specificity is not im-
posed by any previously identified motif that occurs 
in other DNA-binding proteins, but involves amino 
acids that are widely separated in the primary protein 
sequence. In this brief review, we confine our dis-
cussion to biological aspects of restriction and modi-
fication, and focus on the enteric bacteria and their 
phages, although we believe that the information 
broadly applies to bacterial systems in general. 
R—M systems 
Classical R—M systems have two components, a DNA 
endonuclease (restriction enzyme) and a DNA methyl-
transferase (modification enzyme), both of which rec-
ognize the same DNA target sequence. Only unmeth-
ylated target sites are substrates for the restriction 
enzyme, while hemimethylated sites are substrates for 
the cognate methylase, and so the fully methylated 
state of 'self' DNA is regenerated after replication. 
The DNA of an infecting phage will only carry the 
modification required to escape cleavage if it has been 
propagated in a host with an R—M system of the 
same specificity. A single unmodified target in a phage 
chromosome can elicit cutting and is sufficient to 
inhibit, or 'restrict', phage propagation, although ad-
ditional targets increase the level of restriction. This 
can be quantified by measuring the efficiency of plating 
(e.o.p.) of a phage on a restricting strain relative to 
that on a nonrestricting strain. 
The degree of restriction varies 
depending on the phage and 
the restriction system chal-
lenged, but the e.o.p. is typi-
cally reduced to between 10_ 1  
and 10 by a single system. 
However, bacteria may have 
more than one system, in. 
- which case phage restriction 
may approach the product of 
the restriction abilities of the 
individual systems. Phage re- 
striction is not generally ab- 
solute, and phage genomes that do escape cleavage 
normally become modified, so that progeny phages 
are protected against restriction by bacteria with an 
R—M system of the same specificity. 
Variations in the e.o.p. of phages consistent with 
the activity of R—M systems were described as early as 
1938, but an explanation based on the host-depen-
dent modification of phages was first suggested in the 
early 1950s6 '7. A decade later, it was shown that DNA 
is the substrate for modification, and that restriction is 
associated with the breakdown of unmodified DNA. 
Restriction enzymes were then purified on the basis of 
their endonucleolytic activity'. Classical R—M systems 
are now divided into three types on the basis of en-
zyme complexity, cofactor requirements and position 
of DNA cleavage (see Fig. 1; for recent reviews, see 
Refs 1,2,9-11), although new systems are being dis-
covered that do not fit readily into this classifi-
cation 12 ' 13 . Some of the systems described in the 1950s 
are not classical R—M systems', but consist only of a 
restriction enzyme that is activated by specifically modi-
fied DNA. Interest in these modification-dependent 
restriction enzymes was stimulated when they were 
'rediscovered' as the enzymes that hampered the cloning 
of genes encoding specific DNA methylases' 4 . 
Type II R—M systems are the simplest. Restriction 
and modification activities are performed by separate 
enzymes that recognize short palindromic sequences, 
and the restriction enzymes cut within this sequence'. 
In contrast, a type I R—M system is a complex of three 
polypeptides (HsdR, HsdM and HsdS) with both 
activities. HsdS confers sequence specificity, and the 
restriction enzyme cuts the DNA at a variable distance 
from its recognition sequence. The type III enzymes 
are intermediate in complexity. They consist of two 
polypeptides, both of which are required to cleave DNA, 
but only the DNA-recognition subunit is required for 
modification". 
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Type I 	 Type II 	 -Type III 
• 20 members 	 • Over 2400 members • 5 members 
• Hetero-oligomeric enzymes 	 • ENase and MTase separate 	• Hetero-oligomeric ENase 
• Require ATP hydrolysis for enzymes 	 • ATP required for restriction 
restriction 	 • Cut DNA within recognition 	 • Cut DNA close to recognition 
• Cut DNA at various distances from 	sequence 	 sequence 
the recognition sequence 	 • DEAD-box proteins 
• DEAD-box proteins 
e.g. EcoKi 	 e.g. EcoRl e.g. StyLTI 
hsdR 	hsdM 	hsdS 	 res 	mod mod 	 res 
HsdR 	HsdM 	HsdS 	I I 	Res 	II  Mod Mod 	Res 
MTase 	 ENase 	MTase Mlase 	 I 
Both ENase and MTase 	 Both ENase and MTase 
Modification-dependent 	 Type us 	 Not classified 
• 4 members 	 • Over 35 members e.g. Eco571 
• Cut modified DNA 	 . Similar to type II, but cut DNA 	• One polypeptide is both an ENas€ 
• No cognate MTase outside recognition sequence and MTase 
e.g. McrBC 	 e.g. Fokl 	 e.g. Bcgl 
Heterodimeric ENase and MTase 
Fig. 1. The distinguishing characteristics and organization of the genetic determinants and subunits of the different types of restriction 
and modification (R—M) systems. R—M systems are classified on the basis of their complexity, cofactor requirements and position of DNA 
cleavage with respect to their DNA target sequence 9 . The type I, Il and Ill systems are the classical R—M systems. The restriction enzymes 
of the type I and Ill systems contain motifs characteristic of DEAD-box proteins 4950 , and may therefore be helicases. The type Ils systems 51 
are a subgroup of the type II systems that cleave DNA outside their recognition sequence. Some systems do not fit readily into the present 
classification 12.13  and -Eco571 has been tentatively termed a type IV system 12. The modification-dependent systems are not classical R—M 
systems, as they have no cognate methylase and only cut DNA that contains certain modifications. ENase, restriction endonuclease; MTase, 
methyltransferase. 
Occurrence of R—M systems 
R—M systems may be encoded by bacterial chromo-
somes or by their plasmids, and occasionally by 
prophages, but, surprisingly, they are also encoded by 
the viruses of the eukaryote Chlorella16 . Of the R—M 
systems identified, type II systems are by far the most 
numerous, with over 2400 members 17. This predomi-
nance probably reflects their importance to molecular 
biologists and the efficient screens that have been devel-
oped to identify them, rather than representing their 
prevalence in nature. There is no effective general 
screen for all types of R—M systems, but a few surveys 
give us some information on their distribution and 
frequency in nature. Of over 1000 strains of enteric 
bacteria, mainly Escherichia coli, that were screened 
for DNA-sequence-specific endonucleases, 25% were 
positive and may therefore have a type II R—M sys-
tem". A collection of 72 E. coli strains that represent 
the genotypic diversity of this species is now avail-
able 19 . A screen using probes for genes encoding type I 
R—M systems identified them in 17 of the 36 strains 
tested 20.  Most type I systems have been identified in 
the commonly studied enteric bacteria, although rep- 
resentatives are now being found in other bacteri 
species21 . Estimatéf the frequency of occurrence 
R—M systems are limited by the screens available, but 
is likely that the majority of bacteria do have a syster 
Escherichia coli C is the only natural isolate that h 
been studied extensively and found not to have o 
R—M system 14, but, like other bacteria, it can readi 
acquire a plasmid-encoded system. 
The type I R—M systems that have been identific 
in natural isolates of Enterobacteriaceae currently hai 
20 different specificities, 17 of which are believed i 
be encoded by alleles of the chromosomal hsd locu 
which was originally identified in E. coli K12. Son 
alleles of hsdR and hsdM encode polypeptides wil 
very similar amino acid sequences (80-99% identity 
even when from different species, but regions of hsc 
always differ considerably if they confer differei 
specificities. Other alleles encode remarkably dissini 
lar polypeptides (20-35% identity), irrespective 
the host species, and retain little evidence of commc 
ancestry20. This unusual allelic diversity is shared t 
other genes that are concerned with differentiatir 
'self' from 'non-self', for example, the major histl 
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compatibility complex class II locus of mammals and 
the self-incompatibility genes of plants 22 . The selec-
tive pressure imposed on a bacterial population for 
variation in the sequence specificity of R—M systems 
may be the challenge by phages 23 . 
Phage antirestriction systems 
The significance of R—M systems to bacteriophages is 
supported by the numerous ways in which phages can 
escape restriction. These include the absence or masking 
of restriction sites and the inactivation or modulation 
of R—M enzymes". Sequence analyses of bacteriophage 
genomes have shown that some phages (for example, 
the Bacillus phage 29) have significantly fewer 
targets for type II restriction enzymes of potential 
hosts than expected 9 ' 11 ' 24, and a recent analysis of nat-
urally occurring coliphages suggests that these target 
sequences are selected against 25 . 
The coliphages T3 and T7 encode an early gene, ocr, 
the product of which binds type I R—M enzymes and 
abolishes both restriction and modification activities. 
The ocr gene is expressed before targets in the phage 
genome are accessible to host restriction enzymes 26, 
so that these phages are protected from restriction 
and modification by type I systems. Bacteriophage P1 
also protects its DNA from type I restriction, but the 
antirestriction function, Dar, does not interfere with 
modification. The Dar proteins are co-injected with 
encapsidated DNA, so that any DNA packaged in a 
P1 head is protected. This allows efficient generalized 
transduction to occur between strains with different 
type I R—M systems. How Dar functions is unclear, but 
it has been suggested that Dar bound to DNA might 
hinder the DNA translocation that type I enzymes 
require for cleavage 27. 
Bacteriophage X encodes a very specialized anti-
restriction function, Ral, that modulates the activity 
of only some type I R—M systems, by alleviating re-
striction and enhancing modification. The systems 
influenced by Ral are those that have a modification 
enzyme with a strong preference for hemimethylated 
DNA. Ral may act by changing the activity of the 
complex from a maintenance methylase to a de novo 
methylase 28 . Unmodified X DNA is restricted because 
ral is not normally expressed before the genome is cut 
by the host R—M system, but phages that escape restric-
tion and express ral are protected by the enhanced modi-
fication of their DNA (G. King and N.E. Murray, 
unpublished). 
Some phages are made resistant to many types of 
R—M system by the presence of glucosylated hydroxy-
methylcytosine (hmC) in their DNA, for example, the 
E. coli T-even phages and the Shigella phage DDVI. 
This modification also identifies phage DNA and 
allows selective degradation of host DNA by phage-
encoded nucleases 29 . Nonglucosylated T- even phages 
are resistant to classical R—M systems because their 
DNA still contains the modified base hmC. These 
phages can be restricted by the methylation-dependent 
systems McrA and McrBC, although T-even phages 
encode a protein, Am, that protects superinfecting 
phages from McrBC restriction. It has been suggested  
that phages have evolved DNA containing hmC to 
counteract classical R—M systems, and that host-
encoded modification-dependent endonucleases are a 
response to this phage adaptation. In this evolution-
ary story, the Arn protein and glucosylation of hmC 
would be the latest mechanisms that render T-even 
phages totally resistant to most R—M systems". 
Evolution of new specificities 
The type I R—M systems are suited to changing their 
specificity because the same subunit, HsdS, defines 
the specificity of both restriction and modification 
activities. Sequence comparisons have shown that the 
type I hsdS genes consist of two variable regions sep-
arated by a central conserved region. These systems 
recognize a DNA target sequence of two half sites, 
each 3-5 nucleotides long, separated by a nonspecific 
spacer of 6-8 nucleotides. Several spontaneous mutants 
have demonstrated how new specificities may be gen-
erated in nature' " 20, and have identified key aspects 
of DNA recognition by type I systems (see Fig. 2 for 
details). The two variable regions of hsdS encode two 
target-recognition domains (TRDs), each of which rec-
ognizes a particular half site in the target sequence. 
New combinations of variable domains and minor 
changes in the length of coding sequence that separ-
ates the variable regions can both generate new speci-
ficities. Functional type I R—M systems have been ident-
ified in hsdS deletion mutants encoding only one TRD 
(Refs 30,31) It seems probable that hsdS originally 
encoded only one TRD, with gene duplication and 
divergence leading to the present arrangement 9. It is 
now apparent that TRDs may be assembled in different 
ways to generate new specificities, but it is not at all 
clear how new TRDs may evolve by the accumulation 
of point mutations. 
Transfer of R—M systems 
R—M systems are transferred between hosts and even 
between species, as implied by DNA sequence compari-
sons of the chromosomal hsd alleles22, and the exist-
ence of plasmid-encoded R—M systems, which may be 
maintained in a broad host range. Self-transmissible 
plasmids may also encode antirestriction functions, in 
particular ard, the product of which is functionally 
similar to T7 Ocr and has regions of sequence identity 
with this protein 12,11.  If an R—M system is transferred 
to a new host, the DNA of the recipient must be pro-
tected from cutting, which may be achieved by ensuring 
that a functional methylase is produced before the re-
striction enzyme. Several systems have been shown to 
have separate promoters for the genes encoding the 
methylase and endonuclease, which provide the po-
tential for differential gene expression 9 . Some of the 
genes encoding type II enzymes are transcriptionally 
regulated by repressor-like C proteins of about 100 
amino acids with a characteristic helix—turn—helix 
DNA-binding motif34'35 . C proteins have a much greater 
degree of similarity to each other, and to some other gene 
repressors, than do the R—M systems with which they 
are associated Perhaps the genes encoding C proteins 
have been recruited independently into R—M systems34. 
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to occur". A mutant has been isolated 
that cannot act as a recipient for 
functional hsd genes by conjugation, 
presumably because the host DNA is 
degraded by an active restriction com-
plex immediately on transfer 41 '. Re-
striction activity is not controlled at 
the transcriptional level, and charac-
terization of this mutant should help 
to identify the mechanism by which 
R—M activity is regulated. 
HsdS structure 	 Enzyme 	Recognition sequence 
(a) 
StySPI 	AA 	OTRC 




I 	 1 1 	EcoDXXI 
EMSSWN 
EcoDXXsI 	TC. N 
FIg. 2. Evolution of new type I restriction and modification (R-M) specificities 11 . 20.  (a) 
Rearrangement of variable regions within hsdS results in R-M systems with hybrid specificities. 
StySJ arose by recombination between the central conserved regions of the hsdS genes of 
StySPl and S1yLTIII, two naturally occurring R-M systems, and recognizes a hybrid sequence of 
the two parental systems. This demonstrates that there are two target-recognition domains 
(TRD5) located in separate regions of the HsdS subunit. The StySQ*  bsdS gene contains only 
the amino-terminal variable region of StySPl and the remaining coding region of StyLTllI. The 
amino-terminal variable region, therefore, encodes the TRD responsible for recognition of the 
trinucleotide component of the recognition sequence and, by analogy, the carboxy-terminal vari-
able region encodes the TRD that recognizes the tetranucleotide component. (b) Illustrates 
changing DNA specificity by altering the length of the hsdS central conserved region. EcoR1241 
and EcoR12411 differ only in the number of repeats of a short sequence within the central 
conserved region of hsdS, with EcoR12411 having an extra repeat. The EcoR12411 recognition 
sequence contains the same two half sites as EcoR1241. but has an extra base in the non-
specific spacer. (C) An active R-M system may have Only one kind of TRD. A transposon-
insertion mutant of the hsdS gene of EcoDXXI encodes a system with a new specificity, 
Ec0DXXsI, that has an HsdS polypeptide with only one TRD. Ec0DXXsI recognizes a bipartite, 
symmetrical sequence, with each half site corresponding to the sequence recognized by the 
single TRD. This is consistent with two truncated HsdS polypeptides replacing one HsdS 
polypeptide with two TRD5 in the R-M enzyme complex. In all parts, colours indicate the origin 
of regions of the HsdS polypeptide; open arrow, HsdS amino terminus; hatched box, variable 
region; open box, conserved region; solid arrow, repeat: R, purine; Y, pyrimidine; N. any base. 
The hsd genes of type I systems also have two 
promoters, one for the genes encoding the methylase 
and another for the gene encoding the additional sub-
unit that is required for restriction, but no differences 
have been detected in transcription from the two pro-
moters 36-38 . However, when the hsd genes are trans-
ferred by conjugation, there is a lag before restriction 
activity is detected, providing time for modification 
Possible roles for R—M systems 
The wide distribution and extra-
ordinary diversity of R—M systems 
suggest that they have an important 
role in the bacterial community. 
Usually, this is considered to be 
protection against phage infection. 
However, laboratory studies on the 
population dynamics of bacteria and 
phages indicate that R—M systems 
provide only a transitory advantage 
to bacteria 4 t. Essentially, a 'novel' 
R—M system can assist bacteria in 
colonizing a new habitat in which 
phages are present, but this advan-
tage is soon lost as phages become 
modified and bacteria acquire mu-
tations conferring resistance to the 
infecting phages. One possible ad-
vantage of a barrier provided by an 
R—M system, rather than a mutation 
conferring phage resistance, is that 
one R—M system can protect simul-
taneously against a variety of phages. 
Maintenance of one or more R—M 
systems may he preferable to main-
taining resistance to multiple phages 
because ph age-ad sorption sites com-
monly have additional functions, 
and their disruption may compro-
mise the fitness of the bacterium in 
nature. This is not supported by the 
laboratory experiments in which 
mutations conferring resistance to 
multiple phages were prevalent 41 . It 
seems relevant that the restriction 
barrier is generally incomplete, irres-
pective of the mechanism of DNA 
transfer, and that the fate of phage 
and bacterial DNA cut by restriction 
enzymes is likely to be different. 
Fragmentation of a phage chromo-
some leads to restriction of phage growth, while some 
of the DNA fragments generated from a bacterial 
chromosome may be rescued by homologous recom-
bination with the host genome. A protective role for 
R—M systems against phage infection does not exclude 
an additional role in genetic recombination. 
Linear DNA fragments are extremely vulnerable to 
degradation by bacterial nucleases. It is not unexpected, 
FREr..JIDS IN IVIIc;RB1D[.c;y 469 VOL.. 2 1'.Tc. 12 DEcErv1RER 1994 
REVIEWS 
therefore, that experiments have shown that the over-
all level of recombination is severely depressed in the 
presence of an active R-M system 2 ' 42 . Similarly, link-
age is reduced 20 . However, the suggestion that the DNA 
ends generated by restriction enzymes are recombino-
genic43 ' 44 is gaining experimental support. Restriction 
in vivo can generate DNA ends that initiate recombi-
nation45 , and recent data give some clues as to how the 
apparent competition between degradation and recom-
bination may be influenced"'. One analysis of trans-
ductants suggests that R-M systems may influence 
the pattern of DNA fragments incorporated into the 
recipient chromosome, creating a mosaic of short 
sequences in the genome 47 . This is consistent with the 
finding that the chromosomes of naturally occurring 
E. coli differ in short regions of DNA sequence 41 and 
the idea that R-M systems are involved in influencing 
the flux of genetic material between bacterial popu-
lations. Current technology permits a refined analysis 
of DNA transfer; the restriction analysis of DNA 
amplified by the polymerase chain reaction can be 
used to trace the origin of even short segments of 
chromosomal DNA. Applying these techniques to 
examine recombinant bacteria, where the parental 
strains are of defined recombination and R-M geno-
types, now allows the influence of restriction on 
genetic transfer to be analysed in detail, at least in the 
laboratory. 
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Chance and selection in the evolution 
of barley mildew 
James K.M. Brown 
Populations of the barley powdery mildew 
fungus are genetically very diverse. 
However, when a new resistance gene is 
introduced into barley to control mildew, 
the population of the pathogen may 
respond by rapid growth of a few virulent 
clones. These phases of rapid clonal 
evolution cause radical changes in the 
frequencies of mildew genotypes. 
J.K.M. Brown is in the Cereals Research Dept, 
John Innes Centre, Colney Lane, 
Norwich, UK NR4 7UH. 
J n 1986,a new winter barley variety, Pipkin, was in-cluded in the list of cereal 
varieties recommended to be 
grown in England and Wales'. 
Although Pipkin's excellent 
malting quality was its main 
attraction to farmers, it also 
had outstanding resistance to 
powdery mildew. Mildew is - 
caused by a fungus, Erysiphe 
graminis f. sp. hordei, and is 
the most serious disease of 
barley in northern Europe. 
Until 1988, Pipkin had a mildew-resistance rating 
of 9, the maximum possible. However, as a result of 
trials carried out in 1988, its rating fell to 4 in 1989 
and then to 2 in 1990, indicating that Pipkin had 
become very susceptible to powdery mildew and 
should not be grown widely for this reason (Fig. 1). 
The resistance to mildew of Pipkin, and of several 
other barley varieties introduced around the same 
time, is conferred by the gene M1a13. In plants, resist-
ance to specific strains of pathogens is under genetic 
control. Therefore, the M1a13 resistance gene became 
ineffective when the combination of the virulence 
alleles Val 3 and V(Ru3) in the pathogen (Box 1), which 
enable mildew to overcome the resistance, reached a 
significant frequency. (For brevity, virulence on M1a13 
is denoted Va13 hereafter.) 
The speed with which mildew adapted to M1a13 is 
neither unexpected nor unusual, as many other mildew-
resistance genes that had been used previously in barley 
breeding also remained effective for only a few years 
(Fig. 1) because of the evolution of matching virulences 2 . 
Current research in several countries in Europe is 
aimed at understanding the structure of populations 
of E. graminis f. sp. hordei and its implications for the 
evolution of the pathogen. 
Emergence of virulent clones 
The heavy mildew infections that first appeared on 
M1a13 varieties early in the summer of 1988 provided 
an opportunity to study a mildew population in the 
process of adapting to a new resistance gene'. Mildew 
isolates were sampled throughout the UK and Ireland 
from farms and field trials and by trapping airborne 
spores. Samples were taken from several M1a13 barley 
varieties, mainly Pipkin and two spring varieties, Digger 
and Sherpa (Fig. 2). 
The range of characteristics that can be used to 
classify mildew isolates is limited because the fungus  
cannot be cultured on artificial 
media. Nevertheless, useful 
variation in virulences on dif- 
ferent barley varieties (Box 1), 
responses to fungicides and 
genetic fingerprints can be ex- 
ploited. The DNA probe that 
was used for fingerprinting 
Va13 isolates hybridizes to 
- repetitive sequences dispersed 
throughout the E. graminis 
f. sp. hordei genome, and can 
therefore be used to determine 
whether a group of isolates be-
longs to a single clone 4 . Two clones predominated 
among Va13 isolates. The more common of the two 
was found over a range of 650 km, while the other 
was isolated in three counties, over a range of 
400 km. A third clone was comparatively rare, but 
was found in three places over 250 km. Several 
isolates with unique genotypes were also identified 
(Fig. 2). It was concluded that the breakdown of the 
M1a13 resistance had largely been caused by the two 
common clones of F. graminis f. sp. hordei. 
Single clones have caused the breakdown of two 
other mildew resistances and the partial loss of effec-
tiveness of a fungicide. The variety Triumph, which was 
introduced in 1980, carried an effective resistance gene, 
M1(Ab), as well as an ineffective one, M1a7 (Fig. 1). A 
survey in 1985 indicated that M1(Ab) had been over-
come by just one clone of the mildew pathogen. In 
the 1980s in north-east Scotland, morpholine-type 
fungicides were used to control mildew on a susceptible 
variety, Golden Promise. Mildew isolates with particu-
larly low sensitivity to these fungicides were sampled 
from this region in 1988 and 1990, and probably con-
stituted a single clone because they shared an unusual 
set of virulences 7 ' 8 . The most spectacular increase of a 
clone occurred in 1986. Until that year, several im-
portant barley varieties had either M1a7, which was 
often combined with Mik, or MILa. No popular variety 
had carried both M1a7 and MILa. However, in 1986, 
10% of spring barley seed sales were of the variety 
Klaxon, which had M!a7, Mik and MILa, while 1.3% 
were of the variety Doublet (M1a7 and MILa). Until 
1986, these combinations of resistances were effec-
tive, because very few mildew isolates had the com-
bined virulences Va7 and VLa (Box 1). However, in 
1986, the frequency of one clone with this virulence 
combination rose from less than 1% to 36% between 
June and October in random samples of isolates from 
the airborne spore population 9 . 
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Restriction alleviation and modification enhancement by 
the Rac prophage of Escherichia coil K-12 
Gareth King and Noreen E. Murray* 
Institute of Cell and Molecular Biology, University of 
Edinburgh, Darwin Building, Kings Buildings, Edinburgh 
EH9 3JR, UK. 
Summary 
Bacteriophage . encodes an antirestriction function, 
Rai, which is able to modulate the activity of the 
Escherichia coil K-i 2 restriction and modification sys-
tem, EcoKl. Here we report the characterization of an 
analogous function, Lar, expressed by E. coil sbcA 
mutants and the hybrid phage kreverse. E. coil sbcA 
mutants and ?.reverse both express genes of the Rac 
prophage, and we have located the iar gene immedi-
ately downstream of recT in this element. The iar 
gene has been cloned in an expression plasmid, and 
a combination of site-directed mutagenesis and label-
ling of plasmid-encoded proteins has enabled us to 
identify a number of translational products of lar, the 
smallest of which is sufficient for restriction allevi-
ation. Lar, like Rai, is able both to alleviate restriction 
and to enhance modification by EcoKl. Lar, there-
fore, is functionally similar to Rai and the nucleotide 
sequences of their genes share 47% identity, indicat-
ing a common origin. A comparison of the predicted 
amino acid sequences of Lar and Rai shows only a 
25% identity, but a few short regions do align and 
may indicate residues important for structure and/or 
function. 
Introduction 
Bacteriophages use numerous mechanisms to escape 
host-encoded restriction and modification (R-M) systems 
(see Bickle and Kruger, 1993, and references therein). 
The activity of the Escherichia coli K-12 R-M enzyme, 
EcoKI, is modulated by a number of anti-restriction sys-
tems, including the Ocr activity of phages T3 and 17 
(Studier, 1975), and the Ral activity of phage X (Zabeau 
et al., 1980). Ocr has been shown to competitively bind 
EcoKl, and block both restriction and modification of the 
phage (Bandyopadhyay et al., 1985). However, Ral is 
Received 22 December, 1994; revised 20 February, 1995; accepted 
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different; it alters the activity of the restriction complex so 
that unmodified DNA that escapes restriction is efficiently 
methylated (G. King and N. Murray, unpublished). EcoKI 
is a member of the Type IA R-M enzymes, which are the 
only prokaryotic DNA methyltransferases (MTases) shown 
to have a strong preference for hemimethylated DNA in 
vivo, and are also the only systems in which restriction is 
known to be alleviated by Ral (Loenen and Murray, 
1986). One ral homologue, that of phage P22, has been 
sequenced; the predicted amino acid (aa) sequences of 
the two gene products are almost identical (Semerjian et 
al., 1989). E. coIl sbcA hosts (Templin et ai., 1972) and a 
derivative of phage X, designated Xreverse (Xrev; Zissler 
et al., 1971), express a Rai-like activity (Simmon and 
Lederberg, 1972; Toothman, 1981). In sbcA mutants, the 
recE and recTgenes, the general recombination functions 
of a defective lambdoid prophage, Rac, have been acti-
vated (Kushner etal., 1974; Clark et al., 1993; Kolodner 
et al., 1994). ?rev also expresses the recE and recT 
genes (Gottesman et al., 1974) acquired by a recombina-
tion event between X and the excised Rac prophage (Kai-
ser and Murray, 1979). The gene encoding the Ral-like 
activity of the Rac prophage has been termed Jar (Tooth-
man, 1981). 
The Type IA R-M systems are encoded by three genes: 
hsdR, hsdM, and hsdS. The HsdM and HsdS subunits 
together form a MTase that methylates two adenine resi-
dues in complementary strands of a bipartite DNA recog-
nition sequence. In the presence of the HsdR subunit the 
complex can also act as an endonuclease, binding to the 
same target sequence but cuffing the DNA some distance 
from this site. Whether the DNA is cut or modified depends 
on the methylation state of the target sequence. When the 
target site is unmodified, the DNA is cut. When the target 
site is hemimethylated, that is when only one adenine resi-
due in the target is methylated, the complex acts as a main-
tenance MTase modifying the DNA so that both strands 
become methylated. This maintenance MTase activity 
ensures that the pattern of DNA methylation is preserved 
after replication. The enzyme recognizes a completely 
modified target sequence, but dissociates from the DNA 
(Suri etal., 1984; Dryden etal., 1993; Powell et al., 1993). 
Experiments dependent on expression of ral from a 
multicopy plasmid suggest that Ral alleviates restriction 
by changing the activity of EcoKI from a maintenance 
Mlase to a de novo MTase, which efficiently methylates 
( 1995 Blackwell Science Lid 
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unmodified DNA (Loenen and Murray, 1986). The efficient 
methylation of unmodified DNA is also observed with Ral 
and the EcoKl MTase alone, and mutations have been iso-






al., 1991). We are interested in the molecular mechanisms 
of these activities, and in defining important domains or 
residues within Ral and EcoKi. 
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Fig. 1. Localization of the region encoding lar. 
Origin of ?rev, XNM891 and the Rac prophage integrated in the chromosome of the E. co/i strain C600 and an sbcA mutant (sbcA8: 
JC541 2). The DNA common to Xrev and the sbcA8 mutant is contained in i.NM891. 
The 7.6 kb HindlIl fragment from kNM891 was cloned in pUC18 (Yanisch-Perron etal., 1985) to generate pGK7. Segments of this 7.6 kb 
Hindill fragment were cloned and screened for restriction-alleviation activity. The BamHl fragment was cloned in pUC18 to generate pGK8. 
The C/a l-EcoRl fragment was excised from pGK8, converted to a blunt-ended fragment using Klenow polymerase, and ligated to pUC1 8 cut 
with Smal, to generate pGK9. pGK10 was similarly made with the 500 bp XhoI-EcoRI fragment from pGK9. Thick line, E. coil chromosome; 
thin line, pUC1 8 DNA; open box, Rac DNA; PB', hybrid Rac attachment site: open triangles, Hindi[] target sites: p1, /acUV5 promoter in 
pUC18: DNA sequence numbering as Clark etal. (1993). 
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= 	 Fig. 2. Schematic showing the open reading 
° 	 frames within the 500bp ClaI—Xhol DNA 
UJ ' 	
'°iac 	 fragment cloned in pGK10. Predicted length 
pGK10 	 orfH 	 orfG 	 recl'l I of gene products; OrfG, 77aa; OrfH, 66 a 
/ 	 (truncated); FroR, 39aa; FroS, 40aa. Brackets 
indicate restriction sites in the Rac prophage 
I 	 /1 	
lost during cloning. 
froS 	 froR 
responsible for Ral-like activity in E. co/i sbcA hosts and 
),rev (Toothman, 1981). We have cloned lar and used 
an expression plasmid to identify its gene product. A 
comparison of the predicted aa sequences of Ral and 
Lar has highlighted a number of common motifs. 
Results 
Identification of the region encoding lar 
To identify the region of the Rac prophage that encodes 
jar, a 7.6kb HindlIl fragment from XNM891 (Kaiser and 
Murray, 1979) that includes DNA common to the E. co/i 
sbcA8 mutant and Xrev was cloned in pUC1 8 to generate 
pGK7 (Fig. 1). An EcoKl restriction-proficient strain 
(NM71 0) was transformed with pGK7 and the restriction-
alleviation activity of the plasmid was examined by 
comparing the titre of Xv.0 on this strain versus a non-
restricting strain (NM792). In this screen, a similar titre indi-
cates restriction alleviation. pGK7 alleviated restriction, 
and the Jar gene was further localized by cloning seg-
ments of the 7.6kb Hindlll fragment in pUC18 (Fig. 1; 
see legend for experimental details). The smallest DNA 
fragment that conferred restriction-alleviation activity was 
a 500 bp insert in pGK10. 
The region of the Rac prophage in pGK10 has been 
sequenced (Clark et al., 1993; GenBank Accession Num-
ber L23927) and contains four open reading frames 
(ORFs), orfG and orfH' (truncated) in one orientation, 
and froR and froS in the other (Fig. 2). All of the clones 
that had Lar activity contained a plasmid insert oriented 
such that the lac promoter produces a transcript of orfG. 
In order to examine the orientation dependence of the 
restriction-alleviation phenotype, the 500 bp EcoRl-Hindlll 
fragment from pGK10 was cloned in pUC19, to generate 
Table 1. Orientation dependence of lar activity. 
Host 	 litre ?,.0 
NM794 4.5x101° 
NM777 pUC18 2.4 x 107 
NM777 pGK1 1 2.1 x1010  
NM777 pGK12 3.8 x 1010 
Restriction-alleviation activity was determined for each host by 
measuring the titre of unmodified X phages (.NM325.0) normalized 
against the titre of modified ).. This corrects for variation resulting 
from factors other than restriction (see the Experimental procedures). 
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pGK11, then removed and recloned in pUC18, to gener-
ate pGK12. pGK11 and pGK12, therefore, differ only in 
the orientation of the 500 bp insert relative to the lac pro-
moter. Restriction-alleviation activity was unaffected by 
the orientation of the insert (Table 1), suggesting that 
there is sufficient Jar expression to alleviate restriction even 
when the gene is in the opposite orientation to the lac pro-
moter. In these experiments, transcription was neither 
enhanced nor opposed by activation of the lac promoter. 
Table 2. Modification-enhancement activity oiler. 
Host 	 Eop of progeny phages 
NM526(DE3) pT7-6 	 4.6 10 
NM526(DE3) pGK15 1.0 
A restriction-deficient, modification-proficient strain (NM526) was 
transformed with the plasmid of interest and infected with unmodified 
X phages (NM325.0). After a single round of infection, the degree of 
phage modification was estimated by measuring the efficiency of 
plating (eop) of progeny phages on a restricting strain (Yme!) relative 
to that on a non-restricting derivative (NM526) (see the Experimental 
procedures). 
Identification of the gene encoding lar 
A 290 bp fragment including orfG (nucleotides 3883-4172, 
Clark et al., 1993) was amplified by the polymerase chain 
reaction (PCR) and cloned in p17-6 to generate pGK15. 
This plasmid was found both to alleviate restriction and 
to enhance modification by EcoKl (Tables 2 and 3). orfG 
is the only complete OAF transcribed from the 17 pro-
moter in pGK15, although froR and froS are read in the 
opposite orientation. To test whether orfG encoded Jar, 
an amber codon was generated within orfG which would 
have no effect on the predicted aa sequence of froS. 
Codon 42 of orfG was changed from AAG to TAG. The 
resulting plasmid (pGK16; K42Am) was examined for 
restriction-alleviation activity in both a sup (NM777) and 
supF (Ymel) host (Table 3). Restriction was not alleviated 
in a sup host, but was alleviated in a supF host. The open 
reading frame orfG, therefore, encodes a Ral-like anti-
restriction activity that is almost certainly the Lar activity 
identified by Toothman (1981). 
Localization of the Lar start codon 
Examination of the DNA sequence at the start of Jar 
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Table 3. Restriction-alleviation activity of/ar mutants. 
Host 	 Lar 	 Titre A0 
NM777(DE3) p17-6 3.3 x 107 
NM777(DE3) pGK15 Wild type 4.0 x 1010 
NM777(DE3) pGK16 K42Am 2.5 x 107 
NM777(DE3) pGK17 Mil 3.1 x 10 10 
NM777(DE3) pGK18 MiOl 2.8 x 10 10 
NM777(DE3) pGK19 M141 1.5 x 10 10 
NM777(DE3) pGK20 M1Am 3.6 x 10 10 
NM777(DE3) pGK21 M10Am 2.8 x 10 10 
NM777(DE3) pGK22 M14Am 1.1 x 107 
NM777(DE3) pGK23 M1OAm M141 2.6 x 107 
Ymel(DE3) p17-6 1.7 x 1 
Ymel(DE3) pGK15 Wild type 2.7 x lOb 
Ymel(DE3) pGK16 K42Am 2.2 x 1010 
Ymel(DE3) pGK22 M14Am 2.1 x 107 
Ymel(DE3) pGK23 M1OAm M141 8.9 x 106 
Restriction-alleviation activity was determined for each host by mea-
suring the titre of unmodified ?. phages (XNM325.0) normalized 
against the litre of modified X (see the Experimental procedures). 
identified a number of possible translational start codons. 
The DNA codon ATG encodes the most common trans-
lational initiation codon (see McCarthy and Gualerzi, 
1990, and references therein), and there are three of 
these close to the start of orfG at positions 1, 10, and 14 
(see Fig. 3). To identify which ATG was the translational 
initiation codon, we mutated each ATG codon individually 
to one for isoleucine; the first ATO codon was changed 
to AlA (pGK17) and codons 10 and 14 were changed to 
ATC (pGK18 and pGK19, respectively). We anticipated 
that a mutation to the ATG codon required for translational 
initiation would abolish Lar activity. However, all three 
mutants retained restriction-alleviation activity (Table 3), 
indicating that a single ATG codon was unlikely to be 
wholly responsible for translational initiation. 
To identify the minimum coding sequence required 
for restriction-alleviation activity, each of the three ATG 
codons was mutated to an amber codon. An amber 
codon is recognized as a translational stop' codon in a 
sup host, whereas, in a supF host, a tyrosine residue is 
substituted at this position. An amber mutation in either 
the first (Ml; pGK20) or second (Mb; pGK21) ATG 
codons did not affect activity, but a change to the third 
ATG codon (M14; pGK22) abolished activity, both in a 
sup and supF host. This showed that translation of the 
AAGCTTCAGAGGAATAATTCAGCCTGGCGGTGTACACCGC 3915 
M H R Lar 
CAACTTGAAATATTTTTTIAGAAAAATTIAGATATGAC 3960 
Q L El F F MR K I MR Y 0 	Lar 
Fig. 3. The DNA and predicted aa sequence of the 5 region of Jar. 
The first 6bp in this sequence comprise the Hindlll recognition site, 
introduced by the PCR and used to clone Jar. DNA sequence 
numbering is as in Clark etal. (1993). 
DNA sequence upstream of the second ATG codon was 
not required for restriction alleviation. To ascertain 
whether the third ATG codon could be mutated to one for 
isoleucine (ATC) when no translation occurred upstream 
of the second methionine codon, a double mutant was 
made (M1OAm M141; pGK23). This double mutant is unable 
to alleviate restriction in either a sup or a supF host. To 
further the interpretation of these results, the polypeptides 
produced by each of the /arclones were examined. 
Identification of the lar gene product 
The products of the Iarclones were visualized by the selec-
tive labelling of proteins encoded by genes under the con-
trol of the 17 promoter (Tabor, 1990). Differently sized 
polypeptides were detected depending on both the 
plasmid and the suppressor genotype of the host (Fig. 4, 
a and b). The host strains alone, BL21(DE3)sup or 
BL21 (DE3)supF, produced no labelled protein (data not 
shown), nor did p17-6 in either the sup (lane 1) or supF 
host (data not shown). pGK15 (wild-type lar; lanes 2 and 
5) produced two main products, with estimated molecular 
masses of 8.8 kDa, and 8.3 kDa; the smaller of these is 
the more abundant. 
The proteins produced by the lar mutants were similarly 
examined. In a sup host, pGK16 (K42Am) produced no 
polypeptides of an appropriate size for Lar (lane 4), 
although a number of smaller products were seen, consis-
tent with truncated forms of Lar. In contrast, in a supF host 
(lane 3) both the 8.8 kDa and 8.3 kDa proteins were pro-
duced by pGK1 6. This correlates well with the observed 
phenotype; pGK16 does not alleviate restriction in a sup 
host, but does in a supF host. 
Both pGK18 (MbOl; lane 9) and pGK21 (M1OAm), in a 
sup (lane 10) or supF host (lane 11), produced only the 
8.3 kDa polypeptide, from which we concluded that the 
second ATG (M10) is the initiation codon for the 8.8 kDa 
protein. 
The third ATG codon (M14) is the major translational 
start of lar, encoding the 8.3kDa protein, as this polypep-
tide was not detected in either a sup or a supF host 
when the third ATG codon was mutated to an amber 
codon (M14Am; pGK22; lanes 13 and 14, respectively). 
Nevertheless, pGK19 (M141; lane 12) and pGK23 (M1OAm 
M141; lanes 15 and 16) both produced small quantities of 
the the 8.3kDa protein. The ATC codon in pGK19 and 
pGK23, therefore, appears to be used as a poor trans-
lational start in these mutants. It seemed unlikely that the 
codons between the second and third ATG codons could 
encode the translational start of the 8.3 kDa protein as 
this polypeptide was not visualized in a supF host trans-
formed with pGK22 (M14Am), and yet the 8.8kDa poly-
peptide (starting at M10) was detected (lane 14). 
A 10 kDa polypeptide, specific to the lar clones, can be 
1995 Blackwell Science Ltd, Molecular Microbiology, 16, 769-777 
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Fig. 4. Visualization of the tar gene products. 
Lane 1, BL21(DE3) p17-6 (vector); lane 2, BL21(DE3) pGK15 (wild-type); lane 3, NM793(DE3) pGK16 (K42Am); lane 4, BL21(DE3) pGK16. 
Lane 5, BL21(DE3) pGK15 wild-type); lane 6, BL21(0E3) pGK17 (Mu); lane 7, BL21(DE3) pGK20 (M1 Am); lane 8, NM793(0E3) pGK20; 
lane 9, BL21(DE3) pGK18 (M101); lane 10, BL21(DE3) pGK21 (M1OAm); lane 11, NM793(DE3) pGK21: lane 12, BL21(DE3) pGK19 (M141); 
lane 13, BL21(DE3) pGK22 (M14Am); lane 14, NM793(DE3) pGK22; lane 15, BL21(DE3) pGK23 (M1OAm M141); lane 16, NM793(0E3) 
pGK24. 
A longer exposure of the autoradiograph showing the lOkDa Lar polypeptide in lanes 5-8. 
visualized after longer exposures of the autoradiograph 	8.3 kDa proteins (lane 8) but, in a sup host, this clone 
(Fig. 4c). The initiation codon for this low-abundance poly- only produced the two smaller polypeptides (lane 7). 
peptide must precede the first ATG codon since, in a supF 	pGK17 (Ml I) did not affect the polypeptides produced 
host, pGK20 (M1Am) produced the lOkDa, 8.8kDa and (lane 6). 
Lar MRYDNVIcPCPFCGCPSVTVKAISGYYRAKCNGCESRTGYGG 54 
:1111. 
Ral ............MTTTIDKNQWCGQFK.RCNGCKLQSECMV 37 
SEKEAL ......... ERWNKRTTG .........NNNGGVHV 77 
I: 	II.:: 
KPEEMFPVMEDGKYVDKWAIRTTA1IIARELGKQNNKAA... 66 
Fig. 5. Comparison of the predicted amino acid sequence of Ral 
and Lar (starting at M14) (see text). Gap weight 3.0; length weight 
0.1; lines indicate identity; dots indicate similarity; % similarity, 52%; 
% identity, 25%. 
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Comparisons between the predicted amino acid 
sequences of Rai and Lar 
The minimum aa sequence required for Lar activity starts 
at the methionine encoded by the third ATG codon 
(M14). The predicted aa sequence of this polypeptide 
was compared with that predicted for Ral using the GAP 
Program of the University of Wisconsin Genetics Com-
puter Group (GCG 7.3, 1991; see Fig. 5). The two pro-
teins are much more dissimilar than ?. Ral and P22 Ral 
(Semerjian et al., 1989). A number of regions do align, 
and these may indicate important structural and/or func-
tional roles for residues within the two proteins. 
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Discussion 
We have identified lar, the gene responsible for restriction-
alleviation and modification-enhancement activity of the 
E. co/i Rac prophage. This gene has been sequenced 
previously, although its function was unknown and it was 
termed orfG (Clark et al., 1993). The lar gene, cloned in 
p17-6, can be translated from three initiation codons to pro-
duce polypeptides with estimated molecular masses of 
lOkDa, 8.8kDa and 8.3kDa. pGK21 (M1OAm) alleviates 
restriction in a sup' host and yet only produces the 
8.3kDa protein, demonstrating that this is the only form 
of Lar that is required for activity. We conclude that the 
translational initiation codon for this protein is codon 14 
(ATG). However, when codon 14 is changed to an ATC 
(pGK19 and pGK23) the 8.3kDa polypeptide is still pro-
duced, although, as is apparent from the labelling experi-
ments with pGK19 (M141; Fig. 4B, lane 12), the amount 
of the 8.3 kDa polypeptide is much reduced relative to 
the 8.8 kDa protein. It has been shown that ATC can be 
used to initiate protein synthesis (Romero and Garcia, 
1991) and our results appear to indicate that, in pGK19 
and pGK23, this codon can be used as a poor trans-
lational initiation codon. Restriction was not alleviated by 
pGK23 (M10Am M141), although there may not have 
been sufficient Lar produced in these phenotypic assays 
to alleviate restriction as transcription of the gene encod-
ing T7 polymerase was not induced. The restriction-
alleviation and modification-enhancement assays provided 
clear phenotypes with uninduced, wild-type Jar (pGKl 5). 
It seemed preferable to use these conditions to examine 
Lar activity rather than those in which the cell physiology 
is perturbed by the gross overproduction of Lar, dependent 
upon 17 RNA polymerase. The initiation codon for the 
10 kDa form of Lar appears to be before the first ATG 
codon (Ml), and that for the 8.8 kDa polypeptide is the 
second ATG codon (Ml 0). The 8.3 kDa protein is the most 
abundant, although it is not possible to predict what forms 
would be produced from the Rac prophage and whether 
the different forms have any biological significance. 
The Rac prophage includes genes that can serve the 
same functions as the early genes of phage ?, including 
integration, recombination, immunity and replication (Low, 
1973; Gottesman et al., 1974; Diaz et al., 1979). The 
recE and recT genes from Rac can substitute for the gen-
eral recombination genes of X, exo and bet, respectively 
(Kushner et al., 1974; Clark et al., 1993). In X, ral is 
upstream of the recombination genes, whereas in the 
Rac prophage, Jar is immediately downstream of recT. 
The ral, exo and bet genes are all transcribed from p1 in 
X and it is logical to expect that they are also cotranscribed 
in Rac. Other genes in this transcriptional unit include 
those required by X for excision (xis) and integration 
(int); analogous functions in the Rac prophage may be  
encoded in the DNA sequence downstream of Jar. Despite 
the rearrangement of gene order in Rac relative to X, the 
DNA sequences of ral and Jar show 47% identity (data 
not shown), suggesting that the two genes have a common 
origin. 
Rai and Lar are both able to alleviate restriction and 
enhance modification by the Type IA R-M systems and 
an examination of their predicted aa sequences may, 
therefore, help identify key residues involved in structure 
and/or function. Cysteine residues are commonly used to 
stabilize the structure of proteins, either forming disul-
phide bridges or associating with divalent metal ions 
(Branden and Tooze, 1991). Lar contains a sequence 
of cysteine residues, Cys—X2 —Cys—X 17 —Cys—X2—Cys, 
that resembles a zinc-binding motif. Rai does not contain 
the same motif but it does contain a symmetrical 
sequence, Cys—X 5—Cys—X2—Cys—X5—Cys, which may 
serve a similar role. When the aa sequences of Rai and 
Lar are compared, a number of regions align. The identi-
ties CNGC and W- -RU may be relevant. The cysteines 
in the sequence CNGC may be of structural relevance, 
whereas the W--RU residues may indicate a region of 
functional importance. The best conservation at the 
nucleotide level is seen in the region encoding W--RU 
(data not shown). Rai is amenable to structural analysis 
by nuclear magnetic resonance, and polypeptide pro-
duced by solid-phase synthesis (Brown et al., 1993) and 
in vivo from the cloned gene (G. King and N. Murray, 
unpublished) will be used for this purpose. Given the struc-
ture of Rai, the motifs identified here should help us to 
further distinguish important residues and define targets 
for site-directed mutagenesis. 
Experimental procedures 
Strains, phages, and microbiological methods 
Bacterial strains and phages are described in Table 4. Media 
and general methods have been described previously (Murray 
etal., 1977). NM71 0 was used as the host for the preparation 
of K-modified lysates (X.K), and NM679 was used as the host 
for unmodified lysates (X.0). Bacteria were made lysogenic for 
A.DE3 by a co-infection with 2NM75, to provide Int in trans, and 
lysogens with the immunity of phage 21 were selected by plat-
ing on L-agar seeded with ?Jmm 21 c/(?.NM507) and a deriva-
tive with the host range of 4)80 (NM508). 
NM793(DE3) was made by a series of P1 transductions. An 
efficient donor of supF, tagged with a closely linked trans-
poson, was generated by the P1-mediated transfer of 
tipC::TnlO from a sup° strain (W3110trpC::Tn10) to the 
supF strain, Ymel. Tetracycline-resistant transductants of 
Ymel were selected on L-agar supplemented with 10igmI 1 
tetracycline, and screened for the retention of supF by 
their ability to suppress XSam7 (XNM123) but not XPam3 
(XNM435). Phage P1 grown on this host (NM787) was used 
to transduce BL21(DE3). Tetracycline-resistant transductants 
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Table 4. Strains and phages 
Strai n/Phagea Relevant features Source 
E. co/i K-i 2 derivative 
NW2 A(mrr-hsd-mcrB) Woodcock et al. 
(1989) 
GAG 12081 zcj3O61::Tn 1Ofnr5Ol Singer et al. 
(1989) 
W3110 sup' C. Yanofsky 
W3110tipC::TnlO t,pC::TnlO C. Yanofsky 
NM679 W31 1 0L(mrr-hsd-mcr) See text 
NM777b W31 10/ar See text 
NM794 NM777hsdRA4 See text 
LE451 C600recAsrl::Tn1OLs(rac) Diaz et al. (1979) 
NM710 C600sr!::Tn1O\(rac) See text 
NM792 NM710hsdR4 See text 
Ymeib supF Lab. collection 
NM526b Ymel hsdRM See text 
NM787 Ymel tipC::Tn 10 See text 
E. co/i B derivative 
BL21 b 	 sup0 hsdS 	 Studier and Moffat 
(1986) 
NM793b 	 BL21 supF 	 See text 
Phage 
Plkc Lennox (1955) 
DE3 ?jnt::/ac//acUV5- Studier and Moffat 
T7gene 1/mm 21 (1986) 
NM22 ?Nam7Nam53cl26 Lab. collection 
NM75 Xb2red3imm X Lab. collection 
NM123 XcI857Sam7 Lab. collection 
NM243 ?vir Lab. collection 
NM325 t.bio232t(int-ra1)imm 4 c I Lab. collection 
NM435 XPam3c 126 Lab. collection 
NM507 Xb2imm 21cl Lab. collection 
NM508 Xh 80imm 21cl Lab. collection 
NM891 XrecE Kaiser and Murray 
(1979) 
NM numbers refer to stock numbers in this laboratory. 
Lysogenic for XDE3, where appropriate. 
were selected for as before and screened for the presence of 
supF by their ability to suppress A.Nam7Nam53 (2,NM22), a 
phage chosen to avoid complications of complementation by 
the resident 1mm 21 prophage. Phage P1 was grown on the 
trpC host and used to regenerate a prototrophic strain 
(NM793). These were selected on M9-minimal agar and 
screened for the presence of the supressor mutation as 
described above. 
The lar and hsd deletion derivatives of W3110 were 
also made by P1 transduction. The former (NM777) 
using CAG12081 (Singer et al., 1989) as the donor of 
fnr501(Lfnr-lar), and the latter (NM679) by first introducing 
the temperature-sensitive lethal mutation dnaC325 by 
cotransduction with zjj::Tn 10. dnaC recombinants were 
selected following transduction with a P1 lysate made on the 
hsd deletion strain, NW2 (Woodcock et al., 1989). Transduc-
tants selected at 42°C were screened for Hsd, McrB and 
tetracycline sensitivity. 
The hsdRA4 derivatives of Ymel (NM526), NM71 0 (NM792) 
and NM777 (NM794) were made by transferring hsdRM from 
a Xhsd phage to the bacterial chromosome (Gough and 
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Murray, 1983). NM71 0 is a recA derivative of the rac deletion 
strain LE451 (Diaz et al., 1979), made by transferring the 
recA allele from a XrecA phage to the host chromosome. 
Restriction-alleviation tests 
Bacteria transformed with plasmids were grown at 37°C until 
mid-Jog phase, in L-broth supplemented with 10mM MgSO4 
and 100igml 1 ampicillin. Samples (0.2m1) were infected 
with appropriate dilutions of ANM325.0 or ?NM325.K for 
15 mm, and plated in top layer on BBL-agar to assay infective 
centres. Plaques were counted after overnight incubation and 
the titre of XNM325.0 was normalized against the titre of 
?.NM325.K. 
Modification-enhancement tests 
Bacteria transformed with plasmids were grown as outlined 
above. Samples (0.2 ml) were infected with ANM325.0 at a 
multiplicity of infection of 0.1, and incubated for 15min to 
allow adsorption of phages. The infected cells were har -
vested and resuspended in lOmI of L-broth supplemented 
with 100llgml 1 ampicillmn. Cultures were incubated with 
aeration at 37°C for 70min to allow a single round of infec-
tion, and the proportion of modified progeny phage was esti-
mated from the titre on NM777 relative to that on a 
restriction-deficient derivative (NM794). XNM325.K was 
used as a control to ensure that the plating efficiencies of 
the indicator bacteria were comparable. 
Plasmids, DNA manipulation and sequencing 
Preparation, cloning and analysis of DNA was carried out 
essentially as described by Midgley and Murray (1985). Com-
petent bacteria were prepared by electroporation (Heery and 
Dunican, 1989) and small-scale DNA isolation performed by 
the method of He et al. (1990). Details of the construction of 
plasmids used to localize restriction-alleviation activity are 
given in the legend to Fig. 1. The PCR, and site-directed 
mutagenesis using the PCR, were performed as described 
by Higuchi. (1990), with a concentration of 50 p dNTP5, 
and 0.2 1.tM primers. DNA fragments generated by the PCR 
were cloned in p17-6 (Tabor, 1990), which does not have a 
ribosome-binding site upstream of the polylmnker and there-
fore relies on sequences cloned downstream of the T7 promo-
ter to initiate translation. Template DNA used in the PCR was 
XNM891 unless otherwise stated. The oligonucleotide primers 
used to generate the insert in pGK15, and flanking primers 
used for site-directed mutagenesis, are 5'-GGAAGCTTCA-
GAGGAATAAUCAG and 5'-GGGAAUClTCClTTTCAA-
TAGTGG. Complementary pairs of primers were used to 
generate mutations and only one primer of each pair is 
described. The primers used to generate the mutations are; 
pGK16 5'-TACCGAGCGTAGTGTAAC, pGK17 5'-GTGTAA-
TACACCGCCAAC, pGK1 8 5'-l7VATCAGAAAAAlTATGAG, 
pGK1 9 5'-GAAAAAlTATCAGATATGAC, pGK20 5'-GTGTA-
TAGCACCGCCAAC, pGK21 5'-lTrTAGAGAAAAAUAT-
GAG, pGK22 5'-GAAAAAlTrAGAGATATGAC. The -40 
universal primer, 5'-GlTrTCCCAGTCACGAC, was used as 
a flanking primer with pGK1 1 DNA template in the PCR to 
generate the fragment cloned in pGK17 and pGK20; the 
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usual flanking primer annealed too close to the mutagenic 
primer to generate a manageable product. pGK21 was used 
as the template in the PCR to generate the insert in pGK23 
with the mutagenic primers used for pGK1 9, in order to gener-
ate a double mutant. All plasmid inserts generated by the 
PCR were analysed by double-strand DNA sequencing, using 
Sequenase 2.0 (Amersham Life Science). pGK17 and pGK20 
both have an additional mutation (G to A) outside any ORF, 
immediately 5' to the PCR primer. We were unable to isolate 
mutants using these primers without a mutation at this posi-
tion. All other plasmids contain the expected sequence 
(Clark at al., 1993). 
Analysis of polypeptides 
Gene products were visualized by the selective labelling of 
polypeptides encoded by genes under the control of the T7 
promoter, essentially as described by Tabor (1990). 
BL21(DE3) and NM793(DE3) were used as the hosts for 
these experiments and expression of the 17 polymerase 
gene was induced by the addition of 0.6mM IPTG (Studier 
and Moffat, 1986). Samples were denatured and reduced in 
'cracking' buffer (50mM Tris-HCI pH6.8, 2% SIDS, 0.1% 
bromophenol blue, 10% glycerol, 10% 2-mercaptoethanol, 
100 m DTT), the polypeptides separated by Tricine-SDS-
PAGE (Shagger and von Jagow, 1987), and visualized by 
auto radiography. 
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